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SUMMARY 
Malaria is a disease caused by Plasmodium parasites and transmitted by female Anopheles 
mosquitoes. Children under the age of five, pregnant women and none-immune individuals are 
at risk of developing severe malaria such as cerebral malaria (CM), caused only by P. 
falciparum. During Plasmodium infection, the parasite and its products are recognised by 
pattern recognition receptors on myeloid cells and dendritic cells (DCs) in the spleen resulting 
in the secretion of pro and anti- inflammatory cytokines, which can drive the disease to either a 
severe outcome or induce tolerance. 
Among the secreted cytokines are the type I interferons (IFNs), which signal via the 
heterodimeric interferon alpha receptor (Ifnar). In the first part of this thesis we show that type 
I IFN signalling via the receptor on myeloid cells plays a crucial role in the mediation of 
pathology during infection with P. berghei ANKA. Mice that lack the receptor on myeloid 
cells (LysM
Cre
Ifnar1
fl/fl
) had a phenotype comparable to the full (knockout) ko mice (Ifnar1
-/-
). 
Upon PbA-infection, these mice showed a stable blood brain barrier, had very few cells (such 
as CD8
+
 T cells, CD4
+
 T cells NK cells and Ly6C
hi
 inflammatory monocytes) present in their 
brains and low inflammatory mediators in comparison to the wild type (WT) mice and the mice 
that lack the receptor on DCs (CD11c
Cre
Ifnar1
fl/fl
). Although these mice were protected from 
ECM, they were able to recognise endogenous parasite-specific antigen and transgenic antigen 
and to mount a specific cytolytic response in the spleen. Importantly, these effector cytotoxic 
CD8
+
 T cells were retained/arrested in the spleen. In the absence of Ifnar on myeloid cells or 
on all cells, the mice had less Ly6C
hi
 inflammatory monocytes in their spleens.  
Importantly, the protected mice contained a special subset of macrophages showing an 
immune-regulatory phenotype. We found in spleens of PbA-infected Ifnar ko alternatively 
activated macrophages (M2), which expressed YM-1, Relm α / Fizz and Arg-1 and produced IL-
10 and arginase. However, mice that lacked the receptor specifically on myeloid cells 
contained very low amount of these cells in their spleens but they had high levels of IL-10 and 
IL-6, which could have been produced by another form of suppressive/regulatory 
macrophages. We conclude that these cells contributed to creating a suppressive milieu in the 
spleens of the protected mice, resulting in retention of immune cells in the spleen. The change 
in the macrophage phenotype to a suppressive/immunoregulatory phenotype occurred without 
altering the Th-1 response.  
In the second part of this thesis we analysed the changes in the immune response after infection 
with elevated parasite dose, which resulted in protection from ECM, thereby mimicking 
malaria tolerance experimentally. This was mediated by complete blockage of IFNγ production 
and partial suppression of the Th1 response. Also the high parasite dose resulted in suppression 
of the expression of MHC class II on Ly6C
hi
 inflammatory monocytes. Using mice that are 
genetically deficient of IL-10 on myeloid cells, we showed that the IL-10 production by 
myeloid cells had a crucial role in the protection of mice from ECM in this malaria tolerance 
model. In conclusion; our results showed that during infection with Plasmodium berghei 
ANKA, type I IFN inflammatory signalling and production of IL-10 by myeloid cells, mostly 
macrophages and monocytes, are crucial in driving the disease to either the severe outcome that 
is observed in C57BL/6 or tolerance that is observed in the high dose infected mice. 
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ZUSAMMENFASSUNG 
Malaria ist eine Krankheit, die durch eine Infektion mit Parasiten der Gattung Plasmodium 
entsteht und durch weibliche Anopheles Mücken übertragen wird. Besonders Kinder unter 5 
Jahren, schwangere Frauen und nicht-immune Reisende haben ein hohes Risiko, eine schwere 
Malaria zu entwickeln, wie zum Beispiel zerebrale Malaria (ZM), die nur durch P. falciparum 
verursacht wird. Während einer Plasmodium-Infektion wird der Parasit selbst und von ihm 
ausgeschiedene Produkte in der Milz durch sogenannte Mustererkennungsrezeptoren auf 
myeloiden und dendritischen Zellen (DZs) erkannt und lösen in diesen Zellen die 
Ausscheidung von verschiedenen pro- und anti-entzündlichen Mediatoren aus, die entweder 
eine schwere Verlaufsform der Krankheit begünstigen oder Immuntoleranz induzieren können. 
Unter den freigesetzten Zytokinen befinden sich Typ I Interferone (IFNs), die an den 
heterodimeren Interferon alpha Rezeptor (Ifnar) binden und weitere Schritte der Immunantwort 
induzieren. Im ersten Teil dieser Arbeit konnten wir zeigen, dass die Typ I IFN Signalkaskade 
über den Rezeptor auf myeloiden Zellen eine wichtige Rolle in der Pathologie einer P. berghei 
ANKA-Infektion (PbA) spielt, die ein akzeptiertes Mausmodell für die Entstehung von ZM im 
Menschen darstellt (experimentelle ZM (EZM)). Mäuse, denen der IFN alpha Rezeptor auf 
myeloiden Zellen fehlt (LysM
Cre
Ifnar1
fl/fl
), zeigen einen ähnlichen Krankheitsverlauf wie Tiere, 
denen der Rezeptor auf allen Zellen fehlt (Ifnar1
-/-
). Nach einer PbA-Infektion zeigten diese 
Tiere im Vergleich zu Wildtyp (WT) Mäusen und Mäusen, denen der Rezeptor auf 
Dendritischen Zellen fehlt (CD11c
Cre
Ifnar1
fl/fl
), eine intakte Blut-Hirn-Schranke und geringe 
Mengen an periphere Immunzellen (wie etwa CD8
+
 T Zellen, CD4
+
 T Zellen, NK Zellen und 
Ly6C
hi
 inflammatorische Monozyten) und Entzündungsmarkern im Gehirn. Trotz ihres 
Schutzes vor EZM konnte in LysM
Cre
Ifnar1
fl/fl
 Mäusen endogenes parasiten-spezifisches und 
transgenes Antigen erkannt werden und eine spezifische zytolytische Immunantwort in der 
Milz gebildet werden. Interessanterweise verblieben die zytotoxischen CD8
+
 T Zellen aber in 
der Milz und migrierten nicht ins Gehirn der Tiere. Milzen aus Mäusen,  denen Ifnar auf 
myeloiden oder auf allen Zellen fehlte, hatten allerdings eine geringere Anzahl an Ly6C
hi
 
inflammatorischen Monozyten. Von besonderer Bedeutung war, dass in geschützten genetisch 
defizienten (ko) Mäusen ein besonderer Untertyp von Makrophagen gefunden wurde, der für 
seine regulatorischen Eigenschaften bekannt ist. Wir konnten in Milzen der PbA-infizierten 
Ifnar1
-/-
 Mäuse sogenannte alternativ aktivierte Makrophagen (M2) nachweisen, die YM-1, 
Relm α / Fizz und Arg-1 exprimierten und außerdem IL-10 und Arginase produzierten. 
Allerdings konnten wir diese Zellen in LysM
Cre
Ifnar1
fl/fl
 Mäusen nur in geringer Anzahl finden, 
konnten dafür aber dort erhöhte Mengen an IL-10 und IL-6 nachweisen, die auch von anderen 
supprimierenden / regulierenden Makrophagen sekretiert werden können. Aus diesen 
Ergebnissen schließen wir, dass diese Zellen ein regulatorisches Milieu begünstigen, welches 
zum Verbleib der Immunzellen in der Milz führt. Die Th-1 Antwort nach PbA-Infektion wurde 
allerdings durch die Änderungen des Phänotyps der Makrophagen in eine supprimierende / 
regulierende Art nicht beeinflusst.  
Im zweiten Teil dieser Arbeit untersuchten wir die Änderungen in der Immunantwort nach 
einer Infektion mit einer höheren Dosis an Parasiten, die zum Schutz vor EZM in WT Mäusen 
führte, was einer experimentell induzierten Malariatoleranz entspricht. Diese Toleranz konnte 
auf die vollständige Verhinderung der IFNγ-Produktion und eine Reduzierung der Th-1 
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Antwort zurückgeführt werden. Die höhere Parasiten-Dosis resultierte außerdem in einer 
reduzierten Expression von MHC Klasse II Molekülen auf inflammatorischen Monozyten. 
Mithilfen von Mäusen, deren myeloide Zellen kein IL-10 produzieren, konnten wir zeigen, 
dass IL-10 aus diesen Zellen eine entscheidende Rolle in diesem Malria-Toleranz-Modell 
zukommt. Zusammenfassend zeigen unsere Daten, dass die Signalwirkung von Typ IFN I 
sowie die Produktion von IL-10 durch myeloide Zellen (hauptsächlich Makrophagen und 
Monozyten) entscheidend sind, um den Krankheitsverlauf zu beeinflussen: entweder in 
Richtung einer schwerwiegenden Verlaufsform in PbA-infizierten WT Mäusen (normale 
Dosis) oder in Richtung einer Toleranzentwicklung nach Infektion mit einer erhöhten 
Parasitendosis.  
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1 Introduction 
1.1 Health burden caused by infection with Plasmodium parasite 
Malaria is still one of the most important tropical infectious diseases of humans, infecting 
nearly 10% of the world population and causing one to two millions deaths, mostly of children, 
every year. The greatest burden of Malaria is borne by the poor and developing countries, 
mainly in sub-Saharan Africa. According to WHO report, in 2015, malaria transmission 
occurred in 95 countries, with 88% of the cases and 90% deaths occurring in Sub-Saharan 
African (WHO fact sheet 2016). This burden has a negative impact on the economy and social-
economy of the region, as considerable amount of working days are lost due to the disease. 
Children under the age of 5 are the most affected in populations living in the areas of high 
transmission, with 70% of disease and death affecting this age group (WHO fact sheet 2016).  
Malaria is a vector-borne disease caused by infection with various species of the protozoa 
Plasmodium that are transmitted to the human host by the female Anopheles mosquito. Five 
different Plasmodium species - of which P. falciparum is the most virulent and prevalent – 
cause disease in humans. Serious pathological complications such as severe malarial anemia, 
metabolic acidosis and cerebral malaria (CM) represent life-threatening risks of infection. CM 
is multi-factorial and a complex syndrome. It is assumed that CM is a consequence of immune-
mediated pathology due to overwhelming inflammatory processes. 
1.2 Life cycle of Plasmodium parasites 
Plasmodium parasites are obligate intracellular blood protozoans of the phylum Apicomplexa, 
transmitted to vertebrates by infective bite of the female Anopheles mosquitoes. Four of the 
species infecting man are human pathogens, P. falciparum, P. vivax, P. ovale and P. malariae, 
while the natural host of P. knowlesi is the macaque monkey of Southeast Asia. Infection with 
P. falciparum results in the most severe and life threatening forms of malaria disease.  
The malaria parasites require two hosts to complete their life cycle, a vertebrate for the asexual 
and an arthropod vector for the sexual stages. The female anopheles mosquitoes are the only 
vectors for the malaria parasite. When the female Anopheles takes a blood meal from an 
infected host, it can pick up gametocytes. The gametocytes exflagellate and develop into macro 
and microgametes, which fertilize and develop into an ookinetes (White 2014). The ookinetes 
migrate into the gut of the mosquito and form oocysts, which develop and burst to produce 
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thousands of sporozoites into the haemolymph (White 2014). The sporozoites will reach the 
salivary gland of the mosquito, where they develop into mature forms. These will be injected 
into the vertebrate during the mosquito’s next blood meal, depending on Plasmodium species 
and temperatures this part of the cycle lasts 10-35 days (White 2014). During its next blood 
meal, the infected mosquito will inject and deposit sporozoites, which will actively invade the 
blood vessels, and of these only 70% manage to enter the blood circulation (Amino et al. 
2006). Once in the blood vessels, the sporozoites will be transported to the liver to invade the 
hepatocytes. Here, the next developmental step called exo-erythrocytic schizogony occurs and 
results in release of mature merozoites into the blood stream upon bursting of the hepatocytes. 
Depending on the on the Plasmodium species, this takes in P. falciparum up to 5.5 days while 
this step in P. malariae lasts 15 days (White 2014). However, in some cases P. ovale and P. 
vivax can acquire an inert status known as hypnozoites, and reactivate at an unknown time to 
cause disease (White 2014). Once the merozoites burst out of the liver into the blood stream, 
they infect red blood cells (RBC) and begin the erythrocytic schizogony. The parasites will 
nourish on haemoglobin and develop into trophozoites, this will mature into a schizont, which 
contains new merozoites. Fully matured schizont will burst and release the merozoites into the 
blood circulation, repeating the erythrocytic cycle (White 2014). This cycle will be repeated 
several times and after some cycles the trophozoite will develop into gametocytes, which can 
be taken up by the mosquito during its blood meal.   
 
Figure 1 Plasmodium life cycle 
(1) Anopheles injects sporozoites during a blood meal, (2) which infect hepatocytes in the liver and develop into 
merozoites, when mature merozoites will enter the blood circulation (3) and infect red blood cells. After several 
cycles the trophozoites develop into gametocytes, (4) which are taken up by the mosquito during its blood meal. 
(5) In the mosquito the gametocyte mate (sexual stage), resulting in production of sporozoites, (6) which move 
to the salivary gland and are injected into humans during the mosquitoes next blood meal. 
3 
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Adopted from (Winzeler 2008) 
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1.3 Malaria transmission  
Malaria transmission is dependent on several factors, among the important ones are the 
presence of a competent vector, right temperature and humidity and presence of individuals 
harbouring gametocytes. Transmission occurs in areas where the mosquitoes have a long 
lifespan and preferentially feed on humans than other animals, these characteristics makes the 
African vectors competent transmitters (White 2014). Malaria endemic zones are characterized 
as either stable or unstable, in the stable zone they are also characterised depending on parasite 
rates in children between the ages of 2-9 years (White 2014). These zones are divided into 
hypoendemic areas (parasite rates: 0-10%), mesoendemic areas (parasite rates: 10-50%), 
hyperendemic areas (parasite rates: 50- 75%) and holoendemic areas (parasite rates:  ˃75%) 
(White 2014). 
1.4 Complications due to Plasmodium infections 
Patients suffering from malaria present with several symptoms, fever being a classical feature 
of the disease, headache, vomiting, general malaise and flu like symptoms. The disease is 
categorised into two broad groups, uncomplicated and severe complicated malaria.  
1.4.1 Uncomplicated malaria 
Uncomplicated malaria can be caused by any of the species that infect humans and is defined 
by the absence of severe complications in patients who are positive for Plasmodium parasites 
(White et al. 2014). 
1.4.2 Severe malaria 
Severe malaria is caused mainly by P. falciparum parasite and is defined as the presence of 
complications in patients who are positively tested for parasites and other causes for the 
complications can be excluded. These complications can be one or more of the following 
symptoms: Coma, convulsions, acidosis, hypoglycaemia, severe anaemia, pulmonary oedema, 
renal injury, bleeding, shock and hyperparasitemia (Gachot & Ringwald 2014; White et al. 
2014). Although P. vivax and P. knowlesi can in some cases cause severe malaria, the impact is 
not as high as that caused by P. falciparum. The occurrence of severe malaria is multifactorial, 
with sequestration, immunopathology and endothelial dysfunction being some of the key 
factors that are implicated (Cunnington et al. 2013). 
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1.4.2.1  Cerebral malaria (CM) 
CM is the severest outcome of infection with P. falciparum with high risk of mortality. Clinical 
diagnosis is based on peripheral parasitemia accompanied by unarousable coma, neurological 
symptoms without any other alternative cause, with scores of; ˂11 for with Glasgow coma 
scale or ˂3 Blantyre coma score (Gachot & Ringwald 2014). The cause of CM is multi-
factorial, with parasite sequestration in the brain microvascular, inflammatory cytokines, 
activation of the endothelial, blood brain barrier disruption being some of the key factors 
proposed (Cunnington et al. 2013; Storm & Craig 2014).  
1.4.3 Sequestration of parasitized red blood cells  
The expression of the P. falciparum erythrocyte membrane protein 1(PfEMP-1) on the surface 
of infected RBCs (iRBCs) enables the infected cells to attach to the endothelium in order to 
evade the destruction of the parasitized red blood cells in the spleen. PfEMP-1 is encoded by 
the var genes, which are variant surface antigens (Storm & Craig 2014). This adherence of 
iRBCs is termed sequestration and is found in the brains, placenta, lungs and other organs 
during P. falciparum infection (Storm & Craig 2014). PfEMP-1 binds to ligands on the 
endothelial cells like ICAM-1, blocking the capillaries and resulting in hypoxia (Idro et al. 
2010). Presence of sequestering parasites in the brain result in activation of the endothelium, 
leading to inflammatory responses, however, sequestration alone as a cause of cerebral malaria 
has been questioned and host immune response thought to also play a part in CM (Cunnington 
et al. 2013). 
1.5 Immune responses towards Plasmodium parasites 
The immune system is a complex and organised system, whose main aim is to protect the body 
from pathogens. A successful immune system is one that is able to recognise harmful agents 
and defend the body accordingly. Pathogens, toxins, cancer cells and allergens are some of the 
triggers for an immune response. The first line of defence is made up of physical and chemical 
barriers. Once pathogens have successfully penetrated these barriers, the second line of defence 
is the innate immunity, which is comprised mainly of phagocytic cells and those which are able 
to respond rapidly to the pathogens due to pattern recognition receptors. This does not require 
previous knowledge of the invading organism and hence the response is almost immediate. The 
innate system will try and control the infection until the adoptive immunity is activated. The 
adoptive immunity is very specific and is also the source of immune memory, for initiating a 
faster response in case of re-infection. The innate and adoptive immune responses are carried 
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out by leukocytes and products of the leukocytes. Leukocytes originate from the bone marrow 
from the pluripotent hematopoietic stem cell and develop into lymphocytes or myeloid cells. 
The myeloid cells develop from the common myeloid progenitor, these are the macrophages, 
monocytes, dendritic cells, neutrophils, eosinophils, basophils and mast cells. The lymphocytes 
develop from the common lymphoid progenitor into: natural killer cells, B- lymphocytes or T-
lymphocytes (Murphy et al. 2012) and allow the specific elimination of pathogens. 
1.5.1 The spleen in malaria 
Once the malaria- causing Plasmodium parasites have successfully managed to evade the 
immune response in the liver, the parasites reach by taking up residence in the erythrocytes the 
next step of their life cycle: the so-called blood stage marks the entry into a systemic infection 
and involves mainly the spleen. Located on the upper left side of the abdomen, the spleen is 
important for the removal of senescent red blood cells, recycling of haem, clearing blood-borne 
pathogens and the initiation of immune response against blood pathogens (Murphy et al. 2012). 
Structurally the spleen has a unique architecture, it is made up of the white pulp, which is 
separated from the red pulp by the marginal zone. The red pulp is mostly composed of red pulp 
macrophages (RPM), which have a role in the filtration of the blood to remove pathogens, as 
well aged RBCs for iron recycling (Mebius & Kraal 2005; Davies et al. 2013). The marginal 
zone separates the white pulp from the red pulp, and it is composed of specialized cells such as 
marginal zone macrophages, marginal metallophillic macrophages, marginal zone B cells, 
immature DCs and few T cell (Mebius & Kraal 2005).  The white pulp has an inner layer, 
which is populated with T cells and an outer layer with B cells. Immature DCs and B cells in 
the marginal zone filter for blood pathogens and antigens, after which they migrate to the T cell 
zone, where they present Ag to the T cells and initiate the adoptive immunity (Mebius & Kraal 
2005). Since Plasmodium parasites infect the red blood cells, the spleen is therefore the most 
important organ in the immune response against these parasites. During the process of blood 
filtration and haem recycling, the red pulp macrophages are among the early immune cells to 
interact with the parasite (Yadava et al. 1996).  
1.5.2 Recognition of Plasmodium parasite by pattern recognition receptors (PRRs) 
PRRs on the surface, cytosol and endosome of innate cells recognise antigen, resulting in 
signalling via the recognition pathways, leading to the production of cytokines, chemokines 
and other signals. When blood flows into the spleen loaded with infected red blood cells 
(iRBCs), pathogen associated molecular patterns (PAMPs), parasites ligands are sensed by the 
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(PRR) being expressed on the surface of macrophage and DCs, majorly in the spleen 
(Gazzinelli et al. 2014). TLRs are key sensors in malaria, since in P. berghei ANKA infection, a 
well-established and accepted experimental model of CM (ECM) - using genetically deficient 
mice, Coban et al. demonstrated the role of TLR2 and TLR9 involvement in the pathogenesis 
of ECM via TLR-MYD88 pathway (Coban et al. 2007). Plasmodium-derived gylycosyl-
phosylphatidylinositol (GPI) is sensed by TLR1/TLR2 or TLR2/TLR6 on macrophages and 
dendritic cells, resulting in production of pro-inflammatory cytokines TNF, IL-1β, IL-12 and 
nitric oxide (NO) (Schofield & Hackett 1993; Schofield & Grau 2005; Zhu et al. 2011).  
Hemozoin crystals are a by-product occurring during the degradation of haemoglobin by the 
parasite and are recognised –in a complex coupled with parasitic DNA -by the endosomal 
TLR-9 and NOD-like receptors NLRP3 and NLRP12 in the cytoplasm (Parroche et al. 2007; 
Gazzinelli et al. 2014). The Plasmodium AT-rich genome is recognised by an unknown 
cytosolic sensor and signals via stimulator of IFN genes (STING) –IRF3-IRF7 pathway, 
inducing the production of type I IFN (Sharma et al. 2011).  
Haem, microvesicals and urate crystals are recognized as danger associates molecular patterns 
(DAMPs); haem is sensed by TLR4, while urate and microvesicals are sensed by cytosolic 
sensors (Gazzinelli et al. 2014). These sensing pathways results in production of massive 
amounts of type I IFNs, IL-1β and other cytokines, in order to eliminate the infection, thus 
intended to be beneficial, but harbour the risk of overwhelming inflammation, therefore may 
also be detrimental. 
1.6 Studying immune responses leading to CM with the help of experimental 
models: experimental cerebral malaria (ECM) 
To enable an effective study of the basis of cerebral malaria, animal models are valuable and 
necessary due to ethical limitations in infected humans. There is plenty of valuable information 
that has been learnt from these models, even if ECM differs in some aspects from human CM. 
In a review by Hunt and Grau, comparing similarities in cerebral malaria between human and 
mouse, several outcomes were found to be comparable: presence of neurological symptoms, 
inflammatory changes in the brain of infected individuals, increased expression of pro-
inflammatory cytokines and some changes of biochemical and metabolic markers (Hunt & 
Grau 2003). There are some factors that are still under investigations, for example, whether 
leukocytes play a role in hCM or whether parasite sequestration in the mouse model is as 
important as in humans (Hunt & Grau 2003). Nevertheless, the short and rapid breeding cycle 
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of the rodent model, and their ability to mimic CM features, makes them suitable for studying 
the immune process and pathology of ECM.  
During ECM, different cells, cytokines and chemokines are involved, which are assumed 
/partically proven to drive the disease to the severe outcome. Next to CD8
+
T cells, which are 
the major effectors of ECM pathology, also DCs, macrophages, NK cells and CD4
+
 T cells 
have been shown to play key roles in driving the disease to the severe outcome (Villegas-
Mendez et al. 2012; Lundie et al. 2008; Hansen et al. 2007; Schumak et al. 2015; Schofield & 
Grau 2005; Piva et al. 2012). 
1.6.1 Antigen-presenting cells in Plasmodium infection 
DCs are the most important APCs, they ingest pathogens and degrade them into peptides, 
which they then present via the MHC molecules to T cells. DCs are largely grouped into two 
groups, plasmacytoid DC (pDC) and conventional DCs (cDC). The cDCs are further 
characterized into CD8α+DCs and CD8αnegDCs. The main role of cDCs is presentation of Ag 
to T cells and priming them, which has been elegantly shown for the infection with P. 
chaubaudi and P. berghei, (Lundie et al. 2008; deWalick et al. 2007; Sponaas et al. 2006), 
while pDCs are the major interferon producers (Murphy et al. 2012:77). 
Although pDCs produced more type I IFNs than cDCs during P.berghei infection, their role in 
ECM was ruled out as their deletion did not protect mice from development of ECM (deWalick 
et al. 2007; Piva et al. 2012). In P. chabaudi infection, both CD8α+DCs and CD8αnegDCs were 
able to present Ag to CD4
+
T cells, as the disease progressed, the CD8αnegDCs became more 
efficient presenters than CD8α+DCs (Sponaas et al. 2006). Not only are DC important in Ag 
presentation during PbA infection, they also induce production of IFNγ by activated CD4+ and 
CD8
+
 T cells (deWalick et al. 2007; Lundie et al. 2008; Sponaas et al. 2006; Piva et al. 2012). 
The key role of CD8α+DCs in pathogenesis of ECM is via the priming of the effectors CD8α+T 
cell (Lundie et al. 2008), the deletion of cDCs in mice resulted high survival and ECM 
protection (deWalick et al. 2007). 
Macrophages originate from the bone marrow as blood monocytes and differentiate in the 
tissue into resident macrophages, depending on the tissue where they are found, they have 
different names (Davies et al. 2013). In the liver, macrophages known as Kupffer cells are 
present, in the brain we find microglia and alveolar macrophages are found in the lungs 
(Davies et al. 2013; Murray & Wynn 2011). In the spleen, diverse subtypes of macrophages are 
named depending on their function or specific localization. The microglia, unlike most 
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macrophages, do not originate from the blood monocytes, but are formed during the early 
embryonic formation from primitive cells (Ginhoux et al. 2010). Macrophages have several 
roles in the induction of specific immune response, since they phagocytise and kill pathogens, 
they recognise pathogens via immune sensing PRR, through which they detected Ag and 
produce chemokines and cytokines, and they are also able to act as antigen presenting cells 
(Franken et al. 2016; Davies et al. 2013; Murray & Wynn 2011).  
Monocytes can be identified as Ly6C
low
CX3CR1
hi
 and Ly6C
hi
CX3CR1
low
, and exist as either 
patrolling or inflammatory monocytes, respectively (Franken et al. 2016; Shi & Pamer 2011). 
The Ly6C
hi
 inflammatory monocytes express the chemokine receptor CCR2 and are recruited 
in a CCR2/CCL2 dependent manner to the site of inflammation (Shi & Pamer 2011). Migration 
and recruitment of monocytes is not limited to CCR2, other receptors CCR1 and CCR5 and 
their ligands CCL3/MIP1, CCL5/Rantes are also found to be involved depending on specific 
diseases (Shi & Pamer 2011).   
During infection, macrophages can be polarized into different phenotypes depending on the 
signals that they receive. In an inflammatory environment and in the presence of inflammatory 
cytokines like IFNγ or inflammatory stimuli like LPS, macrophages acquire a classical 
activated status (Mills et al. 2000; Mulder et al. 2014). In the presence of anti-inflammatory 
Th2 cytokines IL-4 and or IL-13, macrophages acquire an alternative activated phenotype 
(AAM) (Mulder et al. 2014). The classically activated macrophages are also known as M1 
macrophages and AAM are known as M2 macrophages (Mills et al. 2000). M1 are typically 
found in Th1-driven diseases and are characterized by production of pro-inflammatory 
cytokines, such as TNF, IL-12, IL-1β and release nitric oxide (Chávez-Galán et al. 2015; Mills 
et al. 2000; Mulder et al. 2014). M2 macrophages are found in Th2 driven diseases like 
helminth infections and are characterized by production of anti-inflammatory cytokines IL-10, 
TGF-β, expression of Relmα/ Fizz , YM1 and arginase-1 (Mills et al. 2000; Raes et al. 2002; 
Chávez-Galán et al. 2015). M2 macrophages have been further divided into the subclasses 
M2a, M2b, M2c and M2d, the table below (adopted from Rőszer 2015), summaries some of 
the molecules associated with these subsets. 
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Table 1 Alternative activated macrophages subtypes  
 Stimulators Markers expressed Cytokines produced 
M2a IL4, IL13, helminths 
infection 
Arginase-1, YM-1, Fizz, 
CD163, CD206 
IL10, TGF-β 
M2b immune complexes CD86, MHC-II IL-6, IL-1, TNF-α, IL-
10 
M2c IL-10, TGF-β, and 
glucocorticoides 
CD163, CD206 IL-10, TGF-β 
M2d IL-6,  adenosine VEGF-A IL-10, IL-12, TNFα, 
TGF-β 
Adopted with modification from Rőszer et al. 2015). 
In Plasmodium infection, macrophages and monocytes are among the most important cell 
populations. The encounter with the iRBC and parasite Ag in the spleen results in activation of 
several PRR pathways, making them the greatest source of the inflammatory cytokines and 
pro-inflammatory signals (Gazzinelli et al. 2014). As discussed above, TLRs, cytosolic and 
endosomal sensors in macrophages have been shown to recognise the parasite and its derived 
antigens. During ECM, inflammatory monocytes have been shown to infiltrated into the brain 
and to have a crucial role in T cell recruitment into the brain, thereby strongly contributing to 
ECM pathology (Pai et al. 2014; Schumak et al. 2015). The crucial role of monocytes and 
macrophages in ECM was further confirmed by Schumak et al., where early depletion of 
monocytes and macrophages was shown to protect mice from severe disease, in contrast to 
neutrophils (Schumak et al. 2015). Neutrophils belong to the class of granulocytes, as also do 
eosinophils and basophils. Of these, neutrophils constitute the major population with a role in 
infection control, whereas eosinophils and basophils are important in allergy and helminth 
infections (Murphy et al.  2012). As mentioned above, our lab could show that neutrophils do 
not have a role in ECM pathogenesis as their depletion did not protect mice from severe 
disease (Schumak et al. 2015). 
1.6.2 Effector cells and mediators relevant in ECM 
Malaria is generally considered as a Th-1 disease, which has been clearly demonstrated in 
murine PbA infection with detrimental roles of CD8 T cells and interferon gamma. 
1.6.2.1  T cells in Plasmodium infection 
CD8 T cells recognise Ag presented via MHC class I. Upon activation, CD8
+
 T cells 
differentiate into cytotoxic T lymphocytes, which kill their target cells by release of cytotoxic 
effector proteins; granzyme-B, perforin and granulysin (Murphy et al. 2012; 372-377). They 
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also release cytokines IFNγ, TNF and LT-α which helps to further control the infection by 
increasing the expression of MHC class-I and activation of macrophages (Murphy et al. 2012; 
372-377).   
Using murine models, cytotoxic CD8
+
T cells have been shown to be the key mediators of 
pathology in the brain. The role of CD8
+
 T cells in the pathology of ECM was demonstrated 
upon specific depletion of these cells or the use of ko mice which led to protection from ECM 
(Belnoue et al. 2002; Yañez et al. 1996). It was also shown that these brain infiltrating CD8
+
 T 
cells are primed by CD8α+ DCs in the spleen before migrating to the brain (Lundie et al. 2008). 
In the brain, the endothelial cells cross present Ag to these CD8
+
T cells resulting in pathology 
(Howland et al. 2013). Brain-infiltrated CD8
+
 T cells cause pathology by the release of 
cytotoxic granules granzyme B and perforin (Nitcheu et al. 2003; Haque et al. 2011). The 
cytotoxic brain-infiltrated CD8
+
T cells also express CD11c, which is read as an indication of 
cytotoxicity and activation, some of these cells are producers of IFNγ (Tamura et al. 2011; 
Zhao et al. 2014; Haque et al. 2011). Although CD8
+
 T cells are important in the development 
of ECM, it has been demonstrated that their ability to cause pathology is dependent on the 
amount of parasite antigen present in the brain (Baptista et al. 2010; Howland et al. 2013; 
Haque et al. 2011). 
T cell activation is antigen specific and occurs after the T cell receptor on its surface recognises 
antigen displayed as peptide by APC on the MHC molecules. CD4
+
 T cells recognises Ag 
mounted on MHC class II while CD8
+
 T cells recognised peptides mounted on MHC class I 
(Murphy et al. 2012; 148). Depending on the cytokines present CD4
+
 T cells polarize to 
differentiate T-helper (Th) subsets. In the presence of high levels of IL-12, type I IFNs and 
IFNγ, CD4+ T cells polarize to a Th1 phenotype, this is characterised by the expression of 
transcriptional factor T-bet and production of high amounts of IFNγ (Swain et al. 2012). In the 
presence of IL-4, CD4
+
T cells polarizes to a Th-2 phenotype which is characterised by the 
expression of transcriptional factor GATA3 and production of high levels of IL-4, IL-5 and IL-
13 (Swain et al. 2012). Regulatory T cells (T-reg) polarization occurs in the presence of 
cytokines IL-2 and TGFβ, and is characterised by expression of transcriptional factor Foxp3 
and production of high levels of IL-10 (Swain et al. 2012). In the presence of IL-6 and TGFβ, 
CD4
+
T cells are polarized to the Th-17 phenotype, which is characterised by the expression of 
the transcriptional factor RORγt and production of IL-17A, IL-17F and IL-22 (Swain et al. 
2012). In the presence of cytokines IL-6 and IL-21, CD4
+
 T cells are polarized to T-follicular 
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(Tfh) phenotype, and they are characterised by the expression of transcription factor BCL-6 
and production of IL-4 and IL-21(Swain et al. 2012).  
As stated above, ECM is marked by increased production of the pro-inflammatory cytokine 
IFNγ, which is the only member of type II interferons and is produced by lymphoid cells. IFNγ 
signals via the interferon gamma receptor (IFNGR) activating the JAK-STAT pathway 
resulting in the transcription of ISGs (Platanias 2005). IFNγ is produced by NK cells at the 
early stages of in Plasmodium infection and later by CD4
+ 
T cell and CD8
+
 T cells (Gazzinelli 
et al. 2014). Mice lacking the IFNγ gene or the receptor Ifnγr-/- are highly protected from ECM 
(Yañez et al. 1996; Amani et al. 2000). During Plasmodium infection, IFNγ has roles in 
parasite control, activation of macrophages to increase phagocytosis (Stevenson & Riley 2004) 
and trafficking of T cells into the brain (Belnoue et al. 2008) and is one of the key mediators 
involved in ECM pathology. 
During the blood-stage infection, cDCs, particularly CD8
neg 
DCs and CD4
+
DCs were shown to 
be the key cells presenting Ag to CD4
+
 T cells, activating them and inducing production of 
IFNγ (Lundie et al. 2008; deWalick et al. 2007; Sponaas et al. 2006). Depletion of CD4+ T 
cells in early stages of infection or use of knockout mice resulted in protection of mice from 
development of ECM (Yañez et al. 1996; Belnoue et al. 2002). The Th-1 (T bet
+ 
CD4
+
T cell) 
population has been shown to be the CD4
+
 T-cell subset with a key role in driving pathology, 
this was shown using knockout mice lacking T-bet transcriptional factor (Oakley et al. 2013). 
The control of parasite load by CD4
+
 T cell was also shown to be performed mostly by T-
bet
+
CD4
+
 T cell subset (Oakley et al. 2013). The other CD4
+
 T cells subset involved in ECM 
are the natural occurring T-regs, since mice lacking Foxp3
+
CD4
+
CD25
+ 
T cells are protected 
from ECM (Haque et al. 2010; Amante et al. 2007). However, the Th17 subset was shown not 
to have a role in ECM (Ishida et al. 2010).  
NK cells are lymphoid cells that form part of the innate immunity and are not Ag specific, they 
kill the target cells by production of cytotoxic granules granzyme B and perforin, they are also 
producers of interferon gammy (IFNγ) ( Murphy et al. 2012;113). In efforts to analyse the role 
of NK cells in ECM, depletion of these cells by two groups using different antibodies showed 
different results, in one group they showed protection (Hansen et al. 2007) and in another no 
protection (Yañez et al. 1996). Moreover, the Hansen group showed that the role of NK cells in 
ECM was by the recruitment of effector CD8
+
 T cells into the brains in a CXCR3 dependant 
manner (Hansen et al. 2007). 
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1.6.2.2 TNF and chemokine signaling in ECM 
Tumor necrosis factor alpha (TNF) is another strong inflammatory mediating cytokine secreted 
mainly by monocytes, macrophages and T cells, although other cells can also be producers. It 
is important in homeostasis, monocyte/macrophage differentiation, chemo-attraction and 
induction of production of cytokines and chemokines (Sedger & McDermott 2014). TNF has 
been found elevated during severe Plasmodium infection and it is strongly linked with CM and 
other forms of severe malaria, while it is found reduced in mild and asymptomatic malaria 
(Grau et al. 1987; Hunt & Grau 2003; Othoro et al. 1999). However, recent study demonstrated 
the relevance of other members of the TNF superfamily, such as LTα, LTβ rather than TNF 
(Engwerda et al. 2002; Randall et al. 2008). 
CXCR3 is a chemokine receptor that has been strongly associated with ECM development, and 
its role in the migration of effector CD8
+
 T and NK cells into the brain, it is highly expressed 
on CD8
+
 T cells and NK cells that have infiltrated the brain ( Hansen et al. 2007; Van den 
Steen et al. 2008). Its ligands CXCL9 and CXCL10/IP-10 have been found increased in the 
brains of ECM positive mice and knockout mice have some levels of protection (Coban et al. 
2007; Van den Steen et al. 2008; Campanella et al. 2008). Furthermore, CCR5 is important in 
leukocytes trafficking into the brains of mice that develop ECM, receptor ko mice are protected 
up to 80% from ECM, with reduced brain infiltrates (Belnoue et al. 2003; Coban et al. 2007). 
CCR5 has several ligands MIP1α/CCL-3, MIP-1βCCL-4 and RANTES/CCL-5. CCL3 gene 
expression was found up-regulated in ECM positive mice and was suggested to be involved in 
the recruitment of T cells, NK cells and CD11c DCs into the brain (Coban et al. 2007). 
Interestingly, the expression of CCR7 was found to be crucial only on CD8a
+
DC for activation 
of CD8
+
 T cells but was not required for migration of CD8
+
 T cell to the brain (Zhao et al. 
2014). 
1.6.3 Inflammatory and anti-inflammatory cytokines in Plasmodium infection 
The sensing PRR systems on macrophages and DCs trigger the production of several cytokines 
IL-1β, TNF, type I IFNs, IL-6, and IL-12, while NK cells, CD4+ T cells and CD8+ T cell 
produce IFNγ (Gazzinelli et al. 2014). 
1.6.3.1 Type I interferons 
Type I Interferons (IFNs) were first described by their ability to interfere with the spread of 
viruses (Murphy et al. 2012; 111). IFNα, IFNβ, are the main type I IFNs, although there are 
others IFNε, IFNκ and IFNω (McNab et al. 2015). Type I IFNs are produced by cells after 
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recognition of pathogens, PAMP and DAMPs by PRRs (McNab et al. 2015) and although a lot 
of cells can produce type I IFN, pDCs are the strongest producer and are also known as 
interferon-producing cells (Murphy et al. 2012; 111). Recognition of pathogens via TLR3 and 
TLR4 and signalling via adaptor molecule TRIF (TIR- domain-containing adoptor rotein 
inducing IFNβ), or TLR7, TLR8 and TLR9 signalling via adaptor protein MyD88 (Myeloid 
differentiation primary response protein 88), leads to activation of IRF3 and subsequent 
production of IFNα and IFNβ (McNab et al. 2015). Stimulation of cytosolic sensors such as 
NOD2, RIG-I and MDA-5 signalling via adaptor molecule MAVs also results in production of 
type I IFNs (McNab et al. 2015). During Plasmodium infection, recognition of haemozoin, 
parasite RNA, and AT-rich motifs of DNA by PRRs results in the production of type I IFNs 
(Gazzinelli et al. 2014). 
Type I IFNs bind and signal via the heterodimeric receptor, Interferon alpha Receptor 
(IFNaR), located on cell surfaces. On binding of type I IFNs to the receptor, Janus activated 
kinase (JAK) and tyrosine kinase-2 (TYK2) are activated and lead to phosphorylation of Signal 
transducer and activator of transcription (STAT) (Platanias 2005).  
 
Figure 2 Type I IFNs production and signalling. 
The PRRs on the cell surface, endosome and cytosol recognise pathogen, PAMPs and DAMPs and signal via 
their adaptor molecules and bind to either IRF3/7 or STING, which results in production of type I IFNs. These 
Type I IFNs then bind to the receptor IFNAR1/2 and signal via the JAK/STAT pathway, MAPK or P13K resulting 
in production of ISGs. (Adopted from McNab et al. (2015), Nat Rev Immunology. 
The activated and phosphorylated STATs form homodimers STAT1-STAT1, STAT3-STAT3, 
STAT4-STAT4, STAT6-STAT6 or heterodimers STAT1-STAT2, STAT1-STAT3, STAT2-
STAT3 that translocate to the nucleus (Platanias 2005). Binding of type I IFNs to the receptor 
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and signalling via the JAK STAT pathway leads to transcription of Interferon stimulated genes 
(ISG) (Platanias 2005). The most common pathway is the STAT1-STAT2 heterodimers, which 
form together with IRF9 a so-called ISGF3 complex, this binds to Interferon stimulated 
response element (ISRE), leading to production of specific ISGs (Platanias 2005). STAT 
homodimers and other heterodimers bind to interferon gamma activated sites (GAS), resulting 
also in production of ISGs (Hervas-Stubbs et al. 2011). 
Although the JAK-STAT signalling pathway is the classical pathway and mostly used, 
alternative pathways exist, these include the mitogen activated protein kinase (MAPK) 
pathway and NFκB pathway (Hervas-Stubbs et al. 2011). These ISG control cytokine 
production, the upregulation of chemokines and their receptors, they enhance detection of 
pathogens by upregulation of PRRs, they regulate the functions of NK cells, T cells, monocytes 
and macrophages (Hervas-Stubbs et al. 2011; McNab et al. 2015). 
During Plasmodium infection, ISG linked to type I IFNs have been found to be upregulated in 
both blood and liver stages (Aucan et al. 2003; Sharma et al. 2011; Liehl et al. 2014). 
Polymorphisms of the IFNaR due to mutation was shown to protect children from development 
of severe malaria (Aucan et al. 2003). Using mice that are genetically deficient in expression of 
the Ifnar, Ifnar1
-/-
 mice, it was shown that signalling via this receptor had a role in the 
pathogenesis of ECM (Ball et al. 2013; Palomo et al. 2013; Sharma et al. 2011). 
1.6.3.2 Interleukin 10 (IL-10) 
IL-10 is an anti-inflammatory cytokine produced by cells of both innate and adoptive immunity 
(Saraiva & O’Garra 2010). IL-10 is highly produced by macrophages when they polarize to an 
AAM phenotype (Rőszer 2015). Mice lacking IL-10 are prone to developing inflammatory 
bowel syndrome and are also more susceptible to microbial infections (Saraiva & O’Garra 
2010). Parasitic diseases like Leishmania major, Trypanosoma cruzii, Toxoplasma gondii and 
Schistosoma mansonii among others, stimulate production of IL-10 by macrophages and T-regs 
(Couper et al. 2008). Plasmodium infection induces the production of IL-10 by T-regs, 
macrophages and other cells (Couper et al. 2008). Increased level of IL-10 has been found in 
asymptomatic pregnant women and children with mild malaria in Africa (Wilson et al. 2010; 
Othoro et al. 1999; Guiyedi et al. 2015). 
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1.7 Aims and Objectives of the study 
Cerebral malaria is a complex disease, with several interplays between the parasite and the host 
immune system trying to control and to terminate the infection. The first part of the study was 
based on the observation that type I IFN signalling was important in ECM pathology (Aucan et 
al. 2003; Ball et al. 2013; Palomo et al. 2013). However, in those studies they did not show the 
mechanisms that resulted in prevention of the disease or as to whether the lack of the receptor 
impaired the priming and activation of the effector cells. Thus, we addressed here the following 
questions: 
 Was the protection of PbA-infected Ifnar ko due to impaired parasite-specific CTL 
responses? 
 Could we identify a specific cell population that was responsible for transmitting the 
Ifnar signals and /or is also relevant for disease? 
In the second part of this thesis, we worked on a “Malaria tolerance” mouse model that was 
established in our lab. This bases on the observation that mice infected with elevated parasite 
dose were protected from the development of ECM, in IL-10 dependent manner. In this part of 
the study, we addressed the following questions;- 
 Was the tolerance = protection from ECM due to impaired inflammatory /adaptive 
immune response in these mice? 
 Would we be able to localize to a specific cell population that were providing the IL-10 
that was mediating survival? 
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2 Materials and Methods 
2.1 Materials 
2.1.1 Anaesthesia 
Anaesthesia route of admin. Drug Company 
Inhalation Isofluran Abbott (Wiesbaden, Germany) 
Intramuscular  Rompun 2% 
Ketamin 50mg/ml 
Bayer (Leverkusen, Germany) 
Ratiopharm GmbH (Ulm, Germany) 
2.1.2 Buffers 
FACS buffer; PBS supplemented with 1% FCS, stored at 4°C. 
MACS buffer; PBS supplemented with 1% FCS and 2mM EDTA, stored at 4°C. 
2.1.3 Cell culture medium 
For cell culture RPMI 1640 medium was supplemented with 10 % FCS, 1% 
Penicillin/Streptomycin or Gentamicin and 2mM L-Glutamine was used, stored at 4
0
C. 
2.1.4 CFSE stock 
5,6-carboxy-succinimidyl-fluoresceine-ester (CFSE) was dissolved in DMSO to 5mM and 
stored at -20°C. 
2.1.5 FarRed stock 
CellTrace Far Red DDAO-SE (FarRed) was dissolved in DMSO to 1mM and stored in aliquots 
at -20°C. 
Reagents Manufacturer  
Antibiotics; Penicillin, Streptomycin and Gentamicin Lonza, (Wuppertal, Germany) 
CFSE (carboxy-succinimidyl-uoresceine-ester) Invitrogen (Darmstadt, Germamy) 
DMSO (Dimethyl sulfoxide) Merck KGaA (Darmstadt, Germany) 
EDTA (Ethylendiamintetraacetatedehydrate) Roth (Karlsruhe, Germany) 
FarRed (CellTrace Far Red DDAO-SE) Invitrogen (Darmstadt, Germamy) 
FCS (Fetal calf serum) PAA, (Cölbe, Germany) 
L-Glutamine PAA, (Cölbe, Germany) 
PBS (Phosphate-buffered saline) PAA, (Cölbe, Germany) 
RPMI 1640 medium Sigma, (Munich, Germany) 
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2.1.6 Machines 
Machine & Manufacturer Location 
autoMACS® Pro Separator Miltenyi Biotec GmbH Bergisch Gladbach, Germany 
BD FACS Canto. I® BD Biosciences Heidelberg, Germany 
BD FACS Canto. II® BD Biosciences Heidelberg, Germany 
BD LSRFortessa® BD Biosciences BD, San Jose, USA 
CASY® TT Cell Counter, Schaerfe Systems Reutlingen, Germany 
Rotorgene RG-3000®, Corbett Research Qiagen Hilden, Germany 
Spectra Max 340pc384m, Photometer Molecular Devices Sunnyvale, USA 
2.1.7  Analysis software 
FlowJo® TreeStar Software Ashland, USA 
Prism 5 GraphPad Software® (Statistics) La Jolla, USA 
Rotor-Gene 6.1®, Corbett Research Qiagen Hilden, Germany 
SoftMax® Pro 3.0 Pro Molecular Devices Sunnyvale, USA 
2.2 Methods 
2.2.1 Animals 
Six (6) week old female C57BL/6N mice were purchased from Janvier or Charles River. 
Ifnar1
-/-
 , LysM
Cre
Ifnar1
fl/fl
, CD11c
Cre
 Ifnar1
fl/fl
, IL-10
-/-
, LysM
Cre
IL-10
fl/fl
, Irf1
-/-
 and Irf3
-/-
 mice 
were breed in the House of Experimental Therapy (HET), University Hospital Bonn. Mouse 
studies were approved by local regulatory agencies (LandesamtfuerNatur, Umwelt und 
Verbraucherschutz Nordrhein-Westfalen (LANUV NRW) §84-02.04.2012.A264). Water and 
food were provided ad libitum.  
Conditional floxed Ifnar and IL-10 mice were crossed with Cre expressing mice leading to 
deletion of the gene on the cells expressing Cre. Conditional knockout Ifnar
fl/fl
 LysM
Cre
 have 
deletion of the Ifnar on CD11b
+
 populations, resident monocytes CD11b
+
Ly-6C
lo
, 
inflammatory monocytes CD11b
+
Ly-6C
hi 
and granulocytes (Prinz et al. 2008). Conditional 
knockout Ifnar
fl/fl
 CD11c
Cre
 have deletion of the Ifnar on conventional dendritic cells 
(Cervantes-Barragan et al. 2009). Conditional knockout, IL-10
fl/fl 
LysM
Cre
 have deletion of the 
IL-10 on CD11b
+
 populations. 
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2.2.2 Parasites, infection and disease 
Plasmodium berghei transgenic parasite (PbAMA) containing MHC class I restricted epitopes 
from chicken ovalbumin were kindly provided by Dr. Ann Kristin Mueller, University of 
Heidelberg. Plasmodium berghei ANKA expressing OVA parasitized red blood cells (RBC) 
were injected intravenously (i.v). Before infection of the test animals, two animals were first 
injected with parasite stock-stabilates intra-peritoneally, the stock contained 1x10
7 
iRBCs in 
glycerine that had been stored in liquid nitrogen. At d+4 post infection (dpi) blood was 
collected and analysed for parasitemia and RBC count. The iRBCs was calculated and diluted 
to an infective dose of 5x10
4
 iRBC, which was then injected into the study animals. From 
d+5p.i animals were observed for symptoms of ECM using the RMCBS score. 
2.2.3 Determination of ECM related symptoms 
Mice were analysed for symptoms related to ECM using RMCBS score described by (Carroll 
et al. 2010). Ten parameters were analysed and for each a score of two was given. These 
parameters are analysed in three minutes; in the first ninty secs, the mice are assessed for 
hygiene by how the fur was groomed and movements which was assessed by its gait, 
exploration of the cage. In the next ninty seconds the reflexes of the mice and aggression were 
measured. The maximum score for a healthy mouse in twenty, due to ethical consideration and 
as required by the animal grant, animals with a score of five or less were sacrificed. 
2.2.4 Harvesting and preparation of organs 
Mice were anaesthetized, and blood collected either from the orbital-vein or the heart. The 
mice were then perfused intra-cardially with 1x PBS for 5 minutes. Spleens and brains were 
isolated, brains were cut into small pieces, while spleens were first injected with collagenase A 
(Roche (Basel, Switzerland), then cut into small pieces. The organs were then and digested 
with 0.5 mg/ml collagenase A by incubation at 37
°
C for 30 min. The organs were then gently 
pressed through a metal sieve to obtain single cells and washed with MACs buffer at 1500rpm 
for 5 minutes as 4
°
C. 
Spleens; the supernatant was discarded and the cells resuspended in 5ml medium and counted 
using CASY® TT Cell counter, the cells were then adjusted to 1x10
7
 cell per ml. 
Blood; collected blood was kept on ice and centrifuges at 8000rpm for 5 minutes and the serum 
or plasma collected. 
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Brains; To enrich for lymphocytes in the brain, after centrifugation the homogenates were 
resuspended in 5 ml of 30% Percoll (GE Healthcare, Freiburg, Germany), which was carefully 
underlayed with 5 ml of 70 % Percoll. Cells were centrifuged for 25 min at room temperature 
at 2000 rpm without brake. The leucocytes were collected from the interphase of the two 
percoll solution, by aspiration. The cells were then resuspended in 30ml MACs buffer, 
centrifuged at 1500rpm for 5 minutes at 4
°
C and counted using CASY® TT Cell counter. 
2.2.5 Parasitemia determination 
Blood was collected from the tail vein and thin blood smears made. The blood slides were air 
dried and fixed in absolute methanol. Giemsa staining solution was made by mixing 1:20 
Giemsa stock (Merck KGaA (Darmstadt Germany)) and Giemsa buffer pH 7.2. Slides were 
stained for 20 minutes followed by rinsing in tap water for 1 minute, after which they were left 
to airdry. Approximately 800 red blood cells were counted and the infected cells noted, and 
percentage of iRBCs calculated (=(iRBCs/counted RBCs)*100). 
2.2.6 Evans Blue Assay: 
Mice were infected as described above and on d+6p.i injected intravenously with 200µl of 2% 
Evans Blue in 0.95% NaCl. After 1 hour mice were sacrificed and the brains removed, 
photographed and weighed, thereafter they were placed in falcon tubes containing 2 ml 
formamide and incubated for 48 hours at 37°C. Quantification of Evans Blue extravasation was 
done by taking 100µl of the incubated Formamide/brain solution in 96 well plates in triplicates. 
The standard curve was prepared by diluting Evans Blue to 200µg/ml with 0.95% NaCl 
(starting concentration), and diluted 1:2 in duplicates with Formamide. The concentration of 
Evans Blue was measured sprectophotometrically at 620nm. The amount of infiltrated dye was 
calculated as µg Evans Blue/ g brain tissue *2. 
2.2.7 Antibodies for FACS 
Directly conjugated monoclonal antibodies that were used for FACS analysis (anti-mouse 
CD3, CD4, CD8α, CD11b, CD11c, CD19, CD45, CD54, CD206, CCR2, CCR5, CCR7 
CXCR3, FOXP3, F4/80, GATA3, Granzyme B, I-Ab, Ly6C, Ly6G, NK1.1, Relm-α, RORγT, 
Tbet and 1A8) were bought from Biolegend (Fell,Germany), BD Pharmingen (Heidelberg, 
Germany) or eBioscience (Frankfurt, Germany). 
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2.2.8 Flow cytometry 
For analysis by flow cytometry, either 2x10
6
 spleen cells or all cells collected from the brain 
were stained in sterile 1x PBS containing 1% FCS for 20 min on ice. Intracellular staining was 
performed without stimulation using Fix-Perm and Perm Buffer protocol from eBioscience 
(eBioscience, Heidelberg, Germany) according to the manufacturer´s protocol. Acquisition was 
performed on a FACS Canto II® flow cytometer and LSR Fortessa® (BD, San Jose, USA). 
Data were analysed with FlowJo® Software (Treestar Inc., Ashland, USA). 
2.2.9 In vivo cytotoxicity assay and peptide restimulation 
CTL activity in PbAMA infected animals was determined in vivo on day 6 p.i.. In vivo 
cytotoxicity assay was used to measure the ability of CD8
+
 T cells to recognise antigens 
presented on MHC-I by APCs and lyse them. Splenocytes from syngenic donor mice were 
pulsed with 1µM of the specific H-2k
b
 peptide SIINFEKL (Ovalbumin) and MSP1 peptides for 
30 min at 37°C and subsequently with 1µM of CFSE for 15 min (CFSE
high
, specific target 
cells) for SIINFEKL, and 1µM of FarRed for MSP1 peptides. Reference cells were not pulsed 
with peptide and labeled with 0.1µM CFSE for 15 min (CFSE
low
, reference cells). After 
fluorochromelabeling, the cells were washed and the cell number was determined. The cell 
populations were mixed at a 1:1:1 ratio (CFSE
high
/CFSE
low
/FarRed). Each recipient received 
5x10
5 
cells per 50µl of each population mixed with 50µl on NaCl to a final solution 200 µl of 
cells into the tail vein on day 5. Mice were sacrificed 18 hours later on day 6 after infection and 
spleens were isolated and single-cell suspensions prepared as described above. Lysis of 
peptide-loaded cells was quantified by measuring the ratio of CFSE
high
/ CFSE
low
 cells via flow 
cytometry (Canto II, BD Biosciences). The percentage of specific lysis, termed SL8-specific 
lysis, was calculated using the following equation:  
100 - [(CFSE
high
/CFSE
low
)immunized/(CFSE
high
/CFSE
low
)naïve] x 100 and  
100 - [(FarRed/CFSE
low
)immunized/(FarRed
high
/CFSE
low
)naïve] x 100. 
2.2.10 Cytokine ELISA 
Organs from experimental animals were isolated on day 6 p.i. and single cell suspensions were 
prepared as described above. 10
6 
splenocytes or 1.25x10
6
 cells from brain homogenates were 
cultured in triplicates in 200µl RPMI medium over night. The supernatant were analysed for 
cytokines by sandwich ELISA according to the manufacture’s guide. 
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CCL2 R&D (Minneapolis USA) 
CCL3 R&D (Minneapolis USA) 
CCL5 R&D (Minneapolis USA) 
Granzyme-B R&D (Minneapolis USA) 
IFN-γ eBioscience (Frankfurt, Germany) 
IL-4 BD Pharmingen (Heidelberg, Germany) 
IL-6 eBioscience (Frankfurt, Germany) 
IL-10 BD Pharmingen (Heidelberg, Germany) 
TNF eBioscience (Frankfurt, Germany) 
2.2.11 Magnetic beads cell sorting  
Spleen cells 4x10
7
 were taken into sterile falcon tubes, centrifuged at 1500 rpm for 5 min 4
°
C 
and the supernatant discarded. Cells were then re-suspended in 300µl sterile MACS buffer, and 
anti CD11b
+
 or anti CD8
+
 beads added (10µl beads per 10
7
 cells). The cells were then 
incubated for 15 mins at 4
°
C, followed by washing the cells 2x. The cells were then 
resuspended in 5ml MACS buffer, filtered through sterile gaze immediately before separation 
step at the autoMACS. Eluted cells were counted and stained to check purity. 
2.2.12 Real Time PCR 
Whole brain tissues were removed after perfusion and immediately frozen in liquid nitrogen, 
then stored at -80 till further use. MACS sorted cells CD11b
+
 cells were stored in -20 
overnight. The next day the samples were homogenized with 1ml of TRIzol
®
 (Thermo Fisher 
Scientifics, WA, USA) in BashingBeads tubes (Zymo Research, Freiburg, Germany). 
PeqGOLD HP Total RNA Kit was used for purification according to the manufacturer’s 
instructions. Thereafter, on-membrane DNase I digestion (peqGOLD, Erlangen, Germany) was 
performed. For qPCR, TaqMan® RNA-to-Ct™ 1-Step Kit (Life Technologies, Darmstadt, 
Germany) was used with 2 µg total RNA in a reaction volume of 20µl.  
2.2.12.1 Primer sequence 
Gene Primer FWD Reverse 
Brain 18sRNA 5’ ctaacatggctttgacgggta 3’ 5’ ctgctgccttccttagatgtg 3’ 
IL-10 5’ ggttgccaagccttatcgga 3’ 5’acctgctccactgccttgct 3’ 
YM1 5’ gcccttattgagaggagcttta 3’ 5’ tacagcagacaagacatcc 3’ 
Relm 5’ actgctactgggtgtgcttgt 3’ 5’ gggttctccacctcttcatt 3’ 
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iNOS 5’ cagctgggctgtacaaaccctt 3’ 5’ cattggaagtgaagcctttcg 3’ 
TNF 5’ catcttctcaaaattcgagtgacaa 3’ 5’ tgggagtagacaaggtacaaccc 3’ 
Arginase 5’ cctatgtgtcatttgggtgga 3’ 5’ caggagaaaggacacaggttg 3’ 
Beta actin 5’ agagggaaatcgtgcgtgac 3’ 5’ caatagtgatgacctggcggt 3’ 
2.2.12.2 qRT-PCR master mix 
Master-mix were prepared using the dilutions listed below and the samples analysed in 
triplicates. 
 β- actin 18sRNA 
H2O 10.8 µl 10.4 µl 
10x buffer 2 µl 2 µl 
MgCl2 (25 mM) 2.4 µl 1.2 µl 
dNTPs (40 mM) 0.1 µl 0.1 µl 
Forward primer (5 µM) 1.2 µl 2 µl 
Reverse primer (5 µM) 1.2 µl 2 µl 
Sybr green (1:1000) 0.2 µl 0.2 µl 
HSTaq (250 U) 0.1 µl 0.1 µl 
DNA 2 µl 2 µl 
 
 Arg1, IL10 &YM-1 iNOS &Relm-α TNF 
H2O 13.6 13 12.4 
10x buffer 2 2 2 
MgCl2 (25 mM) 0.4 0.8 1.2 
dNTPs (40 mM) 0.1 0.2 0.1 
Forward primer (10 µM) 0.8 0.8 1 
Reverse primer (10 µM) 0.8 0.8 1 
Sybr green (1:1000) 0.2 0.2 0.2 
HSTaq (250 U) 0.1 0.1 0.1 
DNA 2 2 2 
2.2.12.3 Formula for fold change 
Fold change was calculated using the formula below from (Pfaffl 2001), samples were 
normalised to beta actin which was used as the housekeeping gene 
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Fold change =      
(         )          
(               )                 
                  
 CT-target=(C T Naive -CT-PbAMA infected) 
 CT-housekeeping=(C T naive housekeeping -CT-housekeeping PbAMA infected). 
2.2.13 Arginase assay 
Arginase reagents (Abnova, Taiwan) were brought to room temperature and buffers preheated 
to 37°C. MACS sorted CD11b
+
 cells (described above) were counted and 1x10
6
 cells plated 
into 96 well plates and centrifuged at 1000g at 4
°
C for 10 mins. Cells were then lysed for 10 
mins with 100µl of 10mM Tris-HCl pH 7.4 (Sigma-Aldrich, Munich, Germany), containing 1 
µM pepstatinA (Sigma-Aldrich, Munich, Germany), 1µM leuppeptin (Sigma-Aldrich, Munich, 
Germany), and 0.4% (w/v) Triton X-100 (Sigma-Aldrich, Munich, Germany). Lysates were 
centrifuges at 14,000g at 4
0
C for 10 mins. Supernatant was taken and used for arginase assay. 
Analysis for urea quantity was then performed according to manufacturer’s instructions 
(Abnova, Taiwan). The amount of arginase activity was calculated was denoted as units per 
liter of sample (U/L). 
2.2.14 CD11b+ adoptive transfer to LysMCre Ifnar1fl/fl mice 
Twenty WT mice and twenty LysM
Cre
 Ifnar1
fl/fl
 mice were infected with PbA. On d+3p.i ten of 
the PbA-infected WT mice were sacrificed and spleens harvested. CD11b
+
 cells were sorted 
from the spleen cells as described above. These cells were counted and 5x10
6
 cells were 
injected into ten of the PbA infected LysM
Cre
 Ifnar1
fl/fl
 mice, the other ten ko mice were used as 
controls. The Mice were scored from d+5p.i for survival and ECM related symptoms using 
RMCBS score.  
2.2.15 Statistical analysis 
Survival experiments were performed with 10 mice per group and analysed with Log-rank 
(Mantel-Cox) test. Ex vivo analyses experiments were performed with 3-5 mice per group and 
statistical analysis was performed using non-parametrically One-way analysis of variance 
(ANOVA) test with Bonferroni post-test when comparing more than 2 groups. If not otherwise 
stated, mean and standard error of the means are shown. Significant differences are indicated 
by the stars in brackets between the groups (*p<0.05; **p<0.01, ***p<0.001). All statistics 
were performed in GraphPad Prism®. 
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3 RESULTS             
3.1.1 Type I IFN signalling plays a role in the pathogenesis of ECM 
During infection with Plasmodium parasites, infected red blood cells (iRBC), Pathogen 
associated molecular patterns (PAMP) and damage associated molecular patterns (DAMP) 
related to the parasite are recognised by pattern recognition receptors (PRR) on innate cells 
mainly in the spleen. These cells trigger a cascade of immune responses leading to production 
of pro- and anti-inflammatory cytokines. Among the cytokines produced are the type I 
interferons, which bind to the heterodimeric surface cell receptor (interferon alpha/beta 
receptor IFNaR1 and IFNaR2), thereby leading to signalling and production of interferon-
stimulated genes. 
This study bases on the observation that mice deficient of the receptor (Ifnar1
-/-
) were partially 
protected from experimental cerebral malaria (ECM) (our own obserations, Ball et al. 2013; 
Palomo et al. 2013). Since detailed analysis of the adaptive immune responses have not been 
performed, we addressed the question of whether the protection of Ifnar ko mice resulted from 
impaired CTL responses towards the parasites. To first confirm whether using our transgenic 
parasites, PbAMA-OVA, would also result in an absence of ECM in the transgenic mice, we 
performed a survival experiment on WT and Ifnar1
-/-
 mice using these parasites. We observed 
a survival rate of less than 10% among the infected WT mice, with 90% of the mice dying by 
d+7p.i. In contrast, 75% of the infected Ifnar1
-/-
 mice, survived past the ECM phase (Figure 3). 
The Ifnar1
-/-
 mice that survived past the ECM phase, later on developed symptoms related to 
anaemia and high parasitemia and were sacrificed.  
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Figure 3 PbA-infected Ifnar1
-/-
 are protected from 
experimental cerebral malaria (ECM).  
C57BL/6 (WT and Ifnar1-/- ☐) mice were 
inoculated with 5x10
4
 red blood cells infected 
(iRBC) with P. berghei ANKA-Ama1 (PbAMA) i.v. 
and monitored from d+5 p.i for survival. The 
shaded area indicates the ECM phase. n=8 per 
group. Statistics: Log-rank (Mantel-Cox) test. 
  
Taken together, the survival rate of the Ifnar1
-/-
 mice shown here correlates with what had been 
shown by others (Ball et al. 2013; Palomo et al. 2013). As it has not yet been addressed 
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whether the protection from ECM in PbA-infected Ifnar1
-/-
 mice was due to impaired parasite-
specific CTL responses and /or impaired inflammation in the brain of the mice or whether it 
can be localized to a specific cell population that is responsible for transmitting the type IFN 
signals, we proceeded with a detailed characterization of the infected and protected mice versus 
the ECM-positive WT mice. 
3.1.2 Type I IFN signalling in myeloid cells is crucial for ECM development 
As shown above using the Ifnar1
-/-
 mice, type I IFN signalling has a role in the development of 
ECM. However, as the receptor is widely expressed (on almost all nucleated cells), we were 
interested in the role of type I IFN signalling in myeloid cells and its role in the pathogenesis of 
ECM. To this end, we employed the use of cell-specific conditional knockout mice. When 
LysM
Cre
 mice are crossed with Ifnar1
flox/flox 
(LysM
Cre
Ifnar1
fl/fl
), there is deletion of the Ifnar1 
gene on LysM expressing cells, in particular on macrophages, monocytes and granulocytes 
(Clausen et al. 1999; Prinz et al. 2008). Similarly when CD11c
Cre
 mice are crossed with 
Ifnar1
flox/flox
 (CD11c
Cre
Ifnar1
f/fl
), specifically conventional dendritic cells lack this receptor 
(Caton et al. 2007; Cervantes-Barragan et al. 2009).  
We infected WT, Ifnar1
-/-
, LysM
Cre
Ifnar1
fl/fl
 and CD11c
Cre
Ifnar1
fl/fl
 mice with 5x10
4 
PbAMA 
iRBCs and analysed the mice from d+5p.i for survival, parasitemia using Giemsa stain and 
evaluation of the specific neurological score upon PbA infection using “rapid murine coma and 
behaviour scale” (RMBCS), a health score for quantitative assessment of ECM described by 
Carroll et al (Carroll et al. 2010).  
As before, 90% of PbA-infected WT mice developed ECM by day 7, while the PbA-infected 
Ifnar1
-/-
 had a survival rate of 75%. We observed that mice lacking Ifnar1 on LysM
+
 expressing 
cells were protected against the development of ECM syndromes and had a survival 
comparable to that of the full receptor ko (Figure 4A). These mice did not develop neurological 
symptoms associated with ECM, as was demonstrated by a high RMBCS (Figure 4B). In 
contrast, lack of the IFN receptor on cDCs (CD11c
cre
Ifnar1
fl/fl
) did not provide protection and 
the mice developed neurological symptoms and succumbed to ECM with only one day delay in 
comparison to the infected WT (Figure 4A). It was important to observe that the survival 
occurred independently of the peripheral parasitemia, since the percentage of infected RBCs on 
d+6p.i was comparable among the infected groups (Figure 4C). This indicated that there was 
equal antigen load among all the infected groups and therefore the protection observed was not 
due to reduced antigen load. Taken together; our observation showed type I IFN signalling on 
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LysM expressing cells was more relevant for the pathogenesis of ECM, than signalling on 
DCs.  
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Figure 4 LysM
Cre
Ifnar1
fl/fl 
mice have a better survival upon 
PbA-infection independently of parasitemia. 
C57BL/6 (WT, Ifnar1
-/-
, LysM
Cre
Ifnar1
fl/fl
 and 
CD11c
Cre
Ifnar1
fl/fl
) mice were infected with 5x10
4
 PbAMA 
iRBC i.v. and monitored from d+5p.i for survival, parasitemia 
and RMBCS. Blood smears were taken on d+6p.i and stained 
with Giemsa, parasitized RBCs percentages were calculated 
versus uninfected RBCs. A) Survival analysis of the Ifnar1
-/-
 , 
LysM
Cre
Ifnar1
fl/fl
 and CD11c
Cre
Ifnar1
fl/fl
, in comparison to the 
WT control. n=8 per group, statistics =Log-rank (Mantel-Cox) 
Test. B) RMBCS on d+6 p.i., data compiled from 3 different 
experiments. n=12-18, statistics= One-way ANOVA with 
Bonferroni post test. C.) Parasitemia on day 6 p.i compared 
among the experimental groups data compiled from 3 
different experiments n=10-13 animals per group. 
3.1.3 Stabile blood brain barrier in PbA-infected Ifnar ko  
Breakdown of the BBB is one of the hallmarks of ECM and is demonstrated with the 
appearance of neurological symptoms in ECM positive mice. We assessed whether the survival 
we had observed in PbA-infected Ifnar ko was due to a stable BBB, by performing an Evans 
blue assay. Evans Blue dye binds to serum albumin, which is not able to permeate the BBB due 
to its size, however, upon disruption of the barrier, infiltration of the albumin- bound dye into 
the brain is facilitated resulting in blue brains. 
We observed strong coloration of the brains of infected WT mice (Figure 5A) which could be 
quantified with the help of a colorimetric assay (Figure 5B), reflecting a disrupted BBB and 
significant leakage of the dye into the tissue. In contrast, samples from naïve controls remained 
completely bright (Figure 5A) and contained only background levels of the dye (Figure 5B), 
thus demonstrating a stable BBB (Figure 5A&B). Importantly, brains of PbA-infected Ifnar1
-/-
, 
A 
B 
C 
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LysM
Cre
Ifnar1
fl/fl 
and CD11c
Cre
Ifnar1
fl/fl
 mice, showed a reduced amount of infiltrated dye, as 
compared to samples from PbA-infected WT mice (Figure 5A&B). This confirms the link 
between stable BBB and ECM, whereas brains of non-ECM mice lacked any dye infiltration. 
This observation further supported our hypothesis on the role of type I IFN signalling in the 
pathogenesis of ECM and indicated a role in BBB disruption. 
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Figure 5 Stable BBB in PbA-infected Ifnar ko  
C57BL/6 (WT, Ifnar1
-/-
, LysM
Cre
Ifnar1
fl/fl
 and 
CD11c
Cre
Ifnar1
fl/fl
,) mice were infected with 5x10
4
 
PbAMA iRBC. On d+6p.i., mice were scored for 
RMBCS and then injected i.v. with Evans blue dye. 
Brains were removed after 1hr, weighed and photos 
taken. The brains were incubated at 37
0
C for 48hrs 
in formamide, after which the extravasated dye was 
quantified colorimetrically. 
A) Representative photos of the brains taken 1 hour 
after Evans Blue injection. B) Spectrophotometrically 
quantification of infiltrated dye in the brains of the 
experimental animals. n=3/4 animals per group, 
Statistics= One-way ANOVA, Bonferroni post test. 
3.1.4 Brain of PbA-infected Ifnar ko mice contained parasites 
Several factors are attributed to the breakdown of the BBB during ECM, among them are the 
presence of effector CD8
+
 T-cells and sequestration of iRBCs in the brains of infected mice. In 
ECM models, these iRBCs are shown to adhere to the endothelial cells (Shaw et al. 2015). 
Howland et al. showed that iRBC present in the brains provided antigen, which is cross-
presented to cytotoxic CD8
+
T cells by endothelial cells and thereby contributed to the 
destruction of the BBB (Howland et al. 2013). Parasite-load due to sequestration of iRBCs in 
the brain was also shown to be important for ECM development (Baptista et al. 2010). We next 
addressed the question whether the protection and stable BBB we had observed was due to 
reduced numbers of parasites in the brain. We therefore quantified the parasite load in the 
brains of WT and Ifnar ko PbA-infected mice by qPCR using P.bA-specific 18s rRNA primers. 
Our results show that all infected mice contained sequestered iRBCs in the brain tissue as 
B 
A 
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measured by copy numbers. We observed a non-significant difference in the parasite load in 
brain tissue of PbA-infected Ifnar1
-/-
 and PbA-infected LysM
Cre
Ifnar1
fl/fl
 mice (Figure 6), but 
sample numbers were too low to reach significant differences. Furthermore, we could not 
distinguish between parasites that were still present in the blood circulation and others that had 
passed the BBB, providing parasite Ag in these brains that was probably contributing to 
pathology. 
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Figure 6 All PbA-infected mice contained parasites in their 
brain 
C57BL/6 mice (WT, Ifnar1
-/-
, LysM
Cre
Ifnar1
fl/fl
 and 
CD11c
Cre
Ifnar1
fl/fl
) were infected with 5x10
4
 PbAMA, iRBC. 
i.v. On d+6p.i, mice were scored for RMBCS and perfused 
with PBS, the brains were removed and placed in liquid 
nitrogen. RNA was isolated using the Trizol-chloroform 
protocol. RNA was reverse transcribed into cDNA. Parasite 
18s rRNA was quantified using qPCR. n=5 animals per 
group, Statistics = One-way ANOVA with Bonferroni post 
test. p = 0.2096. 
 
3.1.5 Lack of type I IFN signalling resulted in reduced brain infiltrates 
Infiltration of immune cells from the periphery into the brain is another important factor that is 
associated with the breakdown of the BBB during ECM. We have demonstrated above the 
presence of parasite = Ag in the brains of the ECM protected mice (Figure 6); however the 
presence of effector CD8
+ 
T-cells and other leukocytes are also required for brain pathology to 
occur (Lundie et al. 2008; Baptista et al. 2010; Howland et al. 2013; Haque et al. 2011). 
We therefore questioned whether the protection from ECM in PbA-infected Ifnar1
-/-
 and 
LysM
Cre
Ifnar1
fl/fl
 mice was due to the lack of infiltrating peripheral immune cells into their 
brains. To quantify infiltrating cells, single suspensions were prepared and lymphocytes were 
enriched via percoll gradient as described in the methods section, then the total cell count was 
calculated. Cells were first gated according to their expression of CD45 and CD11b, since 
cellular infiltrates from the periphery can be identified via flow cytometry by high expression 
of the surface marker CD45 and thus easily differentiated from brain resident cells such as 
microglia, which express low levels of CD45 but high levels of CD11b (Schumak et al. 2015). 
The CD45
pos 
were defined as peripheral immune cells and separated from the CD11b
hi
CD45
int
 
microglia. Next, they were further categorized into infiltrated leukocytes (CD11b
low
CD45
hi
) 
and mononuclear cells (CD11b
hi
CD45
hi
) as shown in schematic Figure 7A. The gating strategy 
contained three populations of interest-; P1= infiltrated lymphocytes and other CD11b 
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negative/low populations, P2= infiltrated inflammatory monocytes and neutrophils and P3= 
resident microglia cells. 
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Figure 7 Type I IFN signalling was important for infiltration of cells into the brain 
C57BL/6 mice (WT, Ifnar1
-/-
, LysM
Cre
Ifnar1
fl/fl
, CD11c
Cre
Ifnar1
fl/fl
) were infected with 5x10
4 
PbAMA, iRBC i.v. On 
d+6p.i, mice were scored for RMBCS and perfused with PBS, the brains were then collagenase-digested. Single cell 
suspensions were prepared and counted, cells were stained, then analysed by flow cytometry. A) Scheme showing 
the gating to discriminate CD45
hi
 cells populations infiltrated to the brain from brain-resident CD11b
hi
 CD45
lo
 
microglia. B) Raw data from representative samples from all experimental groups C) Total brain count D) Total 
infiltrated cell counts according to CD45
hi
 expression. E) Frequency of infiltrated cell counts according to CD45
hi
 
expression. Statistical analysis= One-way ANOVA with Bonferroni’s post test. p.value= 0.008. Data representative of 
more than 4 independent experiments. n=4/5 per group. 
The processing of brain tissue of naïve mice resulted only in an average yield of ˂5x105 cells 
per sample and minor cell fractions in the CD11b vs CD45 staining, whereas the recovery of 
lymphocytes from brain tissue of infected WT, resulted in a significantly elevates number of 
both total cell count and CD45
hi
 positive population indicating strong infiltration of cells from 
the periphery into the brains (Figure 7C & D).  
D 
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The total count of brain infiltrated cells was 2.3 fold higher in the PbA-infected WT in 
comparison to the samples of the naïve mice. The same trend was observed in comparison to 
the brain samples of the infected Ifnar ko mice, with the infected WT having fold increase of 
2.2 x to Ifnar1
-/-
, 2.5 x to LysM
Cre
Ifnar1
fl/fl 
and 1.3x to CD11c
Cre
Ifnar1
fl/fl
 (Figure 7C). 
We observed in brains of the infected WT mice a significant increase of the CD45
hi
 population, 
with multiple increases in comparison to the samples of the other groups (6.2x to naïve, 4.1x to 
infected Ifnar1
-/-
, 4.6 x to LysM
Cre
Ifnar1
fl/fl 
and 1.8x to CD11c
 Cre
Ifnar1
fl/fl
) (Figure 7D). No 
significant differences were observed between the infected Ifnar1
-/-
 and LysM
Cre
Ifnar1
fl/fl 
in 
comparison to brains of the naïve mice. However, CD11c
Cre
Ifnar1
fl/fl
 had a 3.5 fold increase 
compared to the samples of naïve control mice (Figure 7D). Also the comparison of the CD45
hi
 
population in the brains of the infected WT mice and the other experimental groups revealed 
differences regarding the counts and frequencies (Figure 7B & E). Brains of PbA-infected WT 
mice contained on average, 27.3% more cells than the brains of the naïve, 17% more cells than 
brains of PbA-infected Ifnar1
-/-
 and LysM
Cre
Ifnar1
fl/fl
, but only 10% more cells than the brains 
of the CD11c
Cre
Ifnar1
fl/fl
 mice (Figure 7E). There were no significant difference in the 
frequency of CD45
hi
 between the naïve and the PbA-infected Ifnar1
-/-
, LysM
Cre
Ifnar1
fl/fl 
and 
CD11c
Cre
Ifnar1
fl/fl 
mice
 
(Figure 7E). Taken together, our data show an important role of type I 
IFN signalling in the accessibility of peripheral immune cells to the brain during ECM.  
3.1.6 Infiltration of lymphocytes from the periphery into the brain was dependent 
on type I IFN signalling 
We have shown above a significant difference in the amount of brain-infiltrated cells, between 
PbA-infected WT and Ifnar1
-/-
 mice (Figure 7B-E). We next characterized the composition of 
the infiltrated cell populations, to see which different cell populations had infiltrated into the 
brains. T cells were gated from population P-1, shown in Figure 7 A, as CD3
+
CD45
hi
CD11b
neg
, 
and from this group, CD8
+ 
and CD4
+
 T cells.  
We looked for effector CD8
+ 
T cells, as these cells have an undisputed role in mediating the 
pathology observed during ECM. CD8
+
T cells have been proven to be the effector cells during 
ECM, as deletion of CD8
+
 T cells prior to the onset of ECM or use of T cell deficient mice 
conferred protection from fatal outcome. Furthermore, these brain recruited cells have been 
shown to be parasite-specific (Belnoue et al. 2002; Haque et al. 2011; Howland et al. 2013; 
Lundie et al. 2008; Shaw et al. 2015). The CD8
+
T-cells mediated pathology involves several 
effector molecules, granzyme-B, perforin and IFNγ ( Belnoue et al. 2008; Haque et al. 2011; 
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Nitcheu et al. 2003; Rénia et al. 2006; Howland et al. 2013). In contrast, CD4
+
T-cells have 
been show to exhibit relevant functions only in early phases of infection but their presence is 
not required in late stage for pathology (Belnoue et al. 2002; Yañez et al. 1996). 
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Figure 8 Impaired T cell infiltration into the brains of Ifnar ko 
mice 
C57BL/6 (WT, Ifnar1
-/-
, LysM
Cre
Ifnar1
fl/fl
 and CD11c
Cre
Ifnar1
fl/fl
) 
mice were infected with 5x10
4 
PbAMA, iRBC. On d+6p.i, mice 
were scored for RMBCS and perfused with PBS, before 
extraction of the brains and collagenase digestion. Single cell 
suspensions were prepared and counted, the cells were 
stained and analysed by flow cytometry. A) Total percentage 
of brain infiltrated CD3
+
T cell count. B) Percentage of brain-
infiltrated CD8
+
T cells. C) Percentage of brain-infiltrated 
CD4
+
T cells D) Calculation of fold increase to CD8
+
T-cells of 
naïve mice. Statistical analysis: One-way ANOVA, Bonferroni’s 
post test. p.value = 0.001. n=4/5 per group. Representative 
data of more than 4 independent experiments. 
We observed in brains of PbA-infected WT mice a massive infiltration of T cells (Figure 8A), 
which is in agreement with what has been previously reported. CD8
+ 
T cells composed more 
than 80% of the brain infiltrated cells, which resulted in them accounting for ~56% (+4% ) of 
the total brain infiltrated cells (Figure 8B). These cells were not present in the brains of the 
naïve animals, indicating that they had infiltrated into the brains of the infected mice. When we 
compared samples from PbA-infected WT with those from infected Ifnar1
-/- 
mice, the samples 
from the infected WT and CD11c
Cre
Ifnar1
fl/fl
 mice contained the highest frequencies of 
infiltrated T cells (Figure 8A). Furthermore, they both had 20% more infiltrates in their 
samples than brain samples from PbA-infected Ifnar1
-/-
 and LysM
Cre
Ifnar1
fl/fl
 mice (Figure 8A). 
PbA-infected WT and CD11c
Cre
Ifnar1
fl/fl
 had comparable frequencies of CD4
+
T cells in their 
brains, which was twice as much as that determined in brains from PbA-infected Ifnar1
-/-
 and 
LysM
Cre
Ifnar1
fl/fl 
mice (Figure 8C). Here, the LysM
Cre
Ifnar1
fl/fl
 continued to show a phenotype 
similar to that of the full Ifnar ko with very few CD8
+
 T cells and CD4
+
 T cells infiltrating into 
B A 
C 
D 
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their brains (Figure 8B & C). However, PbA-infected WT and CD11c
Cre
Ifnar1
fl/fl 
displayed 
equally high percentages in both CD8
+ 
and CD4
+
 T-cells that had infiltrated into the brains 
(Figure 8A-C). When we calculated the fold increase of CD8
+
 T cells in relation to the results 
from brains of the naïve control mice, we observed the highest fold increase in the WT with a 
mean fold increase factor of 19.5, followed by CD11c
Cre
Ifnar1
fl/fl
 with factor of 10.7, while 
Ifnar1
-/-
 and LysM
Cre
Ifnar1
fl/fl 
had each a mean factor of 4 (Figure 8D). Taken together, we 
observed that PbA-infected Ifnar1
-/-
 or LysM
cre
Ifnar1
fl/fl
 showed strongly impaired infiltration 
of effector CD8
+
 T-cell into the brain, thus indicating that the protection we observed was due 
to reduced number of effector CD8
+
T cells that had infiltrated into the brains of Ifnar1
-/-
 and 
LysM
Cre
Ifnar1
fl/fl
 and which was probably not sufficient to induce pathology, since it was 
possible that they did not pass the BBB. 
3.1.7 Ifnar1-/- and LysMCreIfnar1fl/fl contained less infiltrated cytotoxic CD8+Tcells in 
their brains 
As shown above, PbA-infected mice deficient of the type I IFN receptor had an intact BBB 
(Figure 5) and less infiltration of cells into the brain (Figure 7D), in particular less CD8
+
T cells 
(Figure 8B). However, there was a small number of infiltrated CD8
+
T-cells that has infiltrated 
into the brains, therefore we further analysed these infiltrated CD8
+
T-cells for cytotoxicity by 
analysing for the expression of granzyme-B and expression of CD11c. Pathology in the brains 
of ECM positive mice was shown to be mediated via production of cytotoxic molecules, 
granzyme-B and perforin (Haque et al. 2011; Nitcheu et al. 2003), with Ag specific cytotoxic 
CD8
+
T cells expressing CD11c (Tamura et al. 2011; Zhao et al. 2014). 
As expected, there was no expression of granzyme-B in brain derived CD8
+
 T cells of naïve 
mice (Figure 9 A&B). Importantly, we detected in brain samples from PbA-infected WT mice 
elevated levels of granzyme B expression in CD8
+
 T cells by gMFI as well as absolute cell 
numbers of granzyme-B
+
CD8
+
T-cells population (Figure 9A & B). In comparison to the naïve 
mice, CD8
+
 T cells in brain samples from PbA-infected Ifnar1
-/-
 and LysM
Cre
Ifnar1
fl/fl
 mice 
showed increased granzyme-B expression (Figure 9A), although the absolute cell number of 
CD8
+ 
T-cells expressing granzyme-B was reduced in comparison to the PbA-infected WT mice 
(Figure 9B).  
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Figure 9 Lack of Ifnar led to reduced presence of cytotoxic CD8
+
T cells in the brain. 
C57BL/6 mice (WT, Ifnar1
-/-
 , LysM
Cre
Ifnar1
fl/fl
 and CD11c
Cre
Ifnar1
fl/fl
) were infected with 5x10
4  
PbAMA-iRBC i.v. 
On d+6p.i single cell suspensions from perfused and digested brains were prepared. The cells were counted, 
stained first for surface markers and followed by intracellular markers, then analysed by flow cytometry. A) 
gMFI of granzyme-B in gated brain infiltrated CD8
+
T cells. B) Total count of brain infiltrated granzyme B
+
 CD8
+
T 
cells. C) gMFI of CD11c in gated brain infiltrated CD8
+
T cells. D) Count overlay of granzyme B
+
CD8
+ 
T cells.         
E) Count overlay of CD11c
+
CD8
+
T cells. Statistical analysis = One-way ANOVA with Bonferroni’s post test. n=4/5 
per group. Data representative of 2 independent experiments. 
This observed difference in gMFI and cell count can be explained by Figure 9D, since we 
observed that although few CD8
+
T cells had infiltrated into the brain, all the infiltrated CD8
+
T 
cells were expressing granzyme-B (Figure 9D). PbA-infected CD11c
Cre
Ifnar1
fl/fl
 mice 
contained a similar expression of granzyme-B (gMFI) by CD8
+
T-cells as the infected WT 
mice, however, the cell count was slightly different (Figure 9A, B &D). Furthermore, we 
observed in the brain samples from all the infected groups of mice (both WT and ko), but not 
in samples from naïve mice that >95% of the CD8
+
 T cells highly expressed CD11c (Figure 9 
C &E). Taken together these results suggest that the protection against ECM we observed 
among Ifnar1
-/-
 and LysM
Cre
Ifnar1
fl/fl
 was probably due to reduced/low numbers of cytotoxic 
CD8
+
T-cell infiltrating into the brains. Finally, we cannot exclude that these few cells did not 
infiltrate but maybe rather were on the other side of the (intact) BBB. 
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3.1.8 Increased expression of ICAM-1, CCR5 and CXCR3 on brain infiltrated CD8+T 
of PbA-infected Ifnar ko 
We have shown above less infiltration of CD8
+
T-cells in the brains of ECM protected mice, 
however, more than 95% of those cells showed still signs of cytotoxicity (Figure 9D & E). We 
then next evaluated the activation status of these CD8
+ 
T cells in the brain samples by 
analysing expression of intercellular adhesion molecule ICAM-1, chemokine receptors CCR2, 
CCR5, CXCR3, CCR7 and the activation marker CD69. 
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Figure 10 ICAM-1, CCR-2 and CD69 on infiltrated CD8
+
T cells. 
C57BL/6 mice (WT, Ifnar1
-/-
, LysM
Cre
Ifnar1
fl/fl
 and CD11c
Cre
Ifnar1
fl/fl
) were infected with 5x10
4 
PbAMA, iRBC i.v. 
On d+6p.i, single cell suspensions from brains were prepared, stained and analysed by flow cytometry. A) 
ICAM-1 expression on brain infiltrated CD8
+
T cells. B) Expression of CCR2 on brain infiltrated CD8
+
T cells. C) 
Expression levels of CD69 on brain infiltrated CD8
+
T cells. D) Expression of CCR5 on brain infiltrated CD8
+
T cells. 
E) Expression of CXCR3 on brain infiltrated CD8
+
T cells. F) Expression of CCR-7 on brain infiltrated CD8
+
T cells. 
Statistical analysis = One-way ANOVA with Bonferroni post test. n=3/4/5 animals per group. 
We detected elevated ICAM-1 levels on CD8
+
 T cells from brains of all infected groups of 
mice in comparison to samples of the naïve mice, although the expression levels in samples 
from PbA-infected LysM
Cre
Ifnar1
fl/fl 
were slightly reduced in comparison to the infected WT 
mice (Figure 10A). CCR-2 expression levels on CD8
+ 
T cells were similar among most of the 
PbA-infected mice in comparison to the samples from naïve mice, but importantly, we 
A B C 
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observed decreased CCR-2 expression on CD8
+
 T cells of PbA-infected Ifnar1
-/-
 in comparison 
to those of PbA-infected WT and infected CD11c
Cre
Ifnar1
fl/fl 
mice (Figure 10B). We did not 
observe a difference in CD69 expression between naïve mice, PbA-infected WT and infected 
Ifnar1
-/-
 mice, whereas CD8
+
T cells from LysM
Cre
Ifnar1
fl/fl
 mice showed increased levels of 
CD69 in comparison to infected Ifnar1
-/-
 mice (Figure 10C). Brain samples from all infected 
animals showed elevated expression levels of CCR5 and CXCR3 on CD8
+
T cells, here, 
infected CD11c
Cre
Ifnar1
fl/fl
 presented the highest expression of CCR5 (Figure 10D & E). 
Expression levels of CCR7 were comparable between all the brain samples (Figure 10F). These 
data show variation in the expression of activation markers on brain infiltrated CD8
+ 
T cells, 
and partially impaired expression of CCR2 and CCR5 on effector T cells from ECM negative 
mice, which might explain /contribute their protection from brain inflammation due to less 
signals from T cells that are required for brain infiltration. 
3.1.9 Increased expression of ICAM-1 and CXCR3 on brain infiltrated CD4+ T cells 
We next addressed the question whether also the few infiltrated CD4
+ 
T cells observed in 
brains of infected Ifnar ko mice had a different phenotype than those of the PbA-infected WT 
mice. Therefore, similarly to the CD8
+ 
T cells, we evalutated the expression levels of adhesion 
molecule ICAM-1, activation marker CD69, chemokine receptors CCR5 and CXCR3 on CD4
+ 
T cells found among brain infiltrated lymphocytes. As CD4
+ 
T cells have been described in 
some conditions to exert also cytotoxic functions, we also analysed their production of 
granzyme B. 
We observed an increased expression of ICAM-1 on brain infiltrated CD4
+ 
T cells of all the 
infected mice in comparison to the CD4
+ 
T cells in the samples from the naïve mice (Figure 
11A). Although CD4
+
 T cells from infected WT showed elevated CD69 expression on CD4
+ 
T 
cells in comparison to the CD4
+
 T cells from the naïve mice, this was not statistically 
significant (Figure 11B). Expression of CD69 on brain infiltrated CD4
+ 
T cells from PbA-
infected Ifnar1
-/- 
mice was reduced in comparison to the CD4
+
 T cells of infected WT mice 
(Figure 11B). CD4
+ 
T cells from brains of LysM
Cre
Ifnar1
fl/fl 
mice had more CD69 in 
comparison to the naïve and Ifnar1
-/-
, however comparable to the PbA-infected WT mice 
(Figure 11B). Importantly, brain-infiltrated CD4
+ 
T cells of infected WT mice showed the 
highest expression of granzyme B, whereas CD4
+ 
T cells from naïve did not express any 
granzyme B (Figure 11C). However, it is important to bear in mind here, that the level of 
granzyme B expressed by CD4
+
T cells was 4.5 times lower than that expressed by CD8
+
T cells 
of the same mice (Figure 9A). We observed significantly less granzyme-B
+
CD4
+
 T-cells in 
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brain samples from Ifnar1
-/-
 and LysM
Cre
Ifnar1
fl/fl 
mice in comparison to infected WT mice 
(Figure 11C). CD4
+
 T cells from brain samples derived from CD11c
Cre
Ifnar1
fl/fl
 showed similar 
high granzyme production as those from the infected WT mice (Figure 11C), which both 
suffered from ECM.  
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Figure 11 CD4
+
T cells from Ifnar1
-/-
 are less activated  
C57BL/6 mice (WT, Ifnar1
-/-
 , LysM
Cre
Ifnar1
fl/fl
 and CD11c
Cre
Ifnar1
fl/fl
) were infected with 5x10
4  
PbAMA, iRBC i.v. 
On d+6p.i, Single cell suspensions were prepared from brains, counted and analysed by flow cytometry.               
A) Expression of ICAM-1 on brain infiltrated CD4
+
T cells. B) Expression of CD69 on brain infiltrated CD4
+
T cells. 
C) Expression of Granzyme B by brain infiltrated CD4
+
T cells. D) Expression of CCR5 on brain infiltrated CD4
+
T 
cells. E) Expression of CXCR3 on brain infiltrated CD4
+
T cells. Statistical analysis = One-way ANOVA with 
Bonferroni post test. n=3/4/5. 
Expression of the chemokine receptor CCR5 was significantly elevated only in brain samples 
from CD11c
Cre
Ifnar1
fl/fl
 in comparison to the naïve control and Ifnar1
-/-
 mice (Figure 11D), 
whereas expression of CXCR3 on CD4
+
T cells was elevated on all the brain samples from 
PbA-infected mice in comparison to the naïve control mice (Figure 11E).  
Taken together, our data show that brain infiltrated CD4
+
T-cells from infected Ifnar1
-/-
 mice 
were less activated and also produced less effector molecules (grz B) than from infected WT 
mice. Lack of type I IFN signalling did not interfere with the expression of ICAM-1 and 
CXCR3 on CD4
+ 
T cells during PbA infection. 
A B 
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3.1.10 Reduced levels of brain infiltrated natural killer cells in PbA-infected 
LysMCreIfnar1fl/fl mice 
Natural killer (NK) cells are innate lymphocytes with the ability to kill target cells by release of 
cytotoxic granules. Their role during ECM is still unclear, the Hansen group showed a role for 
NK cells in the recruitment of T cells into the brain, but not in performing effector functions 
(Hansen et al. 2007). Therefore, we next analysed whether there was a difference in the 
proportions of NK cells that had infiltrated into the brains of PbA-infected WT suffering from 
ECM and Ifnar ko mice that were protected from ECM.  
We did not observed any differences in frequencies of NK cells in the brains of the infected 
WT mice in comparison to those of the naïve mice (Figure 12A). But it is important to note 
that the absolute cell counts calculated per brain were higher in the infected WT mice. The 
frequencies of NK cells among the PbA-infected Ifnar1
-/-
 and CD11c
Cre
Ifnar1
fl/fl
 mice were 
comparable to the results from naive and WT infected mice, but importantly, significantly 
decreased in brains of PbA-infected LysM
Cre
Ifnar1
fl/fl
 mice (Figure 12A). 
NK cell are also able to produce granzyme B, another important effector molecule in ECM. We 
observed the strongest signals of intracellular granzyme B in NK cells within brain samples 
from the infected WT, in comparison to the naïve mice (Figure 12B). Although there was an 
increase in the expression levels of granzyme-B in NK cells among Ifnar1
-/-
 and 
LysM
Cre
Ifnar1
fl/fl
 mice in comparison to the naïve control mice, this increase was not as high as 
that observed among the infected WT mice (Figure 12B). NK cells from brains of PbA-
infected CD11c
Cre
Ifnar1
fl/fl
 mice had increased levels of granzyme-B, which were comparable 
to the infected WT mice (Figure 12B), which both suffered from ECM. Similar to the trend 
observed with T cells, these data indicate a role of type I IFN signalling in myeloid cells in 
recruitment of NK cells into the brain during PbAMA infection, and subsequent production of 
effector molecules, since the ECM protected ko mice showed impaired NK cell presence and 
also less granzyme B production, thereby contributing to less brain inflammation.  
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Figure 12 Less infiltration of NK cells into 
brains of PbA-infected Ifnar ko 
C57BL/6 mice (WT, Ifnar1
-/-
 , 
LysM
Cre
Ifnar1
fl/fl
 and CD11c
Cre
Ifnar1
fl/fl
) 
were infected with 5x10
4 
PbAMA iRBC i.v. 
On d+6p.i, Single cell suspensions were 
prepared from the brain, counted, stained 
and analysed by flow cytometry.               
A) Percentage of brain infiltrated NK cells.   
B) Expression of granzyme-B on brain 
infiltrated NK cells. Statistical analysis = 
One-way ANOVA with Bonferroni post 
test. n=4/5 animals per group. 
3.1.11 Insignificant amounts of brain infiltrated B cells during PbAMA infection 
So far, the role of B cells in the pathogenesis of ECM is not well understood. Published 
experimental studies with mice, did not indicate the presence of B cells within the brain 
infiltrated cells (Belnoue et al. 2002). In our experiments, we did not detect relevant amounts 
of B cells in the brains of infected WT, Ifnar1
-/-
 and CD11c
Cre
Ifnar1
fl/fl
 mice (Figure 13). 
Although there was some B cell population in brain samples from infected LysM
Cre
Ifnar1
fl/fl
 
and naïve mice the difference between all the groups was not statistically significant. We did 
not pursue the role of B cells in the brain any further.  
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Figure 13 Non-significant amount of B cells in 
the brains of experimental mice 
C57BL/6 mice (WT, Ifnar1
-/-
 , LysM
Cre
Ifnar1
fl/fl
 
and CD11c
Cre
Ifnar1
fl/fl
) were infected with 5x10
4 
PbAMA, iRBC i.v. On d+6p.i, Single cell 
suspensions from the brain were prepared, 
counted, stained and analysed by flow 
cytometry for the presence of B cells as 
determined by CD19 expression. Statistical 
analysis= One-way ANOVA with Bonferroni’s 
Multiple Comparison test. n=4/5 animals per 
group. 
3.1.12 Low counts of infiltrated CD8α+DCs in brains of Ifnar ko mice 
CD8α+ dendritic cells (DCs) from the periphery have been shown to infiltrate into the brain 
during ECM; however, effector CD8
+ 
T cells do not require a second priming from DCs in the 
brain (Shaw et al. 2015). To address the question whether the ECM negative Ifnar1
-/-
 mice 
showed differences in the composition of antigen-presenting cells that had migrated to the 
brains, we analysed them by flow cytometry. DCs were gated from population P1 (Figure 7A) 
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and characterized as CD11c
+
CD45
hi
CD11b
low
CD3
neg
. The DCs were then further characterised 
as CD8α+ DCs or CD8αneg DCs.  
We did not observe a significant difference in the frequency of infiltrated CD8α+ DCs among 
the infected WT, Ifnar1
-/-
 and CD11c
Cre
Ifnar1
fl/fl 
mice in comparison to the naïve mice (Figure 
14A). We observed a decrease in the percentage of CD8α+ DCs in brain samples of infected 
LysM
Cre
Ifnar1
fl/fl
. However when we calculated the absolute cell count, there were very few 
CD8α+ DCs that could be detected in the brains samples of infected Ifnar ko, with cell counts 
being similar to those of the naïve mice (Figure 14B). 
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Figure 14 Ifnar ko had low numbers of 
brain infiltrated CD8
+
DCs 
C57BL/6 mice (WT, Ifnar1
-/-
 , 
LysM
Cre
Ifnar1
fl/fl
 and CD11c
Cre
Ifnar1
fl/fl
) 
were infected with 5x10
4 
PbAMA, iRBC 
i.v. On d+6p.i, single cell suspensions 
from the brain were prepared, counted, 
stained and analysed by flow cytometry. 
A) Frequency of CD8α
+ 
DCs (brain) B) 
Total cell count of CD8α
+ 
DCs (brain). 
Statistical analysis = One-way ANOVA 
with Bonferroni’s Multiple Comparison 
test. n=4/5 animals per group. 
3.1.13 Infiltration of inflammatory monocytes into the brain was dependent on 
type I IFN signalling on macrophages 
Infiltrated CD8
+ 
T cells and inflammatory monocytes have been found to compose the bulk 
percentage of brain infiltrated cells during ECM. Infiltrated monocytes were shown to play a 
role in recruitment of effector CD8
+ 
T cells into brains of mice during ECM (Pai et al. 2014; 
Schumak et al. 2015). We have shown the relevance of Ly6C
hi
 inflammatory monocytes rather 
than neutrophils in ECM development (Schumak et al. 2015). We have shown above, that there 
were less lymphocytes infiltrating into the brains of Ifnar1
-/-
 and LysM
Cre
Ifnar1
fl/fl
 mice in 
comparison to the infected WT mice during PbA infection. To further confirm the role of type I 
IFN signalling in brain inflammatory processes during ECM, we evaluated the infiltration of 
inflammatory monocytes and neutrophils into the brain. We defined infiltrated inflammatory 
monocytes as Ly6C
hi
CD11b
hi
CD45
hi
Ly6G
neg
 and neutrophils as Ly6G
hi
Ly6C
int
CD11b
hi
CD45
hi
, 
these cells were gated from P-2 as indicated in (Figure 15A).  
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40 
 
 
 
CD11b+CD45hi frequency
W
T-
na
iv
e
W
T-
P
bA
-/-
Ifn
ar
fl/
fl
Ifn
ar
C
re
Ly
sM
fl/
fl
Ifn
ar
C
re
C
D
11
c
0
5
10
15
20
25
******
PbAMA infected
 %
Ly6Chi inflam. monocytes
W
T-
na
iv
e
W
T-
P
bA
-/-
Ifn
ar
fl/
fl
Ifn
ar
C
re
Ly
sM
fl/
fl
Ifn
ar
C
re
C
D
11
c
0
5
10
15
20
******
ns
**
PbAMA infected
 %
 p
e
rc
e
n
ta
g
e
 i
n
fi
lt
ra
te
d
 c
e
lls
          Neutrophils
W
T-
na
iv
e
W
T-
P
bA
-/-
Ifn
ar
fl/
fl
Ifn
ar
C
re
Ly
sM
fl/
fl
Ifn
ar
C
re
C
D
11
c
0.0
0.5
1.0
1.5
**
PbAMA infected
 %
 p
e
rc
e
n
ta
g
e
 o
f
in
fi
lt
ra
te
d
 c
e
lls
            ICAM-1 on infl. Monocytes
W
T-
na
iv
e
W
T-
P
bA
-/-
Ifn
ar
fl/
fl
Ifn
ar
C
re
Ly
sM
fl/
fl
Ifn
ar
C
re
C
D
11
c
0
2000
4000
6000
8000
10000
*****
PbAMA infected
g
M
F
I
       CCR-2 on inflam. monocytes
W
T-
na
iv
e
W
T-
P
bA
-/-
Ifn
ar
fl/
fl
Ifn
ar
C
re
Ly
sM
fl/
fl
Ifn
ar
C
re
C
D
11
c
0
1000
2000
3000
4000
5000
****
PbAMA infected
g
M
F
I
 
Figure 15 Type I IFN signalling has a crucial role in recruitment of inflammatory monocytes into the brain 
C57BL/6 mice (WT, Ifnar1
-/-
 , LysM
Cre
Ifnar1
fl/fl
 and CD11c
Cre
Ifnar1
fl/fl
) were infected with 5x10
4 
PbAMA, iRBC i.v. 
On d+6p.i, Single cell suspensions from the brain were prepared, counted, stained and analysed by flow 
cytometry A) Gating schematic for infiltrated monocytes and neutrophils. B) FACS picture of inflammatory 
monocytes and neutrophils from representative groups. C) Total percentage of brain infiltrated CD11b
+
 
population. D) Total percentages of Ly6C
hi
 inflammatory monocytes in the brain E) Total percentages of 
neutrophils in the brain F) Expression of CCR2 on Ly6C
hi 
inflammatory monocytes (brain). G) ICAM-1 expression 
levels on Ly6C
hi 
inflammatory monocyte. Statistical analysis = One-way ANOVA with Bonferroni’s post test. 
n=4/5 per group. Data is representative of 4 independent experiments. 
Brains of infected WT mice contained significantly increased frequency regarding 
CD11b
+
CD45
hi
 cells, compared to the naïve mice (Figure 15C). Ly6C
hi
 inflammatory 
monocytes composed more than 75% of the CD11b
hi
CD45
hi 
population among the brain 
A 
B 
C D E 
F G 
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samples from the infected WT (Figure 15B). We detected >4x more inflammatory monocytes 
in brains samples from infected WT in comparison to the naïve (Figure 15D). All groups of 
infected Ifnar ko mice had approximately half the frequencies of infiltrated CD11b
hi
CD45
hi
 
cells in their brains compared to the brain samples from the infected WT mice (Figure 
15C&D). The infected Ifnar ko mice showed a phenotype similar to the naïve mice with very 
few inflammatory monocytes in their brain samples (Figure 15D). We did not observe any 
significant difference in the frequency of infiltrated neutrophils between samples from the 
PbA-infected mice and the naïve mice, however, LysM
Cre
Ifnar1
fl/fl 
mice had a higher frequency 
of neutrophils in their brains in comparison to brain samples of the infected WT (Figure 15E).  
We further analysed the phenotype of the Ly6C
hi
 inflammatory monocytes in the brain samples 
by examining the expression of CCR2 and ICAM-1 on their surface. CCR2 and ICAM-1 have 
important roles in the recruitment of monocytes to the site of inflammation during infection. 
We observed an elevated CCR2 expression on Ly6C
hi
 inflammatory monocytes from brains of 
all infected animal, in comparison to those of the naïve mice (Figure 15F). Also, we detected 
increased levels of ICAM-1 expression on Ly6C
hi
 inflammatory monocytes from brain samples 
of all the infected animals in comparison to the monocytes in brain samples from naïve mice 
(Figure 15G). However, in comparison to the samples from infected WT mice, monocytes in 
brain samples from both infected Ifnar1
-/-
 and LysM
Cre
Ifnar1
fl/fl
 mice had significantly lower 
ICAM-1 levels (Figure 15G). This observation further supports the role of type I IFN 
signalling on recruitment of Ly6C
hi 
inflammatory monocytes to the brain during ECM upon 
PbA infection, whereas ECM negative mice contained decreased levels of monocytes and less 
adhesion markers. 
3.1.14 Brains of PbA-infected Ifnar1-/- and LysMCreIfnar1fl/fl lacked inflammatory 
cytokine TNF, chemokines CCL3 and CCL5 
Cytokines are another important factor considered to contribute in the disruption of the BBB. 
Members of the TNF family, which belong to the inflammatory cytokines, have been found in 
increased levels in the brains of both human malaria patients and mice during (experimental) 
cerebral malaria. Chemokine are a group of cytokines mediating chemotaxis. CCL3 and CCL5 
are inflammatory chemokines secreted during inflammation, with a central role in the 
recruitment of T cells, NK cells and monocytes to the site of infection.  
Here, we observed significant TNF production in supernatants from brain samples of infected 
WT and CD11c
Cre
Ifnar1
fl/fl
 mice in comparison to the naïve control (Figure 16A). Analysis of 
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supernatants from brain samples of infected Ifnar1
-/-
 and LysM
Cre
Ifnar1
fl/fl
 mice, did not reveal 
any TNF production and showed comparable values as the samples from naïve mice (Figure 
16A). Elevated levels of secreted chemokines CCL3 and CCL5 were measured from 
supernatants of brain samples of infected WT and CD11c
Cre
Ifnar1
fl/fl
 mice in comparison to 
supernatants from naïve mice (Figure 16B &C). Importantly, supernatants from brain samples 
of infected Ifnar1
-/-
 and LysM
Cre
Ifnar1
fl/fl
 mice contained very low levels of secreted CCL3 and 
CCL5 with comparable results to samples from naïve mice (Figure 16B &C). This low levels 
in secreted inflammatory chemokines, matches with the observation made earlier, where we 
detected very low numbers of infiltrated T cell and inflammatory monocytes in the brains of 
the Ifnar1
-/-
 and LysM
Cre
Ifnar1
fl/fl
 mice. The lack of TNF production observed in supernatants 
from brain samples of the PbA-infected Ifnar1
-/-
 and LysM
Cre
Ifnar1
fl/fl
 mice correlated to the 
lack of inflammatory monocytes in the brains of these mice, thus indicating the protective 
effect of impaired monocyte migration and subsequent reduction of effector molecules. 
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Figure 16 No TNF in brains of PbA-infected and ECM negative Ifnar1
-/-
 and LysM
Cre
Ifnar1
fl/fl 
mice 
C57BL/6 mice (WT, Ifnar1
-/-
 , LysM
Cre
Ifnar1
fl/fl
 and CD11c
Cre
Ifnar1
fl/fl
) were infected with 5x10
4 
PbAMA, iRBC i.v. 
On d+6p.i. Brains were perfused, colagenase digested and homogenised, the cells were counted and 1.5x10
6
 
cells were cultured in triplicates in 96 well plates overnight at 37
0
C for 24 hrs supernatant were collected and 
ELISA performed as described in methods. A) Levels of TNF production in the brain B) Levels of CCL3/MIP1α 
production in the brain C) Levels of CCL5/RANTES production in the brain. Statistical analysis = One-way ANOVA 
with Bonferroni post test. n=3/4/5 animals per group. 
 
  
A B C 
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3.1.15 Summary of brain results  
Taken together, the results from the brains of the experimental PbA-infected animals described 
above indicate a crucial role of type I IFN signalling (on LysM expressing cells) in causing 
ECM pathology due to brain inflammation. Intact signalling via Ifnar in PbA- infected WT 
mice resulted in infiltration of granzyme B producing effector CD8
+
T cell and TNF producing 
Ly6C
hi
 inflammatory monocytes into the brain of C57Bl/6 during infection with P. berghei 
ANKA, whereas PbA-infected Ifnar ko mice were protected from ECM and showed markedly 
decreased amounts of effector cells and soluble mediators. The table below summarises our 
major observations in the brain. 
Table 2 Summary of results from the brain of PbA-infected mice 
 Naïve WT Ifnar
-/-
 LysM
Cre
Ifnar
fl/f
 CD11c
Cre
Ifnar
fl/fl
 
Develop ECM  - Positive Negative Negative Positive 
Breakdown of BBB  Yes No No No 
Infiltration of cells 
into the brain 
- High Low  Low Intermediate 
CD8
+
T cell presence - High  Low  Low  High  
GzmB
+
CD8
+
T cell - High  Low  Low  High  
CD11c
+
CD8+T cells - High  Low  Low  High  
Infl. Monocytes - High Low Low Intermediate 
TNF - Positive Negative Negative Positive 
CCL3 - Positive Negative  Negative Positive 
CCL5 - Positive Negative  Negative Positive 
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3.2 Analysis of peripheral immune responses in the spleen of PbA infected Ifnar 
ko mice in comparison to WT mice 
The spleen is a vital organ during infection with Plasmodium parasites, as this is the organ 
where immune induction against blood-borne pathogen occurs. We have shown above that the 
Ifnar1
-/-
 and LysM
cre 
Ifnar1
fl/fl 
mice were protected from ECM, characterized by a stable BBB 
with few cells infiltrating into their brains independently of parasitemia. We next addressed the 
question whether the protection from ECM we had observed among the Ifnar1
-/-
 and LysM
cre 
Ifnar1
fl/fl
 mice was due to altered immune responses in the spleen.  
3.2.1 Ifnar ko mice had marked splenomegaly 
First we performed a general analysis of the spleen. We measured the weight, size and 
determined the total cell count of the spleen.  
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Figure 17 Splenomegaly among the Ifnar ko mice. 
C57BL/6 mice (WT, Ifnar1
-/-
 , LysM
Cre
Ifnar1
fl/fl
 and CD11c
Cre
Ifnar1
fl/fl
) were infected with 5x10
4 
PbAMA, iRBC i.v. 
On d+6p.i, Mice were perfused using PBS, spleens were photographed, weighed, then collagenase-digested. 
Single cell suspensions were prepared and cells counted A) Representative photos of the spleen. B.) Total 
spleen cell count, data pooled from 3 independent experiments n=12/16. C) Spleen weights, data pooled from 
2 independent experiments n=7/10 per group. Statistical analysis = One-way ANOVA with Bonferroni post test. 
Although we observed an increase in the size of the spleen upon PbA infection, in comparison 
to the naïve (Figure 17A), there was no statistical difference in both the weight of the spleen 
and the total cell count of splenocytes between the infected WT and the naïve control mice 
(Figure 17B & C). Interestingly, we observed a remarkable increase in the size, weight and 
total number of splenocytes in the infected Ifnar ko mice compared to those of the infected WT 
A 
B C 
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and naïve mice (Figure 17A-C). The increase in splenocytes number and size was highest in 
the infected Ifnar1
-/-
, in comparison to the infected WT (Figure 17B&C). 
3.2.2 Unimpaired CD8+T cells immune induction in the spleens of Ifnar ko 
We questioned whether the protection among the ECM negative mice was due to impaired 
CD8
+
T cell priming and cytotoxicity. Parasite-specific CD8
+
T cells are primed in the spleen by 
CD8α+DCs (Lundie et al. 2008; Shaw et al. 2015), these CD8+T effector cells then migrate into 
the brain where they cause pathology (Haque et al. 2011; Howland et al. 2013; Lundie et al. 
2008). Brain-infiltrated CD8
+
T-cells do not require a second activation in the brain after 
activation in the spleen (Shaw et al. 2015). We therefore investigated whether the CD8
+
T cells 
in the spleen of the PbA-infected Ifnar ko were cytotoxic and able to recognize parasite-
specific antigen presented via MHC class I and to mount an Ag specific response. To this end, 
we performed an in vivo cytotoxic lysis assay, where we infected mice with transgenic PbAMA 
expressing ovalbumin. On day 5p.i., we injected defined amounts of fluorochrome-labelled 
splenocytes pulsed with MHC class I peptides SIINFEKL derived from ovalbumin and also 
from the parasite-endogenous antigen merozoite-surface protein 1 (MSP-1) and non-pulsed 
reference cells into PbA-infected mice and naïve control animals. After additional 18 hrs, the 
mice were sacrificed and splenocytes were isolated to determine the fluorescent signals via 
flow cytometry, which enabled us to calculate the specific cytolytic activity of peptide-specific 
T cells that were generated in immunized animals, but not in non-immune naïve control mice. 
Importantly we measured in both PbAMA infected WT and Ifnar ko mice comparable parasite 
specific CTL activity, which was demonstrated by a specific lysis of peptide-loaded target cells 
presenting OVA and MSP-1 peptides (Figure 18C&D). Figure 18A shows the summary of the 
experiment layout and the cells were gated as indicated in Figure 18B. The CTL activity was 
calculated against naïve control that also received target cells but should not be able to 
recognise or lyse these cells as they have not yet encountered the Ag. 
These data demonstrated that there was efficient parasite specific priming and cytotoxic CD8
+
 
T-cells lytic activity in the spleen of all the infected mice. This was further confirmed by 
granzyme-B expression and production by splenocytes of only infected animals and not by 
naïve mice (Figure 18E-G). The expression levels of granzyme-B on CD8
+
T cells was 
comparable among almost all the infected groups, with the mice having the comparable 
frequencies of granzyme-B
+
CD8
+
 T cell population, (Figure 18 E&F).  
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Figure 18 CD8
+
T-cells in the spleen of Ifnar ko were able to recognise and mount an Ag specific response 
C57BL/6 mice (WT, Ifnar1
-/-
, LysM
Cre
Ifnar1
fl/fl
 and CD11c
Cre
Ifnar1
fl/fl
) mice were infected with 5x10
4
 transgenic 
PbAMA expressing OVA. On d+5p.i., target cells were prepared from syngeneic naive donor mice by pulsing 
them with MHC- class I peptides SIINFEKL and peptides from MSP-1, labelled with fluorochromes FarRed and 
CFSE respectively, and were then injected i.v into the naïve uninfected and PbAMA infected mice. Another 18 
h later, cytolytic activity was measured and calculated against naïve controls. A) Experiment layout B) 
Schematic of how cells were gated. C&D) Measurement of in vivo kill of MSP-1 and SIINFEKL loaded target 
cells. E) Representative histograms of granzyme-B expression on CD8
+
T cells. F) Frequency of granzyme-
B
+
CD8
+ 
T cells. G) ELISA analysis of granzyme–B production by splenocytes. Statistics= One way ANOVA with 
Bonferroni post test. n=4/5 animals per group. 
A 
D 
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Granzyme-B was not only being expressed, but was also being released as shown by ELISA 
assay, except for PbA-infected CD11c
Cre
Ifnar1
fl/fl
 mice, which showed decreased granzyme-B 
levels, the other infected groups were comparable (Figure 18G).  
Expression of CD11c on CD8
+ 
T cells was observed among all infected mice, but not among 
the naïve mice (Figure 18H), interestingly, infected Ifnar1
-/- 
mice had more CD11c
+
CD8
+
T-
cells in their spleen than the infected WT mice (Figure 18H). Taken together, these results 
show that lack of type I IFN signalling was dispensable in induction of CTL response in the 
spleen, as splenic parasite-specific CD8
+
T cell were efficiently generated. However, there were 
more cytotoxic CD8
+
T-cells in the spleens of Ifnar1
-/- 
mice, which could be a result of 
inefficient activation or rather active retention in the spleen. 
3.2.3 Lack of type I IFN signalling did not change time points of innate and 
adoptive immune response during PbA infection 
Furthermore, we addressed the question, whether the lack of type I IFN signalling might 
influence the immune milieu already during the early phases of PbA infection. Therefore, we 
next compared two different time points of infection; we examined d+2 post infection to 
analyse the innate immune responses and d+5 before the exit of the primed effector cells from 
the spleen. In addition, we analysed naïve WT and naïve ko mice to define the baseline. 
We observed on d+2 p.i. an increase of splenic DCs among all the infected groups when 
compared to the non-infected control animals. Although the increase in DCs was observed in 
both infected WT and Ifnar ko in comparison to the naïve, infected WT had the highest 
increase of splenic DC populations on d+2 in comparison to the infected Ifnar ko, with 
significant difference to LysM
Cre
Ifnar1
fl/fl 
and CD11c
Cre
Ifnar1
fl/fl 
mice (Figure 19A). However, 
a sharp decline in the number of DCs was observed on d+5 among the infected WT in 
comparison to d+2, with decline resulting in the values at d+5 being comparable to the naïve 
(Figure 19A). The increase in the total DCs cell counts resulted in elevated amounts of 
CD8α+DCs and CD8αnegDCs on d+2, with the highest increase being observed among the 
infected WT mice (Figure 19B &C). We detected similar amounts of CD8α+DCs on d+2 
among infected Ifnar1
-/-
 and LysM
Cre
Ifnar1
fl/fl 
mice, however, this population was decreased in 
splenic samples from CD11c
Cre
Ifnar1
fl/fl 
mice (Figure 19B), whereas the population of CD8αneg 
DCs was increased comparably on day 2 among all the groups (Figure 19C). On day 5p.i, the 
total cell counts of CD8α+DCs and CD8αnegDCs were strongly reduced among all the infected 
groups (Figure 19B&C).  
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Figure 19 Ifnar ko were not delayed in induction of both innate and adoptive immune response 
C57BL/6 mice (WT, Ifnar1
-/-
, LysM
Cre
Ifnar1
fl/fl
 and CD11c
Cre
Ifnar1
fl/fl
) were infected with 5x10
4
 PbAMA iRBCs i.v. 
On d+2 p.i and d+5 p.i., spleens were harvested, digested, and single cell suspensions prepared. The cells were 
counted, stained and analysed using flow cytometry. (A-F) Compares cells counts between (d+0) un-infected 
naive, d+2 and d+5, for total DCs, CD8
+
DCs, CD8
neg
DCs, CD11b
+
, total T cells and CD8
+
T cells, (G-O) Shows 
expression levels of co stimulatory molecules and MHC class-II on APC populations (P-Q) Production of IL-6 and 
IFNγ measured by ELISA from supernatants of spleen cells from d+2. Statistics= One-way ANOVA with 
Bonferroni post test analysis, n=3/4 animals per group. 
We observed at first a slow increase in the total cell count of CD11b
+
 on d+2p.i. in relation to 
the counts of the naïve in all the infected mice (Figure 19D). But by d+5p.i, the CD11b 
population had increased significantly as compared with d+2 p.i, with 2x fold increase in 
infected WT, 5x in infected Ifnar1
-/-
, and 3.8x in LysM
Cre
Ifnar1
fl/fl
 and CD11c
Cre
Ifnar1
fl/fl
 mice 
(Figure 19D). 
Total T cell count cells and its CD8
+ 
T cells fraction were comparable between the infected 
groups and the naïves on d0 and d2, but importantly, with an increase being observed on d5 
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(Figure 19E & F). We observed slightly elevated numbers of CD8
+ 
T cells among the infected 
WT on d+2 compared to the infected Ifnar ko mice, however, this difference was not 
statistically significant (Figure 19F). On d+5 p.i., PbA-infected Ifnar ko mice contained the 
strongly elevated numbers of CD8
+ 
T cells in comparison to the infected WT, with the highest 
increase being observed among the LysM
Cre
Ifnar1
fl/fl
 mice (Figure 19 F). 
The expression levels of MHC class-II molecule and co stimulatory molecules CD86 and 
CD40 on DCs on d+2 were comparable among all the animals, with the exception of 
CD11c
Cre
Ifnar1
fl/fl mice, which had increased expression of CD86 on CD8α+DCs (Figure 19G-
L). We detected enhanced expression of CD40, CD86 and MHC class-II molecule by CD11b
+
 
cells in samples from the infected CD11c
Cre
Ifnar1
fl/fl
 mice in comparison to the naïve control 
mice and to all the other infected groups (Figure 19M-O). Interestingly, we observed early 
production of IL-6 and IFNγ in the supernatant from LysMCreIfnar1fl/fl mice; here, IFNγ was 
statistically significant from naïve and other infected ko group, but not to the infected WT mice 
(Figure 19P & Q). Taken together our data show that induction of innate and adoptive immune 
response was not impaired or delayed in ECM protected mice. Also, we observed early 
production of pro-inflammatory cytokines among the infected LysM
Cre
Ifnar1
fl/fl
 mice, which 
could have had a role in their observed protection ECM. 
3.2.4 Splenocytes of Ifnar1-/- and LysMCreIfnar1fl/fl produced both pro and anti- 
inflammatory cytokines at balance. 
Plasmodium infection is characterised by the production of both pro- and anti-inflammatory 
cytokines. Next, we evaluated whether differences in cytokine production might have a role in 
the ECM protection that we had observed among PbA-infected Ifnar1
-/-
 and LysM
Cre
Ifnar1
fl/fl
 
mice. We analysed on day 6 p.i. the production of the pro-inflammatory cytokines TNF, IFNγ 
and IL-6, as well as the anti- inflammatory cytokine IL-10 in splenocyte cultures from the 
different experimental groups. 
We measured increased levels of IFNγ in splenocytes cultures prepared from PbA-infected WT 
and Ifnar ko mice in comparison to the naïve mice, which - as expected - did not produce any 
IFNγ, while cells from PbA-infected CD11cCreIfnar1fl/fl produced higher amounts in 
comparison to the samples of PbA-infected WT mice (Figure 20A). In contrast to our 
observation in the brain-derived primary cells, TNF was highly produced by splenocytes from 
infected Ifnar1
-/-
 and LysM
Cre
Ifnar1
fl/fl 
mice in comparison to samples from the naïve control 
mice (Figure 20B). Samples from infected WT and CD11c
Cre
Ifnar1
fl/fl
 mice contained increased 
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TNF levels, however, when compared to the splenocyte cultures from naïve mice, infected 
Ifnar1
-/-
 and LysM
Cre
Ifnar1
fl/fl 
mice, no statistical significance was observed (Figure 20 B). We 
were surprised to observe strong production of IL-6 by splenocytes of infected Ifnar1
-/- 
and 
LysM
Cre
Ifnar1
fl/fl
 mice, as their levels were significantly higher than the PbA-infected WT 
mice, whose values were comparable to the naive control mice (Figure 20 C). 
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 Figure 20 Splenocytes from Ifnar ko produced both pro- and anti- inflammatory cytokines 
C57BL/6 (WT, Ifnar1
-/-
 , LysM
Cre
Ifnar1
fl/fl
 and CD11c
Cre
Ifnar1
fl/fl
) mice were infected with 5x10
4
 PbAMA iRBCs i.v. 
On d+6 p.i., spleens were harvested, digested, and single cell suspensions prepared. The cells were counted 
and 1x10
6
 cells plated in triplicates in 96 well plates, the cultures were then incubated for 24hrs at 37
0
C. 
Supernatants were collected and ELISA performed as described in methods. (A) IFNγ Production (B) TNF 
production. (C) IL-6 production.(D) IL-10 production (E) Ratio of IFNγ:IL-10 . Statistics = One-way ANOVA with 
Bonferroni post test analysis. n=3/4/5 animals per group. 
Splenocytes from PbA-infected LysM
Cre
Ifnar1
fl/fl
 produced almost twice as much IL-6 as cells 
from infected Ifnar1
-/-
 mice and thrice as much as the splenocytes from PbA-infected WT and 
the naïve mice (Figure 20C). We did not observe a significant induction of IL-10 production in 
the splenocyte cultures of infected WT mice compared to the naïve mice (Figure 20D). but 
importantly, splenocytes from infected Ifnar1
-/-
 mice produced the highest amounts of IL-10, 
which was 5x more than the splenocytes from naïve, 3x more than those of the infected WT 
and 1.5x times more than the infected LysM
Cre
Ifnar1
fl/fl
 (Figure 20D). Splenocytes from PbA-
infected LysM
Cre
Ifnar1
fl/fl
 produced three and two times more IL-10 than those from naïve and 
A B C 
D E 
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those from PbA-infected WT mice respectively, while splenocytes from CD11c
Cre
Ifnar1
fl/fl
 
produced four times more than from naïve and  2x more than from infected WT, respectively 
(Figure 20D). This increase resulted in a distinct shift of the ratio of IFNγ vs IL-10 in ECM-
negative groups of mice (Figure 20E). Taken together, this data suggest a role of IL-10 
produced by splenocytes of PbA-infected Ifnar1
-/-
 and LysM
Cre
Ifnar1
fl/fl 
mice in counteracting 
IFNγ, and probably controlling inflammation that occurs during PbAMA infection. 
3.2.5 Altered CD4+:CD8+ T-cell ratio in the spleens of infected Ifnar ko mice 
We have shown that upon PbA infection, the priming of effector CD8
+
T cells in the spleens of 
Ifnar ko was apparently unimpaired and comparable to that of the infected WT mice, since the 
infected groups of Ifnar ko mice were able to recognise and lyse peptide-loaded target cells 
(Figure 18C&D). Interestingly, Ifnar ko mice presented pronounced splenomegaly and 
increased total cell counts (Figure 17A-C). We next evaluated splenocyte populations in 
details; first we analysed the T cells as these are the major effector cell population during ECM 
and made responsible for pathology.  
We did not observe a difference between the cells from infected WT mice and the naïve in the 
total number of splenic CD3
+ 
T cell, CD8
+ 
T cells or CD4
+
T cells (Figure 21A-C). But, 
importantly the infected Ifnar ko presented with an increase in splenic cell counts of CD3
+
T 
cell, CD8
+
T cells and CD4
+
T cells in comparison to the naïve and WT infected mice (Figure 
21A-C). Infected Ifnar1
-/-
 mice had increased CD3
+
T cells counts in their spleen samples, this 
was an average fold increase of; 2.4x to the naïve, 2.2x to the infected WT, 1.4x to the infected 
LysM
Cre
Ifnar1
fl/fl
 mice but comparable to the CD11c
Cre
Ifnar1
fl/fl
 (Figure 21A). This increase in 
total T cell counts resulted in a significant increase in CD8
+
T cells counts in spleens of Ifnar1
-/-
 
mice, with fold increase of; 2.8x to the naïve, 2.5x to the infected WT and 1.4x to the infected 
LysM
Cre
Ifnar1
fl/fl 
mice (Figure 21B). We also measured increased cell counts of CD4
+
T on 
splenocytes from Ifnar1
-/-
 mice, with fold increase of ~1.7% (+0.2%) to the naïve and infected 
WT mice, whereas, the counts were comparable to the infected LysM
Cre
Ifnar1
fl/fl 
and 
CD11c
Cre
Ifnar1
fl/fl
 mice (Figure 21C). Splenocytes samples of infected LysM
Cre
Ifnar1
fl/fl
 mice 
had increased CD3
+
T cells counts, resulting in high CD8
+
T cells count, with a fold increase; of 
~1.86% (+0.1%) to the naïve and infected WT mice (Figure 21B). The CD4
+
T cell counts from 
the spleen samples of infected LysM
Cre
Ifnar1
fl/fl 
mice were equally increased in comparison to 
the naïve and the infected WT with fold increase of ~1.5% (+0.15%) to the naïve and infected 
WT mice (Figure 21C). While infected CD11c
Cre
Ifnar1
fl/fl
 had comparable values of CD3
+
 T 
cells, CD8
+
 T cells and CD4
+
 T cells to the infected Ifnar1
-/-
 mice (Figure 21A-C). 
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Figure 21 Altered CD4:CD8 ratio in PbA-infected Ifnar ko 
C57BL/6 mice (WT, Ifnar1
-/-
, LysM
Cre
Ifnar1
fl/fl
 and 
CD11c
Cre
Ifnar1
fl/fl
) were infected with 5x10
4
 transgenic PbAMA 
expressing OVA. On d+6 p.i spleens were harvested, digested 
for single cell suspensions and analysis using flow cytometry. 
(A)Total count of splenic CD3
+
 T cells, B) Total count of splenic 
CD8
+
 T cells C) Total count of splenic CD4
+ 
T cells D) Total 
percentage of C3
+
 T cells in the spleen. E) Percentage frequency 
of CD8
+
T cells from the CD3
+
 T cells population. F) Percentage 
frequency of CD4
+
T cells from the CD3
+
 T cells population. (G) 
Ratio of CD4:CD8 T cells in the spleen. Statistics = One way 
ANOVA with Bonferroni post test analysis. n=4/6 animals per 
group, Data representative of more than 5 independent 
experiments. 
The percentage of total T cells in the spleen were comparable among the naïve, infected WT, 
Ifnar1
-/-
 and LysM
Cre
Ifnar1
fl/fl
 mice, however, CD11c
Cre
Ifnar1
fl/fl
 had a significant increase in 
their percentage of splenic T cells (Figure 21D). Most important, we observed a major switch 
in the frequency of CD8
+
T cells and CD4
+
T cells in the spleen of the infected Ifnar ko, with 
CD8
+
T cells being the major population in their spleens and not CD4
+
T cells (Figure 21 E-F). 
This increase in the total count and shift in frequency of CD8
+
T cells, resulted in an altered 
CD4:CD8 ratio among the Ifnar ko (Figure 21G). Taken together, the altered CD4:CD8 ratio 
indicates either that the observed protection from ECM might be due to inefficient activation, 
or actively blocked emigration of CD8
+ 
T cells from the spleen after priming and proliferation. 
G 
F 
A B 
D 
C 
E 
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3.2.6 Spleens of Ifnar ko mice contained high percentage of CXCR3+CD8+T cells  
As we have demonstrated above, the cytotoxic activity and the priming of CD8
+
T cells was 
apparently unimpaired in ECM negative PbA-infected Ifnar ko mice in comparison to ECM 
positive PbA-infected WT mice. However, we also observed accumulation of T cells in the 
spleens of Ifnar ko mice. We next addressed the question whether the retained T cells displayed 
a different phenotype to that of the equivalent T cells in the spleens of PbA-infected WT mice, 
which suffered from ECM. We therefore compared the expression of activation markers LFA-
1α (CD11a), CD69, PD-1, CTLA-4 and intercellular adhesion molecule ICAM-1. We also 
examined for expression of chemokine receptors CCR5, CXCR3 and CCR7, which have been 
shown to have a role in the migration of T cells into the brain during ECM (Belnoue et al. 
2003; Zhao et al. 2014; Van den Steen et al. 2008). 
We observed increased expression of activation markers CD69, CD11a, ICAM-1, as well as of 
regulatory markers CTLA-4 and PD-1 on splenic CD8
+
T cells in all PbA-infected animals in 
comparison to the naïve (Figure 22A-E). Expression of CD69, CD11a, ICAM-1 and CTLA-4 
on splenic CD8
+
T cells was equally elevated in the infected WT and infected ko mice (Figure 
22A-D). Although the splenic CD8
+ 
T cells from infected Ifnar1
-/-
 had increased levels of PD-1 
in comparison to the naïve mice, these levels were significantly lower than the infected WT 
mice and infected CD11c
Cre
Ifnar
fl/fl
 mice (Figure 22E). We observed a slight but non-
significant increase in the percentage of CD8
+
T cells expressing CCR5 in the spleens of 
infected WT mice in comparison to the naïve control mice, which ,as expected, did not express 
this inflammatory chemokine receptor (Figure 22F). The percentage of splenic CD8
+
T cells 
expressing CCR5 was significantly higher among the infected Ifnar ko mice in comparison to 
the infected WT mice (Figure 22F). CXCR3 was strongly expressed only on CD8
+
T cells of 
infected mice but not on CD8
+
T cells of naive mice (Figure 22G). Importantly, we observed 
significantly elevated frequency of CXCR3
+
CD8
+
T cells in the spleens of the infected Ifnar ko 
mice, (16%+3 difference), in comparison to the infected WT mice (Figure 22G). The 
percentage of splenic CD8
+
T expressing CCR7 was increased in samples from all the infected 
groups of mice in comparison to the naïve, although infected CD11c
Cre
Ifnar1
fl/fl
 had higher 
percentages in comparison to the other infected groups of mice (Figure 22H). 
These data show that the CD8
+
 T cells from ECM negative ko mice expressed similar levels of 
activation markers as those of the infected WT, with the exception of PD1. Strikingly, PbA-
infected ko mice contained more CD8
+ 
T cells expressing the important chemokine receptors 
required for emigration from the spleen, suggesting the arrest or retention of these CD8
+ 
T cells 
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in the spleens of the Ifnar ko mice was not due to the lack of activation or lack of expression of 
the chemotaxis receptors. 
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Figure 22 CD8
+
 T cells of Ifnar ko display an activated status during PbAMA infection 
C57BL/6 (WT, Ifnar1
-/-
, LysM
Cre
Ifnar1
fl/fl 
and CD11c
Cre
Ifnar1
fl/fl
) mice were infected with 5x10
4
 transgenic PbAMA 
expressing OVA, on d+6 p.i ,spleens were harvested, digested and single cell suspensions prepared. The cells were 
counted, stained and analysed using flow cytometry. (A-E) Expression of CD69, CD11a, ICAM-1, CTLA-4 and PD1 
on CD8
+ 
T cells. (F-G) Percentages of splenic CD8
+
T cells expressing CCR5, CXCR3 and CCR7. Statistics = One-way 
ANOVA with Bonferroni post test analysis. n=4/5 animals per group. 
3.2.7 CD4+T cells of lfnar ko developed a similar Th-1 response as the WT 
We further investigated if the protection from ECM in PbA-infected Ifnar ko mice we had 
observed was due to alteration in splenic CD4
+ 
T cells. As malaria is a T-helper 1 (Th-1) driven 
disease, we questioned whether the protection we had observed in the ECM protected mice was 
due to a shift of the subtype, from a Th-1 to either a regulatory or anti inflammatory CD4
+
 T 
cell subtype in the splenic milieu, as mice deficient of the transcriptional factor T-bet have 
A B C 
F G H 
D E 
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been shown to be 70% protected from ECM (Oakley et al. 2013). We therefore analysed on 
day 6 p.i  splenic CD4
+
CD3
+ 
T cells for presence of the different CD4
+
 T cell subsets, by 
analysing the expression of their phenotype driven transcription factors; T-bet for Th-1, 
GATA3 for Th-2, FoxP3 for T-regs and RoRγ for Th-17. We also analysed the expression 
pattern of activation markers, adhesion molecules chemokine receptors and cytotoxic granules 
on splenic CD4
+
T cells, similar to the analysis of the CD8
+
T cells described above.  
We observed in all the PbA-infected mice an increased percentage of splenic CD4
+
T cells 
displaying a Th-1 phenotype, characterised as CD4
+
T cells expressing the transcription factor 
T-bet, Tbet
+
CD4
+
CD3
+
CD8
neg
NK1.1
neg
 (Figure 23A & B). The percentage of CD4
+
T cells 
expressing a Th-1 phenotype was significantly higher (~24%) among the infected WT mice in 
comparison to the naïve control mice that had only ~3% of their CD4
+
 T cells expressing T-bet 
(Figure 23A & B). Importantly, we observed that the splenic CD4
+
T cells of ECM-protected 
mice contained a clear Th-1 population, PbA-infected Ifnar1
-/-
 mice had an average 20% more 
splenic CD4
+
T cells expressing T-bet compared to the infected WT mice (Figure 23A & B). 
The percentage of splenic Th-1 cells in samples from the infected LysM
Cre
Ifnar1
fl/fl 
mice were 
comparable to the infected WT, and significantly lower than the infected Ifnar1
-/-
 mice and 
CD11c
Cre
Ifnar1
fl/fl 
mice (Figure 23B). We observed an elevated splenic Th-1 population in 
infected CD11c
Cre
Ifnar1
fl/fl 
mice in comparison to the infected WT mice, however, the 
percentage were significantly lower than in the infected Ifnar1
-/-
 mice (Figure 23B). The 
percentage of splenic CD4
+
 T cells that expressed the transcription factor FoxP3, T-regs, were 
significantly reduced among all the infected groups of mice in comparison the naïve control 
mice (Figure 23A & C). The percentage of splenic CD4
+
T that had differentiated into T-regs, 
were comparable among the infected WT, Ifnar1
-/-
 and CD11c
Cre
Ifnar1
fl/fl 
mice, however, the 
infected LysM
Cre
Ifnar1
fl/fl 
mice
 
had significantly higher percentages than the other infected 
groups of mice (Figure 23A & C). The percentage of splenic CD4
+ 
T cells expressing 
granzyme B was increased among all the infected groups of mice in comparison to the naïve, 
with the Ifnar ko having a significantly higher percentage of these cells in compared to the 
infected WT mice (Figure 23D). We did not detect any hints indicative for splenic Th-2 or Th-
17 cells in samples from all the mice groups, through the analysis of their transcriptional 
factors GATA3 and RORγ T (data not shown). 
Regarding the expression of activation or regulatory surface markers, we observed elevated 
expression of CD69, PD1and ICAM-1 on splenic CD4
+
T-cells among all infected animals in 
comparison to the naïve (Figure 23E, F&G). Expression of CD69 on splenic CD4
+
T cells in 
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samples from infected WT were comparable to the infected LysM
Cre
Ifnar1
fl/fl
 mice, but were 
higher than in the infected Ifnar1
-/- 
mice (Figure 23 E). Even though all the infected groups of 
mice had elevated levels of PD1 and ICAM-1 on splenic CD4
+
T cells, CD11c
Cre
Ifnar1
fl/fl
 mice 
had significantly higher levels than the other infected groups of mice (Figure 23F & G). 
Although, we observed increased expression of CTLA-4 on splenic CD4
+
T cells of the infected 
WT mice, this was statistically insignificant in comparison to the levels on T cells of naïve and 
infected Ifnar ko mice (Figure 23H).  
We did not observe any differences in the percentage of splenic CD4
+
T cells expressing CCR5 
and CCR7 between the naïve control and the infected WT mice (Figure 23I & J). The 
percentage of splenic CD4
+
T cells expressing CCR5 was ~13% (+1) more in all the infected 
Ifnar ko mice in comparison to the infected WT mice (Figure 23I). The frequency of splenic 
CD4
+
T cells expressing CCR7 were higher in the infected Ifnar1
-/-
 mice in comparison to the 
naïve control and the other infected groups of mice (Figure 23J). In general, splenic CD4
+
T 
cells in samples from the infected groups of mice expressed more CXCR3 in comparison to the 
T cells from naïve mice (Figure 23K). Importantly, infected Ifnar1
-/-
 had the highest frequency 
of CXCR3
+
CD4
+
T cells in their spleen compared to the other infected mice, this increase was; 
~20%x more than infected WT mice, ~8%x more than infected LysM
Cre
Ifnar1
fl/fl
 mice and 
~9.5%x more than infected CD11c
Cre
Ifnar1
fl/fl
 mice (Figure 23K). Infected LysM
Cre
Ifnar1
fl/fl
 
and CD11c
Cre
Ifnar1
fl/fl
 mice both contained more splenic CXCR3
+
CD4
+
 T cells in comparison 
to the infected WT mice (Figure 23K).  
Taken together, these results show that the lack of type I IFN receptor did not alter the 
development of a Th-1 phenotype associated with Plasmodium infection. Importantly, we 
observed an increase in the frequency of Th-1 cells as well as the increase of CD4
+
CXCR3
+
 T 
cells in the spleens of Ifnar1
-/-
. This data also indicate that the T-regs had no major role in the 
protection observed among the Ifnar1
-/-
 as their levels were reduced. We also observed 
differences between LysM
Cre
Ifnar1
fl/fl
 and Ifnar1
-/-
 in the composition of their splenic CD4
+ 
T 
cells, although both groups had displayed the same phenotype during the analysis of their 
brains. 
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Figure 23 All infected mice express Th1 phenotype 
C57BL/6 mice (WT, Ifnar1
-/-
, LysM
Cre
Ifnar1
fl/fl 
and CD11c
Cre
Ifnar1
fl/fl
) 
mice were infected with 5x10
4
 transgenic PbAMA iRBCs i.v. On d+6, 
spleens were harvested, digested, and single cell suspensions 
prepared. The cells were counted, stained and analysed using flow 
cytometry. A) Raw data from representative samples of every 
experimental group. B) Frequency of Th-1 cells 
(Tbet
+
CD4
+
CD3
+
CD8
neg
NK1.1
neg
). C) Frequency of T-regs 
(FoxP3
+
CD4
+
CD3
+
CD8
neg
NK1.1
neg
). D) Frequency of granzymeB
+
CD4
+ 
Tbet
neg
CD3
+
CD8
neg
NK1.1
neg
 T cells. (E-H) Expression level of CD69, PD-
1, ICAM-1 and CTLA-4 on CD4
+
T cells. (I-K) Frequency of CD4
+
T cells 
expressing chemokine receptors; CCR5, CCR7 and CXCR3. Statistics= 
One-way ANOVA with Bonferroni post test analysis. n=4/5 animals per 
group.  
3.2.8 Ifnar deficiency did not impair NK cell cytotoxicity 
NK cells play an important role during innate immune response, as these lymphocytes kill and 
neutralize infected cells without requiring any priming from APCs. During P. berghei 
infection, splenic NK cells numbers decrease in the spleens of ECM susceptible mice (Hansen 
et al. 2007), the Hansen group hypothesised that these phenomenon could be due to high 
turnover or due to migration of these cells out of the spleen. Here, we quantified NK cells in 
the spleen and assessed their expression of granzyme-B in PbA-infected mice.  
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Figure 24 Ifnar deficiency does not impaire NK cytotoxicity 
C57BL/6 (WT, Ifnar1
-/-
, LysM
Cre
Ifnar1
fl/fl 
and CD11c
Cre
Ifnar1
fl/fl
) mice were infected with 5x10
4
 PbAMA iRBc i.v. 
On d+6 p.i, spleens were harvested, digested, and single cell suspensions prepared. The cells were counted, 
stained and analysed using flow cytometry. (A) Total calculated number of NK cells in the spleen (B) 
Percentage of NK cells in the spleen (C) Frequency of NK cells expressing granzyme-B. Statistics= One-way 
ANOVA with Bonferroni post test analysis, n=4/5 animals per group. 
We observed a significant decrease in the total number of splenic NK cells among the infected 
mice, with fold decreases of; 3.3x in infected WT, 1.5x in infected Ifnar1
-/-
, 3x in infected 
LysM
Cre
Ifnar1
fl/fl
 and 2.4x in infected CD11c
Cre
Ifnar1
fl/fl
 mice, in comparison to the naïve mice 
(Figure 24A). PbA-infected Ifnar1
-/-
 mice showed the least reduction in cell numbers, with the 
total counts being double those of infected WT and LysM
Cre
Ifnar1
fl/fl
, but not varying 
A B
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significantly to that of CD11c
Cre
Ifnar1
fl/fl 
(Figure 24A). The decrease in NK cells in samples 
from the infected mice was also observed in the percentages of these cells in the spleen (Figure 
24 B). We detected significant increase in the percentage of granzyme-B expression by NK 
cells in sample from all the infected groups of mice, in comparison to the naïve mice (Figure 
24C). Taken together, these data shows that the lack of the Ifnar did not impair NK 
cytotoxicity. 
3.2.9 Decreased percentage of splenic B cell in PbA-infected ko mice. 
In immune response B cell can perform several functions; they can act as effector cells and 
produce antibodies or as APCs. As CD8
+
T cell are the accepted effector cells during PbA 
infection, we analysed splenic B cell as APC. We analysed their expression of MHC class II, 
CD86 and ICAM-1.  
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Figure 25 splenomegally on Ifnar ko resulted in difference in B cell counts and percentages 
C57BL/6 mice (WT, Ifnar1
-/-
, LysM
Cre
Ifnar1
fl/fl 
and CD11c
Cre
Ifnar1
fl/fl
) mice were infected with 5x10
4
 PbAMA 
iRBCs i.v. On d+6 spleens were harvested, digested, and single cell suspensions prepared. The cells were 
counted, stained and analysed using flow cytometry. A) Total count of B cells in the spleen analysed by 
expression of CD19 (B) Total percentage of B cells in the spleen (C-E) Expression levels of ICAM-1, CD86 and 
MHC class-II on B cells. Statistic= One-way ANOVA with Bonferroni post test analysis, n=4/5 animals per group.
 
 We did not observe a difference in the total B cell count between the naïve, infected WT, 
Ifnar1
-/-
 and LysM
Cre
Ifnar1
fl/fl 
mice, however, PbA-infected CD11c
Cre
Ifnar1
fl/fl
 had reduced 
counts in comparison to infected WT and Ifnar1
-/-
 mice (Figure 25A). The total percentage of 
C D E 
A B 
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splenic B cells was comparable between the infected WT and the naïve control mice (Figure 
25B). Interestingly, and contrary to the counts, all infected Ifnar ko had decreased percentage 
of B cells in their spleen in comparison the naïve mice (Figure 25B). Infected Ifnar1
-/-
 mice had 
the lowest B cell percentages in their spleen, with mean percentage decrease of 29% to the 
naïve and 23% to the infected WT mice (Figure 25B).  The percentage of B cells in the spleens 
of infected LysM
Cre
Ifnar1
fl/fl
 mice was not significantly different to that of the infected WT 
mice, however in comparison to the infected Ifnar1
-/-
 mice, they had 16% more cells (Figure 
25B). While CD11c
Cre
Ifnar1
fl/fl
 had mean decrease of 18% and 14% to the naïve and infected 
WT mice, but they did not differ significantly to the infected Ifnar1
-/-
 and LysM
Cre
Ifnar1
fl/fl 
mice
 
(Figure 25B). Splenic B cells from all infected groups of mice showed an increased 
expression of ICAM-1 in comparison to those of the naïve mice, however, the levels were 
higher in the Ifnar ko in comparison to the infected WT mice (Figure 25C). The expression 
levels of CD86 on splenic B cells were increased in all the infected mice, although there was 
no statistical significance between cells from LysM
Cre
Ifnar1
fl/fl
 and those from naïve mice 
(Figure 25D). We observed reduced MHC class-II expression on splenic B cells from samples 
of all the infected groups of mice, although the values were decreased among the Ifnar1
-/-
 mice, 
they were not statistically different to those of the naïve control mice (Figure 25E).  
Taken together, these data show that the splenomegaly observed among the Ifnar ko lead to the 
difference in percentage and total count of B cells in the spleen and although there was a 
decreased total percentage of B cells, the total count remained high. The data show reduced 
expression of Ag presenting molecules but elevated expression of co-stimulatory molecules on 
B cells among all infected ko, but varying levels of expression. 
3.2.10 Ifnar1-/- mice had increased amounts splenic conventional dendritic cells 
DCs play a role in the innate immunity, but their most important role is to link the innate with 
the adoptive immune system. After they encounter the pathogen or its associated molecules, 
the DCs process and degrade them into peptides, and these are then presented via MHC 
molecules to naïve T cells. DCs expressing the peptide via MHC molecules, must also express 
co-stimulatory molecules in order to activate naïve T cells properly. DCs are classified as 
either plasmocytoid dendritic cells (pDCs) or conventional dendritic cells (cDCs). During 
infection with Plasmodium berghei, cDCs have been shown to induce CD4
+
 T cell activation 
(deWalick et al. 2007), deWalick also excluded any major role of pDCs in pathogenesis of 
ECM. Lundie et al. further showed that CD8α+DCs are the major APCs to prime and induce 
proliferation of CD8
+
T cells (Lundie et al. 2008).  
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We have already shown an unimpaired T cells response in the spleen of the Ifnar ko mice, 
since CD8
+
T cells were able to recognise parasite derived peptides presented via MHC class-I 
(Figure 18). This ability of CD8
+
T cell to recognise Ag indicates that there was efficient 
priming of the T cells by APCs. As DCs have already been shown to be key APCs during 
ECM, we investigated whether the lack of type I IFN signalling influenced the DC phenotype 
during PbAMA infection. We characterized splenic DCs, first as CD11c
+
MHC class II
+
CD3
-
CD19
- and then further into CD8α+ and CD8αneg DCs. In these DC subsets, we looked for 
expression levels of co-stimulatory molecule CD86 and adhesion molecule ICAM-1, which are 
necessary for T cell activation.  
We observed a non significant decrease in the total count of DCs in spleens of infected WT in 
comparison to the naïve control mice (Figure 26A). LysM
Cre
Ifnar1
fl/fl 
and CD11c
Cre
Ifnar1
fl/fl
 
contained in their spleens more DCs in comparison to their appropriate naïve ko mice, 
however, the difference was statistically insignificant (Figure 26A). Splenic DCs count among 
infected LysM
Cre
Ifnar1
fl/fl 
and CD11c
Cre
Ifnar1
fl/fl
 were not significantly different to the infected 
WT mice (Figure 26A). Interestingly, infected Ifnar1
-/-
 had a 3.4 (+0.3) fold increase in the 
total DCs count in comparison to naïve Ifnar1
-/- 
mice, LysM
Cre
Ifnar1
fl/fl 
and CD11c
Cre
Ifnar1
fl/fl
 
mice and a 10x fold increase in comparison to infected WT mice (Figure 26A). Frequencies of 
splenic DCs in infected WT mice were significantly reduced, with mean difference of 0.7% in 
comparison to naïve, infected LysM
Cre
Ifnar1
fl/fl
 and CD11c
Cre
Ifnar1
fl/fl
 mice (Figure 26D). The 
increase in total DCs calculation among infected Ifnar1
-/-
 mice was also observed as 
percentages, which resulted in mean differences of 1.4% to naïve Ifnar1
-/-
 mice, 2.7% to 
infected WT, ~1.8% to LysM
Cre
Ifnar1
fl/fl
 and CD11c
Cre
Ifnar1
fl/fl
 mice (Figure 26D). 
The same trend indicating decreased cell count of CD8α+DCs was observed in the spleens of 
the infected WT, LysM
Cre
Ifnar1
fl/fl
 and CD11c
Cre
Ifnar1
fl/fl
 mice with significant differences to 
their respective naïve controls (Figure 26B). Unlike the other infected groups, PbA-infected 
Ifnar1
-/- 
mice contained comparable levels of splenic CD8α+ DC to their naïve ko control, but 
differed in comparison to the other infected mice with 5.2x fold increase to infected WT, 2.8x 
to infected LysM
Cre
Ifnar1
fl/fl
 and 1.7x to CD11c
Cre
Ifnar1
fl/fl
 mice (Figure 26B).  
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Figure 26 Ifnar
-/- 
had retention of Splenic cDCs. 
C57BL/6 mice (WT, Ifnar1
-/-
, LysM
Cre
Ifnar1
fl/fl 
and CD11c
Cre
Ifnar1
fl/fl
) were infected with 
5x104 PbAMA iRBCs i.v. On d+6, spleens were 
harvested, digested, and single cell 
suspensions prepared. The cells were counted, 
stained and analysed using flow cytometry.   
A) Total DC count. B&C) Counts of CD8α
+
DCs 
and CD8α
neg
DCs. D) Total percentage of DCs in 
the spleen. E&F) Frequency of CD8α
+
DCs and 
CD8α
neg
DCs. G-J) Expression of CD86 and 
ICAM-1 on CD8α
+
DCs and CD8α
neg
DCs. 
Statistics = One-way ANOVA with Bonferroni 
post test analysis. n=4/5 animals per group. 
Moreover, the infected Ifnar1
-/- mice had an increase in the total number of CD8αnegDCs in 
their spleens in comparison to the other infected groups, with 4.6x fold increase to naïve 
Ifnar1
-/-
, 10x to infected WT, 3.2 (+0.2)x to infected LysM
Cre
Ifnar1
fl/fl
 and CD11c
Cre
Ifnar1
fl/fl
 
mice (Figure 26C). Surprisingly, frequencies of CD8α+ DCs, were comparable and displayed 
an average reduction of ~17% (+2) in all the infected groups in comparison to their respective 
naïve groups (Figure 26 E). The decrease in the frequency of CD8α+DCs resulted in an 
increase in the frequency of CD8αneg DCs in all the infected animals (Figure 26F).  
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We did not observe any significant difference in the expression levels of CD86 on splenic 
CD8α+DCs between the naïve and the infected mice (Figure 26G). There was an increase in the 
expression of CD86 on CD8αnegDCs in spleen samples of the infected WT mice in comparison 
to those of the naïve and the Ifnar ko mice, we observed the least expression of CD86 on 
CD8αnegDCs among the infected Ifnar1-/- mice (Figure 26H). We did not observe an increase in 
ICAM-1 expression on either population of splenic DCs of the infected WT in comparison to 
those samples from the naïve (Figure 26 I&J). In contrast,
 
splenic DCs from Ifnar ko mice 
showed a significant increase in their ICAM-1 expression levels by both CD8α+ DC and 
CD8αnegDC in comparison to the naïve and infected WT mice, with CD11cCreIfnar1fl/fl having 
the highest ICAM-1 expression on CD8αnegDCs (Figure 26 I&J). These data show retention of 
DCs in the spleens of Ifnar1
-/-
 mice, resulting in an increase of the frequency of these cells in 
the spleen.  
3.2.11 Macrophages of Ifnar1-/- acquired an alternative activated phenotype 
During infection with Plasmodium parasites, splenic macrophages are among the first cells to 
come into contact with the parasite, this occurs during the process of clearing infected red 
blood cells. We next analysed the myeloid cells populations and addressed the question as to 
whether there was also retention of these cells in the spleens of ECM protected Ifnar1
-/-
 and 
LysM
Cre
Ifnar1
fl/fl
, and if so, whether the phenotype of these cells differed to that of infected 
WT. We characterized myeloid cells into neutrophils (Ly6G
hi
CD11b
hi
Ly6C
int
F4/80
neg
), 
monocytes (Ly6C
hi
CD11b
hi
F4/80
+
Ly6G
neg
) and alternative activated macrophages (Relm-
αhiF4/80hiCD11bhiLy6CintLy6Gint).  
We observed a significant decrease in the total percentage of splenic CD11b
+
 population in 
samples of PbA-infected WT, LysM
Cre
Ifnar1
fl/fl
 and CD11c
Cre
Ifnar1
fl/fl
 mice in comparison to 
the naïve control mice (Figure 27C). Importantly, infected Ifnar1
-/-
 mice had double the amount 
of splenic CD11b
+ 
cells in their samples in comparison to the other infected mice groups 
(Figure 27C). Although the infected WT, LysM
Cre
Ifnar1
fl/fl
 and CD11c
Cre
Ifnar1
fl/fl
 mice had 
decreased percentages of CD11b
+
 cells in their samples, the cell counts were comparable to the 
naïve mice (Figure 27D). Infected Ifnar1
-/- 
 mice continued to have substantial increase in the 
cell counts when compared to other groups, with fold increase of 2.7x to naïve, 3.1x to infected 
WT, 1.7x to infected LysM
Cre
Ifnar1
fl/fl
 and 2.2x to infected CD11c
Cre
Ifnar1
fl/fl
 mice (Figure 
27D). 
We further characterised / differentiated the CD11b
+
 population into inflammatory monocytes, 
macrophages and neutrophils. We gated the CD11b
+
 population as either F4/80 vs Relm-α or 
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Ly6C vs Ly6G. To confirm that these were three distinct populations, we next gated CD11b
+
 as 
F4/80 vs Ly6G and overlaid with populations that were Ly6C
hi
Ly6G
neg 
(inflammatory 
monocytes) F4/80
hi
Relm
hi
 (macrophages) and Ly6G
hi
Ly6C
int
 (neutrophils) (Figure 27A&B). 
More than 85% of the Ly6C
hi
Ly6G
neg
 population expressed CCR2
+
 hence confirming this 
population as inflammatory monocytes. The splenic CD11b
+
 population of the infected WT 
mice contained an average of 40.5% Ly6C
hi 
inflammatory monocytes, this increase was more 
than double the percentage in the naïve mice (Figure 27E). PbA infected Ifnar1
-/-
 and 
LysM
Cre
Ifnar1
fl/fl
 mice had comparable percentages of Ly6C
hi
 inflammatory monocytes to 
those of the naïve mice, while CD11c
Cre
Ifnar
fl/fl
 mice had ~15% more cells in comparison to 
the naïve (Figure 27E). Interestingly, this observation changed when we analysed total count of 
Ly6C
hi 
inflammatory monocytes, with the highest increase being observed only in samples 
from the infected Ifnar1
-/- 
mice, whilst the samples from infected WT, LysM
Cre
Ifnar1
fl/fl
 and 
CD11c
Cre
Ifnar1
fl/fl
 mice were comparable to those of the naïve (Figure 27H).   
We observed a significant increase in frequency of neutrophils among the infected 
LysM
Cre
Ifnar1
fl/fl 
mice with a means difference of 25% to naive, 23% to infected WT, 24% to 
infected Ifnar1
-/-
 and 17% to CD11c
Cre
Ifnar1
fl/fl 
(Figure 27 F). However, when we calculated 
the total neutrophil count, the increase was observed also among the infected Ifnar1
-/-
 mice, but 
not in the infected WT and CD11c
Cre
Ifnar1
fl/fl
 mice which had counts comparable to the naïve 
(Figure 27 I). Unexpectedly and interestingly, we observed a significant amount of alternative 
activated macrophages (AAM) in spleen samples from infected Ifnar1
-/-
 and a small population 
in samples from infected LysM
Cre
Ifnar1
fl/fl
 (Figure 27G). These AAM accounted for 
approximately 11%(+2) and 5% of the CD11b
+
 population in the spleens of infected Ifnar1
-/-
 
and LysM
Cre
Ifnar1
fl/fl
 mice, respectively, but made up less than 2% in spleen samples from 
infected WT and CD11c
Cre
Ifnar1
fl/fl 
mice (Figure 27G). This increase in the AAM population 
was also observed as total counts in samples from infected Ifnar1
-/-
 mice, the infected WT and 
CD11c
Cre
Ifnar1
fl/fl
 mice almost completely lacked these cell populations (Figure 27J). Although 
the naive control and infected LysM
Cre
Ifnar1
fl/fl
 mice contained some AAM population in their 
spleens, the counts were significantly lower than those observed in samples from Ifnar1
-/-
 mice 
(Figure 27J). 
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Figure 27 Ifnar ko mice contained alternative activated macrophages in their spleens 
C57BL/6 mice (WT, Ifnar1
-/-
, LysM
Cre
Ifnar1
fl/fl 
and CD11c
Cre
Ifnar1
fl/fl
) mice were infected with 5x10
4
 PbA iRBCs 
i.v. On d+6, spleens were harvested, digested and single cell suspensions prepared. The cells were counted, 
stained and analysed using flow cytometry. (A) Example of how cells were gated for selection of desired 
population (B) Raw data with overlayed groups to confirm distinct populations (C) Percentage of CD11b
hi
 cells 
in the spleen (D) Total splenic CD11b
hi
 count. (E-G) Frequency of splenic monocytes, neutrophils and AAM 
from CD11b
hi
 cells (H-I) Total count of splenic inflammatory mononocytes, neutrophils and AAM. (K-L) 
Expression of MHC class-II and ICAM-1 on monocytes. (M) Expression of ICAM-1 on neutrophils. (N) 
Representative raw data on expression of MHC-II and CCR2 on inflammatory monocytes. (O) Histogram 
expression of MHC-II on AAM. n=4/5 animals per group, statistics= One-way ANOVA with Bonferroni post test. 
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Expression of MHC class II molecules on Ly6C
hi 
inflammatory monocytes was increased only 
in samples from PbA infected mice but not in samples from the naïve mice. The expression 
level of MHC class II molecules on Ly6C
hi 
inflammatory monocytes in samples from infected 
Ifnar1
-/-
 mice were slightly lower in comparison to the other infected groups of mice (Figure 
27K&N). The expression levels of ICAM-1 on splenic monocytes were increased in samples 
from all the infected mice in comparison to the naïve, with the expression levels being 
comparable between infected WT, Ifnar1
-/-
 and LysM
Cre
Ifnar1
fl/fl
 mice (Figure 27 L). However, 
samples from infected CD11c
Cre
Ifnar1
fl/fl
 mice had higher expression levels of ICAM-1 on 
inflammatory monocytes in comparison to samples from the other groups of mice (Figure 27 
L). Expression of ICAM-1 on neutrophils was increased in splenic samples from infected 
Ifnar1
-/-
 mice in comparison to the naïve, however, the values were comparable to the other 
infected mice, the infected WT and the other ko did not differ significantly to the naïve (Figure 
27 M). We observed very low expression level of MHC-II on AAM from all the groups of 
mice (Figure 27 O). 
Taken together, our data show that PbA-infection of complete Ifnar ko mice resulted in the 
induction of macrophages that were polarized to an alternative activated phenotype, while the 
presence of the IFN receptor in the infected WT mice resulted in high number of inflammatory 
monocytes in the spleen, that we had correlated with ECM pathology before (Schumak et al., 
2015). Thus, the presence of AAM and decreased presence of Ly6C
hi
 inflammatory monocytes 
in the spleens of infected Ifnar1
-/-
 could be a factor contributing to the protection of these mice 
from ECM. 
3.2.11.1 Up-regulation of M2a genes in splenic myeloid cells from Ifnar1-/- mice 
During infection, macrophages can be polarized to either classically activated macrophages 
(CAM) or alternative activated macrophages (AAM), depending on the cytokine signal 
received or type of infection. These macrophage phenotypes are commonly referred to as M1 
for CAM and M2 for AAM, the terms was coined by Mills et al., after observations from 
macrophages derived from mice that display Th-1 or Th-2 phenotypes (Mills et al. 2000). 
When those macrophages were exposed to the same stimuli, they activated different arginine 
pathways resulting in nitric oxide (NO) production for Th-1 and ornithine in Th-2 mouse 
strains (Mills et al. 2000). Other stimuli like TNF have been now shown to be able to stimulate 
an M1 phenotype. M2 activation can be induced by several stimulus like IL-4, IL-13, IL-10, 
TGF-β, fungal and parasitic infections (Rőszer 2015), however their activation is not limited to 
these factors. The M2 are further categorised into sub groups M2a-2d, depending on stimuli, 
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genes expressed, cytokines and chemokines produced (Rőszer 2015; Martinez & Gordon 
2014). As we had observed significant increase in the presence of Relmαhi F4/80hi CD11bhi 
population among Ifnar1
-/-
 mice and some among LysM
Cre
Ifnar1
fl/fl
 mice, we next wanted to 
confirm further if these were M2 macrophages. We enriched CD11b
+
 splenocytes using MACs 
sorting and isolated cDNA from these cells, then we analysed the mRNA for the expression of 
hallmark genes associated with M2 phenotype, arginase-1, Ym-1and Fizz//Relm-α, (Mills et al. 
2000; Raes et al. 2002). We also analysed the expression of cytokines TNF, iNOS (for M1) and 
IL-10 (for M2). 
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     Calculation of fold change  (Pfaffl etal 2001) 
       Fold change (normalized) =  
       
(         )          
(               )                 
                  
     CT-target=(C T Naïve -CT-PbAMA infected) 
  CT-housekeeping=(CT naïve housekeeping -CT-housekeeping PbAMA infected) 
Figure 28 Ifnar1
-/-
 show an M2a phenotype 
 C57BL/6 (WT, Ifnar1
-/-
, LysM
Cre
Ifnar1
fl/fl 
and 
CD11c
Cre
Ifnar1
fl/fl
) mice were infected with 
5x10
4
 PbA iRBC i.v. On d+6, Single cell 
suspensions prepared. The cells were 
counted and 4x10
7
 spleen cells were 
incubated with anti CD11b magnetic beads 
for 15 mins then sorted using MACs sorter. 
From the sorted CD11b
+
, cDNA was 
prepared as described in methods and 
mRNA expressions measured. (A-F) 
Expression level of YM-1, Relmα/Fizz, Arg-1, 
IL-10, TNF and iNOS. (G) Production of IL-4 
measured from splenocytes by ELISA. (H) 
Arginase activity (1x10
6
 CD11b
+
 cells were 
lysed and supernatants used to measure 
levels of arginase production). Statistics = 
One-way ANOVA with Bonferroni post test 
analysis. n=3/4/5 animals per group. 
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We normalised each sample to β-actin then calculated expression levels as fold increase against 
naïve as described by Pfaffl et al. (Pfaffl 2001). In agreement with our earlier observation, we 
observed in splenic CD11b
+
 sorted samples from Ifnar1
-/-
 high expression of the hallmark 
genes indicative of M2a macrophages.  
Expression levels of Ym-1 and Relm-α/Fizz were significantly up-regulated in samples from 
infected Ifnar1
-/-
 mice
 
(Figure 28A-B). Expression of YM-1 was 10 fold higher in samples from 
Ifnar1
-/- 
in comparison to those from WT, LysM
Cre
Ifnar1
fl/fl
 and CD11c
Cre
Ifnar1
fl/fl 
mice (Figure 
28A). While Relm-α/Fizz expression was completely lacking by the myeloid cells from 
infected WT and CD11c
Cre
Ifnar1
fl/fl
 mice, we detected a slight increase but non-significant in 
the samples from LysM
Cre
Ifnar1
fl/fl 
mice (Figure 28B). We observed an increase in Arg-1 
expression in the splenic CD11b
+
 cells from infected Ifnar1
-/-
 mice, however, this increase was 
not statistically significant in comparison to the other infected group (Figure 28C). Strikingly, 
we did not observe any increased expression of M2a genes in samples from infected 
LysM
Cre
Ifnar1
fl/fl 
mice (Figure 28A-C). Although we had measured significant levels of IL-10 
in splenocyte cultures of infected Ifnar1
-/-
 and LysM
Cre
Ifnar1
fl/fl
 mice, the mRNA expression 
levels of IL-10 in CD11b
+
 cells were decreased in comparison to infected WT and 
CD11c
Cre
Ifnar1
fl/fl 
mice (Figure 28D). We did not observe any difference in the expression of 
TNF and iNOS levels among all groups of infected mice (Figure 28E&F). Expression of 
mannose receptor (CD206) on Relm-αhiF480hiCD11b+ cells was very low with only a slight 
increase in samples from Ifnar1
-/-
 mice (data not shown). Secretion of the cytokine IL-4 has 
been shown to stimulate M2 macrophage genes. Here, increased levels of IL-4 were only 
detected in supernatants of splenocytes of infected Ifnar1
-/-
 mice (Figure 28G). We detected not 
only upregulated expression levels of arg-1 gene among the infected Ifnar1
-/-
 mice, but the 
Macs sorted CD11b
+
 cells from infected Ifnar1
-/-
 showed also a high protein production of 
arginase-1, analysed by conversion of arginine to urea (Figure 28H).  
Taken together, our data demonstrate the phenotype of altered macrophages in infected Ifnar1
-/-
 
mice, meeting the description of an M2a phenotype in contrast to the classical M1 found in WT 
C57BL/6 that develop ECM upon PbA infection. Although the LysM
Cre
Ifnar1
fl/fl
 mice were 
protected from ECM, their macrophages did not polarize to an M2a phenotype, however, they 
could have another M2 phenotype. 
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3.2.11.2 Type I IFN signalling controlled expression of CCL3/ MIP1α 
During infections, macrophage and other cells secrete chemokines that have a role in 
chemotaxis and recruitment of cells to organs of inflammation. We analysed the production of 
inflammatory chemokines CCL2, CCL3 and CCL5 by spleen cells of PbAMA-infected mice.  
We measured significantly increased level of CCL2 on spleen samples from infected WT mice 
in comparison to the naïve control; although the infected Ifnar ko mice had reduced CCL2 
levels in comparison to the infected WT, this difference was not statistically significant (Figure 
29A). The levels of CCL3/MIP1α was significantly reduced among the infected Ifnar1-/- and 
CD11c
Cre
Ifnar1
fl/fl
 mice in comparison to both the naïve and the infected WT, while infected 
LysM
Cre
Ifnar1
fl/fl
 mice were comparable to all the groups (Figure 29B). In contrast to the 
observation in the brain, where we measured high levels of CCL5/Rantes from the infected WT 
mice, the spleen samples of infected WT produced significantly lower amounts of 
CCL5/Rantes in comparison to samples from the the naïve control, infected Ifnar1
-/-
 and 
infected LysM
Cre
Ifnar1
fl/fl 
mice (Figure 29C). The production levels of CCL5/Rantes, was 
decreased in samples from infected CD11c
Cre
Ifnar1
fl/fl 
mice in comparison to the naïve mice, 
but was comparable to the other infected groups of mice (Figure 29C). 
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Figure 29 Ifnar ko mice had reduced levels of CCL3 in their spleens 
C57BL/6 mice (WT, Ifnar1
-/-
, LysM
Cre
Ifnar1
fl/fl 
and CD11c
Cre
Ifnar1
fl/fl
) were infected with 5x10
4
 PbAMA iRBCs i.v. 
On d+6, spleens were harvested, digested, and single cell suspensions prepared. The cells were counted and 
1x10
6
 cells were plated in triplicates and cultured over night. ELISAs were performed from the supernatants as 
described in methods. A-C) Production of CCL2, CCL3 and CCL5 in the spleen. Statistics= One-way ANOVA with 
Bonferroni post test analysis, n=4/5 animals per group. 
Taken together, these data show varying levels of inflammatory chemokines in the spleens of 
the infected mice, with reduced levels of CCL3 in the spleen samples of the infected Ifnar ko 
and less CCL5 in the spleens of WT mice, this may be due to the cells that secrete it, mostly 
CD8
+
T cells, having left the spleen to migrate into the brain where the levels were higher.  
A B C 
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3.2.12 Splenic CD11b+ cells from WT were able to restore pathology 
We next addressed the question whether CD11b
+ 
from infected WT mice would be able to 
restore ECM susceptibility. Thus, we infected 20 WT mice and 20 LysM
Cre
Ifnar1
fl/fl
 mice and 
isolated on d+3p.i. splenic CD11b
+
 cells from 10 of infected WT mice, which were then 
adoptively transferred into 10 of the infected LysM
Cre
Ifnar1
fl/fl
 mice in order to create 4 
different groups, including all controls. The schematic Figure 30 A shows the outline of the 
experiment. 
 
 
Figure 30 CD11b
+
 cells restored ECM pathology  
20 WT mice and 20 LysM
Cre
Ifnar1
fl/fl
 mice were 
infected i.v. with 5x10e
4
 iRBC of PbAMA. On day 3 
p.i., CD11b
+
 splenocytes were MACS-purified from 
10 PbA-infected WT mice, were pooled and 
transferred i.v. into 10 infected LysM
Cre
 Ifnar1
fl/fl
 
mice (1 donor/1 recipient). All mice were 
monitored for survival. Statistics = Kaplan-Meier 
survival and log-rank Test. n=10 in the final 
groups.  
The infected WT mice served as positive control for ECM and they all developed ECM with 
100% death by day 7; in contrast, 50% of the PbA-infected LysM
Cre
Ifnar
fl/fl
 control group 
remained ECM free (Figure 30 B). Importantly, those LysM
Cre
Ifnar1
fl/fl
 mice that had received 
CD11b
+
 splenocytes from PbA-infected WT donors, developed ECM features with 1 day delay 
resulting in a death rate of 70% within the ECM period (day 6-9 p.i.). Thus, the transfer of WT 
macrophages was able to restore type I IFN signaling via CD11b
+
 cells and boosted the onset 
of ECM. 
0 2 4 6 8 10
0
50
100
WT
LysMcrex 
IFNaR fl/fl
LysMcrex IFNAR 
+ WT CD11b+
***
days post PbAma1 infection
P
e
rc
e
n
t s
u
rv
iv
a
l
B 
A 
73 
 
3.2.13 Summary of the spleen results 
Taken together, our data demonstrate a crucial role of type I IFN signalling in ECM 
development. However, type I IFN signalling was dispensable in development of CTL 
responses in the periphery. But importantly, we detected in ECM protected mice the presence 
of alternatively activated macrophages, that were different from the classical M1 found in 
C57BL/6, since they could be identified as M2 in the Ifnar1
-/-
 mice upon PbA infection. 
Furthermore, PbA-infected Ifnar ko contained elevated numbers of immune effector cells in 
their spleen, predominantly CD8 T cells. Thus, our results also strongly indicated retention of 
T cells, DCs and CD11b
+
 population in the spleens of Ifnar ko mice, which might contribute to 
the protection from T-cell dependent brain inflammation in ECM. 
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3.3 High infective parasite dose of PbA mimics Malaria tolerance and prevents 
ECM in susceptible B6 mice  
In endemic malaria zones, school children and adults have been found to have high parasitemia 
without development of either clinical symptoms or severe disease; apparently, repeated 
infections sustain a continuous antigen load, thus the high parasitemia affords them a form of 
tolerance. Primary data from the lab have indicated that WT mice infected with 1x10
7
 iRBCs 
(=high dose) were highly protected from ECM, this protection was shown to be mediated via 
IL-10 as IL-10
-/-
 mice infected with 1x10
7
 iRBCs succumbed to ECM (Data Beatrix Schumak 
). We therefore further analysed the high dose protected mice to understand how the protection 
was mediated, we questioned whether there were differences in the infiltration of cells into the 
brain or whether there was a difference in the generation of parasite specific CTL responses in 
the spleen. 
3.3.1 High dose tolerance mice had infiltration of CD8+ T cells into their brain 
We infected WT mice with the already established dose of 5x10
4
 iRBC and another group of 
WT as well as IL-10
-/-
 with 1x10
7
 iRBC to confirm the ECM protection in the malaria tolerance 
model and its dependence on IL-10. Thus, we first analysed the ECM outcome and then the 
brains of mice for the infiltration of immune cells from the periphery. As described,  the WT 
mice infected with the elevated dose were significantly protected from ECM in comparison to 
low dose infected littermates, whereas this protection was absent in IL-10
-/-
 infected with 1x10
7
 
iRBC, indicated by a low score (Figure 31A). However, the cell counts from brain-enriched 
leukocytes did not differ significantly between the different experimental groups (Figure 31B), 
so the reduced cell count in ECM negative high dose infected mice remained a trend. Next, we 
characterised brain-associated cells from the periphery via flow cytometry (shown in schematic 
Figure 7A). 
We analysed the infiltration of effector CD8
+
 T cell and CD4
+ 
T cells into the brains of the high 
dose mice and compared them with the ECM positive low dose infected WT mice and high 
dose infected IL-10
-/- 
mice. We observed high frequencies of peripheral immune cells as 
stained by CD45 in the brain tissue of all the infected mice in comparison to the naive mice 
(Figure 31 C). Surprisingly, we detected a high percentage of T cells, particularly CD8
+ 
T cells 
in brain samples of the high dose infected WT and IL-10
-/- 
mice in comparison to the low dose 
infected WT mice (Figure 31D&E). The high dose infected WT mice had elevated frequencies 
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of CD8
+
T cell in their brain samples with a mean increase of 30% in comparison to the naïve 
control and 13% in comparison to the low dose infected WT mice (Figure 31 E). 
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Figure 31 High levels of CD8
+
 T cells in the brain of Malaria tolerance mice without ECM  
C57/BL6 WT mice were infected with 5x10
4
 and 1x10
7
, IL-10
-/-
 mice with 1x10
7 
iRBCs i.v, on d+6, mice were 
perfused and brains harvested, digested, and single cell suspensions prepared. The cells were counted, stained 
and analysed using flow cytometry. A) ECM score calculated using RMBCS (B) Total count of brain infiltrated 
cells. C) Raw data from representative samples from every experimental group showing the gating to 
discriminate CD45
hi
 cell. D-F) Percentages of infiltrated CD3
+
, CD8
+
 and CD4
+
 T cells in the brain. G-I) Cell counts 
of infiltrated CD3
+
, CD8
+
 and CD4
+
 T cells in the brain. Statistical analysis = One-way ANOVA with Bonferroni’s 
post test. n=3/4/5 animals per group. 
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In comparison, the brain samples of high dose infected IL-10
-/-
 mice revealed the highest 
infiltration of CD8
+
 T cells, which was 8% more than in the samples from the high dose 
infected WT mice (Figure 31 E). We observed comparable percentages of CD4
+
T cells in brain 
samples of the naïve and the infected groups of mice (Figure 31 F). We also observed 
increased total T cell counts in brain samples of all PbA infected mice in comparison to the 
naïve control mice (Figure 31 G). The CD8
+
 T cell count was significantly elevated in brain 
samples of high dose infected IL-10
-/-
 mice in comparison to the other infected mice groups 
(Figure 31 H). Unlike in the percentage values of CD4
+
T cells, which were comparable among 
all the animal groups, the total cell counts were significantly higher in the low dose infected 
WT mice in comparison to the other infected mice (Figure 31 F&I). Taken together, these data 
indicates the presence of immune cell in the brains of ECM protected high dose infected WT 
mice, however, FACS analysis does not allow to determine if these cells had passed the BBB 
and were arrested in the brain or just present in the circulation and not able to pass the BBB. 
3.3.2 High dose mice contained inflammatory monocytes in brain tissue 
We next analysed whether mononuclear cells had infiltrated into the brains of the high dose 
infected WT mice. As earlier mentioned, inflammatory monocytes have been shown to 
contribute to ECM pathology (Schumak et al. 2015). The mononuclear cells were gated 
according to their expression of CD11b and CD45 (illustrated in schematic Figure 15A). 
Here, we observed increased frequencies of CD11b
hi
 cells from the periphery in the brains of 
low dose infected WT and high dose infected WT in comparison to the naïve, although this 
difference was statistically insignificant (Figure 32A). We observed an increased frequency of 
Ly6C
hi
 inflammatory monocytes in brain samples of both low dose and high dose infected mice 
in comparison to the naïve (Figure 32B). We did not observe significant difference in the 
frequency of Ly6C
hi
 inflammatory monocytes in brain samples of both high dose infected WT 
and IL-10
-/-
 mice in comparison to the low dose infected WT mice (Figure 32B). The frequency 
of neutrophils in brain was reduced in samples from all PbA infected mice in comparison to the 
naïve control mice, however, when we considered cell counts, the low dose infected WT mice 
had higher but non-significant values (Figure 32C&F). We also observed significantly elevated 
cell count of CD11b
hi
 and Ly6C
hi
 inflammatory monocytes in brain samples of low dose 
infected WT in comparison to the naïve (Figure 32D &E). Although there were lower counts of 
CD11b
hi
 and Ly6C
hi
 inflammatory monocytes in brain samples from the high dose infected WT 
in comparison to the low dose infected WT mice, these differences were not statistically 
significant (Figure 32D &E). Brain samples of high dose infected IL-10
-/- 
mice were 
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comparable to both the low dose and high dose infected WT mice (Figure 32D-F). In 
conclusion, although we observed with FACS Ly6C
hi
 inflammatory monocytes in brain 
samples of the high dose infected WT tolerance model, these mice were still protected from 
ECM. 
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Figure 32 inflam. monocytes in brains of mice from the malaria tolerance group despite absence of ECM 
C57/BL6 WT mice were infected with 5x10
4
 and 1x10
7
, IL-10
-/-
 mice with 1x10
7 
PbA iRBCs i.v. On d+6, mice 
were perfused and brains harvested, digested, and single cell suspensions prepared. The cells were counted, 
stained and analysed using flow cytometry. A) Percentage of brain infiltrated CD11b
hi
CD45
hi
 cells. (B) Freq. of 
CD11b
hi
CD45
hi
 that are inflam. monocytes. C) Freq. of CD11b
hi
CD45
hi
 that are Neutrophil. D-F) Total cell counts 
of infiltrated CD11b
+
, inflam. monocytes and neutrophils in the brain. Statistical analysis= One-way ANOVA 
with Bonferroni post test. n=3/4/5 animals per group. 
3.3.3 The high parasite load resulted in dampened inflammatory response 
without impairing the Ag specific response 
As we had observed that WT mice infected with high dose of PbA were protected from ECM, 
but still presented peripheral immune cells in their brains (even if it was not clear whether these 
cells had passed the BBB or not). We questioned whether this protection from ECM was due 
an impaired immune response in the spleen. We therefore analysed the effector CD8
+
T cells in 
the spleens of the Malaria-tolerized mice for the ability to recognise and kill target cells 
presenting parasite specific MSP-1 Ag as described in the section with the Ifnar ko,( page 44). 
Briefly, mice were infected with appropriate doses of transgenic PbAMA expressing 
ovalbumin. On day 5p.i. and 6 p.i. We performed an in vivo kill to calculate the specific 
cytolytic activity of peptide-specific T cells that were generated in immunized animals, but not 
in non-immune naïve control mice. 
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Figure 33 IL-10 damped inflammatory response in Malaria tolerance but did not alter Ag specific kill 
C57/BL6 WT mice were infected with 5x10
4
 and 1x10
7
, IL-10
-/-
 mice with 1x10
7 
PbA iRBCs i.v. On d+6, mice 
were perfused, spleens were digested and single cell suspensions prepared. The cells were counted, stained 
and analysed using flow cytometry. For Elisa 1x10
6
 cells were plated in triplicates and cultured overnight at 
37
0
C, the next day supernatants were taken and ELISA performed as described in methods. (A) Analysis of 
antigen-specific CTL activity in the spleen. (B&C) Production of IFNγ and granzyme B measured by ELISA (D) 
Histogram showing the expression levels of grazyme B on CD8
+ 
T cells. E&F) Frequency of CD8
+
T cells 
expressing granzyme B and CD11c. Statistics =One-way ANOVA with Bonferroni post test. n=3/5 animals per 
group. 
Here, we observed that the high dose infected WT mice were able to recognise and mount a 
parasite specific CTL response against the target cells presenting the MSP-1 peptide, with high 
dose infected IL-10
-/-
 mice demonstrating the highest kill (Figure 33A). Most importantly, 
despite the ability to specifically lyse Ag, we observed a complete lack of IFNγ production in 
spleens of high dose infected WT mice that were protected from ECM in comparison to the 
low dose infected WT and high dose infected IL-10
-/-
 mice, which both suffered from ECM 
(Figure 33B). Interestingly, splenic CD8
+
 T cells from the high dose infected WT mice showed 
in addition reduced granzyme B expression, which was ~14.5% lower in comparison to both 
low dose infected WT and high dose infected IL-10
-/-
 mice. Also, we measured significantly 
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lower amounts of granzyme-B in supernatants from spleen cell of high dose infected WT mice 
in comparison to the ECM positive low dose infected WT and high dose infected IL-10
-/-
 mice 
(Figure 33C-E). In parallel to diminished granzyme-B levels, we also observed ~10% less 
splenic CD11c
+
CD8
+ 
T cell in samples from high dose infected WT mice in comparison to the 
other PbA infected mice (Figure 33F). As expected, the corresponding splenocytes from naïve 
control mice produced neither IFNγ nor granzyme-B nor contained any antigen activated 
CD8
+
T cells (Figure 33B-F). 
Taken together, these data demonstrated the role of the elevated parasite dose in suppression of 
detrimental effector molecules that are crucial for ECM, even if a basic CTL response was still 
detectable. Furthermore, the lack of IL-10 resulted in the production of the inflammatory 
cytokine IFNγ, whereas high-dose infected WT mice that had successful induced malaria 
tolerance benefited from dampening inflammation without affecting the Ag specific CTL 
response. 
3.3.4 Malaria tolerance mice contained an unaltered CD4:CD8 ratio in the spleen 
Above, we had observed in the ECM-protected Ifnar ko mice splenomegaly and an altered 
CD4:CD8 ratio in the spleen, resulting from a retention of CD8 T cells. Here, we also 
compared the spleen weights, total cell counts and CD4
+
 T cells/ CD8
+ 
T cells composition 
between the high dose PbA infected and the low dose infected mice. 
We did not observe a difference in the total spleen cell counts in samples from the low dose 
infected WT in comparison to the naïve control and the high dose infected IL-10
-/-
 mice (Figure 
34 A). However, the high dose infected WT mice had significantly elevated spleen cells count 
in comparison to the naïve and the high dose infected IL-10
-/- 
mice with ~1.46 fold increase to 
both groups (Figure 34 A). Despite the comparable spleen cell numbers between the low dose 
infected WT mice and the naïve control mice, the spleens of the low dose infected WT mice 
weighed ~56mg more than those of the naïve control (Figure 34 B). The spleen weights of the 
low dose and high dose infected WT mice were comparable (Figure 34 B). 
We observed less CD3
+
T-cells in the spleens of low and high dose infected WT mice when 
compared to the naïve control mice, however, this difference was not statistically significant 
(Figure 34C). The percentage of CD8
+
 splenic T cells were comparable in samples from the 
naïve, low dose infected WT and high dose infected WT mice, however, high dose infected IL-
10
-/-
 mice had a significant increase in this population in their samples (Figure 34D). The 
frequency of CD4
+
 T cells in spleen samples from high dose and low dose infected WT mice 
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were comparable to the naive, however, the high dose infected IL-10
-/-
 mice had a significant 
decrease in this population in comparison to the other groups of mice (Figure 34D).  
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Figure 34 IL-10 ko high dose have high CD8
+
 T cells in their spleens 
C57/BL6 WT mice were infected with 5x10
4
 and 1x10
7
, IL-10
-/-
 mice with 1x10
7 
PbA iRBCs i.v. On d+6, mice 
were perfused, spleens weighed, then digested and single cell suspensions prepared. The cells were counted, 
stained and analysed using flow cytometry. A) Total spleen cells count (B) Weight of the spleens. C) Percentage 
of CD3
+
T cell populations in the spleen (D&E) Frequency of CD8
+ 
T cells and CD4
+
 T cells. Statistics= One-way 
ANOVA with Bonferroni post test. n=3/4/5 animals per group. 
Taken together, these data show that the infected WT mice of the so-called malaria tolerance 
model group presented in general splenomegaly, but contained a comparable composition of 
splenic T cell populations as the low dose ECM positive mice. 
3.3.5 High dose infection suppressed the development of a Th-1 phenotype 
As ECM is a Th-1 driven disease, we next analysed, whether the protection from ECM that we 
had observed among the high-dose infected mice was mediated by regulatory T cells (T reg). 
We therefore analyse the different CD4
+
 T cell subsets by staining their transcriptional factors; 
T-bet for Th-1, FoxP-3 for T regs, GATA3 for Th-2 and ROR-γt for Th-17. From the 
FoxP3
neg
Tbet
neg
CD4
+
 T cells, we evaluated the expression of granzyme B.  
We observed an increased frequency of CD4
+
T cells expressing T-bet in spleen samples from 
the low dose infected WT in comparison to the naïve control mice, importantly, the high dose 
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infected WT mice had ~11% less T-bet expressing CD4
+
T cells in their spleen samples in 
comparison to the low dose infected WT mice (Figure 35 A&B). 
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Figure 35 High parasite dose partially suppressed Th-1 response 
C57/BL6 WT mice were infected with 5x10
4
 and 1x10
7 
PbA iRBCs i.v. On d+6, mice were perfused and brains 
harvested, digested, and single cell suspensions prepared. The cells were counted, stained and analysed using 
flow cytometry. (A) Raw data from representative samples from every experimental group (B) Frequency of 
CD4
+
T cells expressing T-bet. (C) Frequency of CD4
+
T cells expressing FoxP3. (D) Frequency of 
CD4
+
Tbet
neg
FoxP3
neg
CD8
neg
NK
neg
 expressing granzyme-B. Statistics = One-way ANOVA with Bonferroni’s 
Multiple post test. n=4/5 animals per group. 
Furthermore, the percentage of FoxP3 expressing splenic CD4
+
 T cells was reduced, in samples 
from both low and high dose infected WT mice in comparison to the naïve mice (Figure 
35A&C). The high dose infected WT mice completely lacked the presence of granzyme B 
expressing CD4
+
T cells in their spleen, therefore being comparable to the naïve mice, unlike 
the low dose infected WT mice that contained ~6% granzymeB
+ 
CD4
+
 T cells in their spleens 
(Figure 35 D). We did not detect any Th-2 or Th-17 cells in the spleen samples of all the mice 
(data not shown). Taken together, this data show that in the high-dose-induced tolerance mice 
the Th-1 response was suppressed to some extent, and the expression of granzyme-B by CD4
+
 
T cell in the spleen completely blocked. This data also indicate that T-regs might just have a 
minor role in the protection observed in the tolerance mice model. 
3.3.6 NK cells from high dose mice produced significantly less granzyme B  
We next analysed splenic NK cells during the high dose infection to see the impact of the high 
parasite dose on this cell population and possible source of further effector molecules. We 
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observed a significant decrease in the percentage of NK cells in the spleen samples from all 
infected groups in comparison to the naïve mice. The percentage of NK cells among the high 
dose infected WT mice was reduced in comparison to the low dose infected WT but was 
comparable to the high dose infected IL-10
-/- 
mice (Figure 36A).  
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Figure 36 PbA high dose affects granzyme-B expression by NK cells  
C57/BL6 WT mice were infected with 5x10
4
 and 1x10
7
, IL-10
-/-
 mice with 1x10
7 
PbA iRBCs i.v. On d+6, mice were 
perfused and spleens harvested, digested, and single cell suspensions prepared. The cells were counted, stained 
and analysed using flow cytometry. (A) Percentage of NK cells in the spleen. (B) Expression level of granzyme-B 
by NK cells as gMFI. (C) Histogram overlay of expression of granzyme B by NK cells.  Statistics= One-way ANOVA 
with Bonferroni post test. n=3/4/5 animals per group. 
Interestingly, we also observed significantly reduced expression levels of granzyme B in 
splenic NK cells from high dose infected WT mice, in comparison to the low dose infected WT 
mice (Figure 36B &C). The high dose infected IL-10
-/-
 mice also had reduced expression of 
granzyme B in their spleen in comparison to the low dose infected WT mice (Figure 36B &C). 
Taken together, this data support the impact of high doses of PbA infection in suppression of 
the important effector molecule granzyme- B by splenic NK cells. 
3.3.7 Infection with high dose of parasites resulted in decreased B cells in the 
spleen 
We next analysed the influence of the high dose parasite load on splenic B cells and DC 
populations, as we had mentioned earlier that DCs are the key APCs during ECM with a key 
role in priming effector T cells (Lundie et al. 2008; deWalick et al. 2007). Here, we observed a 
significant decrease in the percentage of splenic CD19
+
 B cell in samples from high dose 
infected WT mice in comparison to the low dose infected WT and high dose infected IL-10
-/-
 
mice (Figure 37A). The population of splenic CD11c
+
 DCs was significantly reduced in 
samples from all the infected groups in comparison to the naïve mice (Figure 37 B). We did not 
pursue these groups of cells any further. 
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Figure 37 High parasite load resulted in decreased amount of splenic B cells 
C57/BL6 WT mice were infected with 5x10
4
 and 1x10
7
, IL-10
-/-
 mice with 1x10
7 
PbA iRBCs i.v. On d+6, mice 
were perfused and spleens harvested, digested, and single cell suspensions prepared. The cells were counted, 
stained and analysed using flow cytometry. (A) Percentage of B cells in the spleen (B) Percentage of DCs in the 
spleen. Statistics= One-way ANOVA with Bonferroni post test. n=3/4/5 animals per group. 
3.3.8 Comparable IL-10, IL6 and TNF in the spleens of the ECM protected mice 
We further compared the levels of cytokines and chemokine in the spleen of the malaria 
tolerance group of mice in comparison to the ECM susceptible WT mice. Surprisingly, the 
protected mice infected with high dose parasite load had comparable levels of chemokines and 
cytokines to the low dose infected WT mice despite the different disease outcome.  
The levels of IL-10, IL-6 and CCL3 did not differ significantly between the naïve and the PbA 
infected WT mice (Figure 38A, B&E). Also unexpected was the increased level of TNF 
measured in supernatants from splenocytes of the high dose infected WT mice, this increase 
was comparable to the low dose infected WT mice, but significantly higher than the naïve 
control mice (Figure 38C). We measured low amounts of CCL2 in supernatants from spleen 
cells of high dose infected WT in comparison to low dose infected WT mice, the high dose had 
values comparable to the naïve control mice (Figure 38D), whereas CCL3 and CCL5 did not 
differ significantly between the two groups of infected mice (Figure 38E& F). Taken together, 
these data show that tolerance occurred in the high dose infected mice, in spite of the high TNF 
levels in the spleen, which may have been counteracted by a regulatory mediator. 
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Figure 38 Protected high dose infected WT mice produced high levels of TNF in their spleen  
C57/BL6 WT mice were infected with 5x10
4
 and 1x10
7
 PbA iRBCs i.v. On d+6, mice were perfused, spleens 
harvested, digested, and single cell suspensions prepared. The cells were counted and 1x10
6
 cells plated in 
triplicates in 96 well plates, the cultures were then incubated for 24hrs at 37
0
C. Supernatants were collected 
and ELISA performed as described in methods. (A-C) Production of cytokines IL-10, IL-6 and TNF in the spleen. 
(D-E) Production of chemokines of CCL3/MIP-1α and CCL5/Rantes in the spleen. Statistics= One-way ANOVA 
with Bonferroni post test. n=4/5 animals per group. 
3.3.9 High parasite loads partially suppressed the expression of MHC class II on 
Ly6ChiCCR2+ inflammatory monocytes in the spleen 
We have shown the predominant presence of AAMs in splenic samples of ECM protected 
Ifnar1
-/-
 mice (Figure 27). As we did not observe any increase in the T-regs population in the 
high dose infected mice, we next questioned whether the tolerance observed in the high dose 
infection might be also here driven by AAMs. We analysed for the presence of AAM, 
inflammatory monocytes and neutrophils. As described above (Figure 27), we gated first for 
CD11b
hi
 cells and from this population we selected RelmαhiF480hi and Ly6Chi vs Ly6G, and 
then overlayed the populations to confirm they were different populations.  
We observed a reduction in the percentage of CD11b
hi
 cells in the spleen samples of both low 
and high dose infected WT mice in comparison to the naïve control mice (Figure 39 B).  
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Figure 39 Tolerance mice model did not contain AAM  
C57/BL6 WT mice were infected with 5x10
4
 and 1x10
7
 PbA-iRBCs i.v. On d+6, mice were perfused, spleens 
harvested and single cell suspensions prepared. The cells were counted, stained and analysed using flow 
cytometry A) Raw Facs data from representative samples from each experimental groups. B) Percentage of 
CD11b
hi
 in the spleen. C) Percentage of inflam. monocytes. D) Expression of MHC calss II on Inflam. monocytes. 
E & F) Frequency of neutrophils and alternative activated macrophages from CD11b
+
 cells. Statistics= One-way 
ANOVA with Bonferroni post test. n=4/5 animals per group. 
The low dose infected WT mice had significantly more CD11b
+
 cell that were identified as 
Ly6C
hi
CCR2
+
 inflammatory monocytes in comparison to the naive and the high dose infected 
WT (Figure 39C). Although we observed an increased percentage of Ly6C
hi
CCR2
+ 
inflammatory monocytes that had been associated with pathology, in spleen samples of high 
dose infected WT mice in comparison to the naïve control, this population was significantly 
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smaller (~9% less) than in the low dose infected WT mice (Figure 39C). Importantly, we 
measured lower levels of expression of MHC class II on Ly6C
hi
CCR2
+
 inflammatory 
monocytes in spleen samples from high dose PbA infected mice in comparison to the low dose 
infected mice (Figure 39D&G). The percentage of neutrophils was significantly reduced in 
samples from both low and high dose infected WT in comparison to samples from naïve 
control mice (Figure 39E). Unlike in the infected Ifnar1
-/-
 mice (Figure 27G), the CD11b
hi
 
populations of both the low dose infected WT mice and the high dose infected WT mice 
contained very low populations of AAMs (Figure 39F). Taken together, our data show that the 
mice infected with high parasite dose contained less inflammatory monocytes which expressed 
strongly reduced levels of MHC class II, however, tolerance induction and protection could not 
be attributed to AAM here. 
3.3.10 Protection of the high dose infected mice was dependent on IL-10 production 
by myeloid cells 
Results from previous lab experiments showed that protection of the high dose infected mice 
was dependent on IL-10. We have also shown that this protection was apparently not 
dominantly driven by T-regs. We therefore investigated whether the protection was mediated 
by macrophages, since we had observed in the ECM protected Ifnar ko mice a specific 
relevance of this cell population. We performed a survival analysis using LysM
cre
IL-10
fl/fl
 mice, 
which lacked specifically the production of IL-10 by LysM
+
 cells.  
 
Figure 40 protection in the tolerance 
model is mediated by macrophages 
C57/BL6 and LysM
Cre
IL-10
fl/fl
 mice 
were infected with 5x10
4
 and 1x10
7 
iRBCs i.v. They were then monitored 
from d+5 p.i for survival. n=8 animals 
per group. Statistics=mLog-rank 
(Mantel-Cox) Test. 
.  
As expected, 90% of the low dose infected WT mice developed ECM and died by day 7 p.i, 
while 90% of the high dose infected WT mice survived past the ECM phase, importantly only 
25% of the mice lacking IL-10 on LysM expressing cells survived past the ECM phase (Figure 
40). Mice that survived past the ECM phase developed high parasitemia and anemia and were 
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sacrificed. This data demonstrated the role LysM expressing cells in production of IL-10 that 
promoted tolerance during the high dose infection. 
Summary; our results demonstrated the role of IL-10 produced by macrophages in providing 
tolerance during high dose infection. The tolerance model was characterized by complete lack 
of production of pro-inflammatory cytokine IFNγ and reduced granzyme B production by NK 
cells. However, the capacity to recognise and lyse antigen presenting target cells was not 
impaired in mice infected with an elevated dose of parasites. Furthermore, we confirmed an 
essential role of IL-10 in immune regulation during PbA infection and point out that myeloid 
cells, – in particular LysMpos cells /CD11bpos cells – had a key role in balancing the immune 
responses towards inflammation (which can result in ECM) or immune regulation, thereby 
preventing immune damage.  
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4 Discussion 
Malaria has been regarded as a disease of poverty as it is predominantly found in developing 
countries. And although cerebral malaria (CM) in children can be successfully treated, it still 
impacts the “disability-adjusted life years” (DALYs), meaning lost years, and has lasting 
impact on the cognitive development of the children (Idro et al. 2010). CM is multifactorial, 
and murine models have made it easier to study different factors. The contribution of immune 
cells, parasites load in the brain, cytokines and chemokines are continuously being included or 
excluded in their contribution of CM pathology with the help of experimental models. Using 
murine models of CM, we demonstrate here the non-redundant role of inflammatory type I IFN 
signalling via myeloid cells in the pathogenesis of ECM. Ifnar ko mice were protected from 
ECM and lacked brain inflammation. However, they were able to generate parasite-specific 
CTL responses in the periphery, although these were attenuated and paralleled by the co-
presence of alternatively activated macrophages and IL-10, which apparently dominated the 
immune responses. We also examined a model for malaria tolerance, which was induced upon 
infection with an elevated dose of Plasmodium parasites and characterized by reduced 
production of IFNγ and observed that IL-10 plays a role in tolerance. 
The role of type I IFNs in diseases can be compared to the head and tail of a coin, depending 
on the disease the outcome can be beneficial or detrimental. Type I IFNs are beneficial in 
infectious diseases for controlling viral infections and as therapy for Hepatitis B and C 
(González-Navajas et al. 2012). In auto-immune diseases, IFN-β is used as therapy for 
relapsing-remitting multiple sclerosis through reduction of inflammation and episodes of 
relapse (González-Navajas et al. 2012). In contrast to the benefits shown in viral infections and 
multiple sclerosis, type IFN production and signalling during malaria has been shown to be 
detrimental to the host. The crucial role of type I IFN production and signalling in Plasmodium 
infection cannot be underestimated, as the parasite and its by-products, GPI, heme, and parasite 
DNA, trigger the production of type I IFNs via different sensing pathways (Sharma et al. 2011; 
Gazzinelli et al. 2014). These produced type I IFNs then signal via the single heterodimeric 
receptor IFNaR1& IFNaR2. 
Here we observed enhanced survival in mice lacking Ifnar during PbA infection, this is in 
agreement with what has been shown before (Ball et al. 2013; Palomo et al. 2013; Sharma et al. 
2011; Haque et al. 2011). We also show that the protection from ECM occurred independently 
of parasitemia, an observation also shown by Ball et al. using the Ifnar1
-/-
 mice (Ball et al. 
2013). However, Haque et al. showed reduced parasitemia among the ECM-protected Ifnar1
-/-
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mice (Haque et al. 2011), this difference could be attributed to either genetic differences in 
parasites or mice.  
Here, we have gone a step further in our experiments to clearly demonstrate, that the lack of the 
receptor on myeloid cells, specifically the LysM+ population - limiting this to macrophages - 
was crucial in mediating the pathology, while the lack of the receptor on cDCs was 
dispensable. We further propose a mechanism through which the lack of the Ifnar on all cells 
and on myeloid cells mediates the protection against ECM. 
4.1 Type I IFN signalling via Ifnar on myeloid has a role in pathogenesis of 
ECM. 
In our results we observed protection from brain inflammation in mice lacking Ifnar on all cells 
or specifically on myeloid cells. Both groups had a stable BBB, few immune cells from the 
periphery present in their brains and low inflammatory mediators in their brains. In contrast, 
mice deficient of the Ifnar only on cDCs developed ECM, had high presence of immune cells 
from the periphery and inflammatory mediators in their brains, and although they showed a 
stable BBB, this was mostly attributed to the one day delay in ECM that we observed in their 
survival. Since most of the PbA infected WT mice develop neurological symptoms on d+6p.i 
and die shortly after, at the time point of our experiments, PbA infected CD11c
Cre
Ifnar1
fl/fl
 mice 
still showed a stable BBB.  
ECM has been strongly linked to effector CD8
+
T cells primed in the spleen that infiltrate into 
the brain and cause pathology via release of granzyme B and perforin (Lundie et al. 2008; 
Nitcheu et al. 2003; Haque et al. 2011). Expression of CD11c on CD8
+
T cells was shown to be 
a marker of activation, priming and cytotoxicity during PbA infection (Zhao et al. 2014; 
Tamura et al. 2011). We have shown in our results that mice that lacked the Ifnar specifically 
on myeloid cells or on all cells had low numbers of CD8
+
 T cells present in their brains. It was 
therefore crucial to observe, that the few CD8
+
 T cells from the periphery present in the brains 
of the protected mice expressed similar levels of cytotoxicity and activation as those of the 
ECM positive mice. This was demonstrated by expression of granzyme B and CD11c by 
CD8
+
T cells isolated from the brains, hence showing that these cells were as cytotoxic and 
activated as the T cells that were from the ECM positive mice. However, what differed was the 
total amount of these cells present in the brain and we could not rule out by FACS analysis, 
whether these T cells in ECM negative mice really had passed the blood brain barrier, which 
was shown to be intact. Furthermore, the protected mice had lower amounts of parasites in 
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their brains and for pathology to occur it was shown that there has to be a substantial amount of 
parasite load in the brain (Howland et al. 2013; Baptista et al. 2010). Although we observed 
some variation in the levels of expression of ICAM-1 and CCR2 on CD8
+
 T cells, we presume 
that these did not have a role in the ECM protection, as ko mice of CCR2 and ICAM-1 were 
shown to be susceptible to malaria (Belnoue et al. 2003; Ramos et al. 2013). Therefore, we can 
conclude that the low amount of effector CD8
+
T cells, coupled with low parasite antigen in the 
brain, contributed to protection from ECM observed in mice that lacked the Ifnar specifically 
on myeloid cell or on all cells. 
Inflammatory monocytes are the second largest cell population that infiltrates into the brains of 
mice that develop ECM. Increased amounts of Ly6C
hi
 inflammatory monocytes have been 
found in the brains of ECM positive mice and were shown to have a role in the recruitment of 
efffector T cells as their depletion resulted in decreased CD8
+
T cells in the brains (Pai et al. 
2014; Schumak et al. 2015). We show that signalling of type I IFNs via myeloid cells was 
required for the infiltration of Ly6C
hi
 inflammatory monocytes from the periphery into the 
brain. The lack of Ifnar resulted in significantly lower amounts of Ly6C
hi
 inflammatory 
monocytes in the brain, which proved to be beneficial for the mice as there was little or no 
TNF being produced, which would have contributed to creating an inflammatory environment. 
We presume that Ly6C
hi
 inflammatory monocytes were the main source of TNF found in the 
brains of the ECM positive WT and CD11c
Cre
Ifnar1
fl/fl 
mice. We cannot however completely 
rule out that other brain infiltrated cells or resident cells were also producing TNF, however 
Ly6C
hi 
inflammatory monocytes have been shown to be the major producers of TNF in mice 
model for intracerebral hemorrhage (Hammond et al. 2014) and contact dermatitis (Chong et 
al. 2014). As Ly6C
hi
 inflammatory monocytes have been shown to have a role in the 
recruitment of CD8
+
T cells into the brain (Schumak et al. 2015), their absence in the brain 
could be a contributing factor to the low number of CD8
+
T cells in the samples from the ECM 
protected mice. 
The influence of type I IFN signalling in recruitment of cells into the brains was not only 
limited to CD8
+
T cell and inflammatory monocytes, in the absence of Ifnar, CD4
+ 
T cells, NK 
cells and CD8α+DCs were also reduced. NK cells were shown to infiltrate into the brains of 
ECM positive mice and were suggested to contribute to the recruitment of CD8
+
 T cells into 
the brain (Hansen et al. 2007). 
Chemokine ligands and their receptors have roles in homeostasis and migration of immune 
cells to sites of inflammation. In PbA infection, chemokine receptors CXCR3 and CCR5 were 
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shown to be necessary for recruitment of effector CD8
+
T cells into the brains during ECM 
(Campanella et al. 2008; Belnoue et al. 2003). With brain samples of mice that developed ECM 
containing elevated levels of their chemokine ligands CCL3/MIP1α, CCL5/ Rantes, CXCL9 
and CXCL10 (Campanella et al. 2008; Van den Steen et al. 2008; Belnoue et al. 2003). 
In our results we have shown that the ECM protected mice had low amounts of inflammatory 
chemokines CCL3 and CCL5 in their brains. This observation matched the low amount of 
peripheral immune cells in the brains of these mice. The lack of CCL3/ MIP1α could be as a 
result of low inflammatory monocytes in the brains of these ECM protected mice. Although 
microglia are also possible producers of these chemokines (Kohno et al. 2014), we presume 
that in the case of ECM, the infiltrated inflammatory monocytes are the main producers, as we 
observed lack of CCL3/ MIP1α only in mice that had low amounts of inflammatory monocytes 
in their brains. CCL5 is produced by activated T cells, macrophages and monocytes among 
other cells (Aldinucci & Colombatti 2014), its low levels could be associated with the low 
numbers of either of these cells in the brain of the ECM protected mice. These two chemokine 
(CCL3 and CCL5) are ligands for CCR5 and although they were lacking, some of the CD8
+
 T 
cells that had infiltrated into the brains of the ECM protected Ifnar1
-/-
 and LysM
Cre
Ifnar1
fl/fl 
were expressing CCR5. However, the majority of the CCR5
+
CD8
+
 T cells were co-expressing 
CCR7 and therefore these cells might have still been recruited via ligands for CCR7, 
furthermore CCR5 binds to CCL4 /MIP-1β which was not analysed. CXCR3 was expressed by 
the CD8
+
T cells found in the brains of the protected Ifnar ko mice, we however suggest to 
analyse for the expression of CXCL9 and CXCL10/IP-10, which are both ligands for CXCR3 
and linked to recruitment and migration of cells to the brain during ECM (Campanella et al. 
2008). Thus, we conclude that during PbA infection, type I IFN signalling is apparently 
involved in recruitment of immune cells from the periphery into the brain, which secrete 
inflammatory cytokines and chemokines resulting in recruitment of more cells, until the cell-
threshold required for pathology is attained. 
4.2 Antigen specific response is un-impaired in ECM negative Ifnar ko 
In priming of T cells, three signals are required, signal I is provided by interaction of MHC 
molecule presenting antigen and the T cell receptor, signal two is provided by the interaction of 
co-stimulatory molecules and the third signal by cytokines. Either IL-12 or type I IFNs provide 
the necessary signal 3 required for activation of CD8
+
 T cells (Curtsinger et al. 2005). 
Published studies on the role of Ifnar during PbA infection showed partial but high survival, 
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intact BBB and reduced infiltration of cells into the brain (Palomo et al. 2013; Ball et al. 2013), 
however, it has not yet been shown whether protection observed occurred due to altered 
generation of effector CD8
+
 T cells in the spleen. As the activation of the effector CD8
+
 T cell 
occurs in the spleen before the emigration of these cells to the brain, it is paramount to show 
whether these cells are well primed and able to mount a parasite specific response. 
We show for the first time, to our knowledge, the CTL activity of antigen-specific CD8
+
T cells 
in Ifnar deficient mice during PbA-infection. In our results, we have clearly demonstrated that 
CD8
+
 T cells of Ifnar ko mice were able to recognise both parasite specific endogenous antigen 
and transgenic Ova antigen and mount specific CTL response. We have also shown that the 
spleens of the Ifnar ko mice contained elevated numbers of cytotoxic granzyme-B
+
CD8
+
 T cell 
and expressed activation marker CD1lc on their surface. We further confirmed that granzyme-
B was not only expressed but was equally released. We conclude that the protection from ECM 
was not due to generally impaired or inefficient Ag priming or CTL responses in the spleen, 
since the proof of their specific function strongly imply their existence. 
Cerebral malaria is a T hepher-1(Th-1)-driven disease marked by high production of 
inflammatory cytokines IFNγ and TNF (Hunt & Grau 2003). Mice genetically deficient of Th-
1 transcriptional factor T-bet are highly protected (70%) from ECM (Oakley et al. 2013). Here 
we have clearly detected in all the infected Ifnar deficient groups of mice the presence of Th-1 
cells (Tbet
+
CD4
+
) in their spleens. Moreover, we have measured unimpaired production of Th-
1 cytokines IFNγ and TNF in the spleen samples of these protected mice. However, as we 
observed comparable IFNγ production between the WT and infected ko mice, we did not 
analyse for specific cell production. We therefore cannot conclusively say which cells were the 
producer, as IFNγ is produced by several cells during PbA infection; CD4+T cell (Villegas-
Mendez et al. 2012), CD8
+
 T (Zhao et al. 2014; Howland et al. 2013; Schumak et al. 2015), 
NK cells cells (Hansen et al. 2007). Strikingly, despite the presence of Th-1 cells and IFNγ, the 
Ifnar ko mice had concomitantly high levels of anti-inflammatory cytokine IL-10. We 
concluded that the high IL-10 levels could have contributed to control of the inflammation and 
could be one of the reason of the subsequent protection observed among the Ifnar ko. We 
presume that T-regs did not play a major role in the protection observed in Ifnar1
-/- 
mice as 
these mice showed a similar reduction of this population as that observed among the ECM 
positive mice. However, we cannot completely rule out T-regs as contributors to the protection 
among the LysM
Cre
Ifnar1
fl/fl
 mice as we see that they contained more T-regs than infected WT, 
Ifnar1
-/-
 and CD11c
Cre
Ifnar1
fl/fl 
mice. Thus, we conclude that during PbA infection type I IFN 
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signalling is dispensable in the development of, CTL response, Th-1 response and their related 
inflammatory mediators in the periphery and also confirming that the protection was not 
mediated by lack of or alteration of Th-1 response. 
What is crucial during any infection is the ability and capacity of APCs to recognise foreign 
Ag, process it and effectively present it to T cells, initiating pathogen specific immune 
response. As we observed efficient functions of cytotoxic CD8
+
 T cells, thereby implying 
proper priming as well as Th-1 cell in the spleens of all the infected mice groups, we presumed 
unimpaired DCs function. During Plasmodium infection, cDCs were shown to prime and 
activate CD4
+
 T cells and CD8
+
 T-cells, with CD8α+DCs priming CD8+ T cells, while 
CD8αnegDCs and/or CD4+DCs priming CD4+T cell (Sponaas et al. 2006; deWalick et al. 2007; 
Lundie et al. 2008; Piva et al. 2012). The phenomena of decreasing frequencies of CD8α+ DCs 
in the spleen that we observed in our results, has also been observed during infection with P. 
chabaudi and was attributed to increased cell death by apoptosis (Sponaas et al. 2006). 
Although we observed varying expression of co-stimulatory molecules on cDCs between the 
ko and the WT, we presume that these differences did not play a critical role in Ag 
presentation. However, this is worth looking into in future experimens. Current experiments 
from our labs indicate that BMDCs from infected Ifnar1
-/-
 were indeed impaired in priming 
CD8
+
T cells, resulting in low production of IFNγ by antigen-specific T cells (Master’s thesis 
Johanna Scheunemann). In view of this, more detailed ex vivo assays need to be performed. In 
our experiments we analysed B cells as APCs and not as effector cells, as so far no effector 
role during ECM could be attributed to this cell type (Belnoue et al. 2002). In the full Ifnar ko 
mice, we observed decreased percentages but increased total numbers of B cell, this difference 
was due to the observed splenomegaly, however, we did not pursue this population any further. 
4.3 Type I IFN signalling was required for the emigration of effector cells from 
the spleen into the brain 
Whilst we demonstrated here that the cytotoxic functions of effector CD8
+
T cells were 
unimpaired, we also showed that the protection we observed was due to lack of cells 
infiltrating into the brain. This was apparently due to arrest/ retention of these in the spleens, 
contributing to the observed marked splenomegaly. Although we detected an increase in total 
cell numbers in all the cell population among the Ifnar ko, we considered that retention/ arrest 
of CD8
+
T cells occurred as the increase in this population resulted in alteration of the 
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CD4:CD8 ratio in the spleen and it is well-accepted that CD8
+
 T cells are primed in the spleen 
and emigrate to the brain to cause pathology in PbA-infected WT mice. 
Migration of T cells out of the priming site is dependent on chemokines, chemokine receptors, 
intergrins, activation marker CD69, adhesion molecules and sphingosine 1-phosphate receptor 
type 1(S1P1) among other signals (Sheridan & Lefrançois 2011). As CD8
+
T cells are the main 
effector cells, it was surprising to observe that the retained cells had a phenotype comparable to 
that of the infected WT. We confirmed that the retained cells were activated, Ag specific and 
cytotoxic. Secondly, we ruled out the possibility that the retention was mediated by differences 
in the CD8
+
T cell phenotype, as we observed comparable expression of activation markers 
(ICAM-1, CD11a and CTLA-4) among the CD8
+
T cells of the WT. We also confirmed the 
expression of the chemokine receptors CCR5 and CXCR3, which have been shown to be 
important for the recruitment of T cells from the spleen into the brain during ECM (Belnoue et 
al. 2003; Van den Steen et al. 2008). Moreover the mice that lacked the type I IFN receptor had 
more CXCR3
+
CD8
+
 T cells and CCR5
+
CD8
+
 T cells in their spleen in comparison to the 
infected WT mice. Importantly, the antigen specificity of these CD8
+
T cells, expression of 
cytotoxic granules granzyme B, increased expression of activation markers; ICAM-1, CD11a, 
CTLA-4 and increased expression of chemokine receptors CXCR3, CCR5 and CCR7 strongly 
indicate that these cells in the spleens of the ECM protected mice were competent and might 
have been capable of causing pathology if they had emigrated from the spleen into the brain. 
We therefore conclude that during PbA infection, type I IFN signalling on myeloid cells has a 
role in providing the crucial signal for the emigration of effector CD8
+
T cells from the spleen 
into the brain, and in the absence of the receptor, cells are retained/arrested in the spleen. 
Preliminary data of spleen immunohistochemistry indicated increase in size of the white pulp 
among the infected Ifnar1
-/-
 mice in comparison to the infected WT (Bachelor thesis Sarah 
Helow). More studies need to done to confirm whether this is active retention or the signal to 
emigrate is missing. 
4.4 Type I IFN signalling on macrophages and inflammatory monocytes is 
required for emigration of cells from the spleen during PbA infection. 
We show in our results a significant increase in the CD11b
+
 populations only among infected 
Ifnar1
-/-
 mice, with significant increase in both counts and percentages. When we analysed the 
composition of the CD11b
+
 population, we observed low percentages of Ly6C
hi
CCR2
+
 
inflammatory monocytes in the spleen of the mice deficient of Ifnar on all cells and specifically 
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on myeloid cells, however cDCs Ifnar ko mice had higher percentages of these cells. 
Inflammatory monocytes are recruited to sites of infection and contribute to the adoptive 
immune response (Shi & Pamer 2011). Recruitment of inflammatory monocytes to the site of 
inflammation is dependent but not limited to chemokines, chemokine receptors and adhesion 
molecules; CCL2, CCL3, CCL5, CCR2, CCR5, ICAM-1 and VCAM-1 (Shi and Pamer 2011). 
In P. chabaudi infection, Ly6C
hi
 monocytes recruited to the spleen were shown to have a role 
in parasite control (Sponaas et al. 2009).  
Although we observed lower percentages of Ly6C
hi
CCR2
+ 
inflammatory monocytes in  spleen 
samples of Ifnar1
-/-
 and LysM
Cre
Ifnar1
fl/fl
, the amounts of CCL2 were comparable to the 
infected WT mice. Moreover, type IFN signalling via Ifnar was shown not to be required for 
the recruitment of inflammatory monocytes into the spleen during L. monocytogenes infection 
(Jia et al. 2009). One possible explanation of the low numbers of inflammatory monocytes in 
the spleens of the ECM protected mice could be that these cells are recruited to the spleen in 
form of monocyte precursor cells, but differentiate into suppressive macrophages subsets, 
resulting in an increase of the alternatively activated macrophages (AAM) that were observed 
among the Ifnar ko mice and which was a major finding of this thesis. 
The presence of AAMs in the spleens of PbA-infected Ifnar1
-/-
 mice has not been shown 
before. This was also the first time that we observed a major difference in the composition of 
immune effector cells between the mice lacking Ifnar specifically on myeloid cell and the 
complete ko. The presence of AAM was completely unexpected due to two major reasons; 
first, ECM is a T-helper 1 driven disease and macrophages of WT C57BL/6 mice under 
inflammatory conditions are polarized to M-1 classical activated macrophages (Mills et al. 
2000). Secondly, considering that PbA-infection is an inflammatory disease, and the fact that 
we measured increased levels of M1 polarizing cytokines TNF and IFNγ in their spleens, we 
expected that the macrophages should ideally acquire an M1 phenotype. AAM are classified 
into M2a, 2b, 2c and 2d subclasses depending on the present stimulating signal, expressed 
genes, secreted cytokine and chemokines (Rőszer 2015). PbA-infected Ifnar1-/- mice had an 
M2a phenotype, demonstrated by the up-regulation of M2a hallmark genes Relmα/Fizz1, YM-1, 
arg-1 and and also functional protein = arginase-1 production by CD11b
+
 Cells. We also 
measured IL-4 production only among the Ifnar1
-/-
 mice, which is correlated to with M2a 
phenotype. We did not investigate the source of the IL-4, however, we can rule out the Th-2 
cells, as we did not detect presence of these cells in the spleen. One possible producer of the 
measured IL-4 could be type 2 lymphoid cells (ILC2), since it was recently shown that ECM 
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susceptible mice treated with recombinant IL-33 presented an ILC2 population capable of IL-4, 
IL-5 and IL-13 production that polarized macrophages to AAM and resulted in ECM 
protection (Besnard et al. 2015). Furthermore, eosinophils can also contribute to maintain 
AAMs as shown in the adipose tissue by production of IL-4 (Wu et al. 2011). 
During parasitic infections, M2a macrophages are found mostly in helminth infection and have 
a role in tissue healing and controlling inflammation (Kreider et al. 2007). The presence of 
AAM and the production of high volumes of arginase-1, Relm-α and IL-10 are apparently 
beneficial to the PbA infected mice Ifnar1
-/-
 mice, as these molecules have been shown to 
promote healing and suppress T cell activity (Murray & Wynn 2011; Rőszer 2015). Adoptive 
transfer of M2 macrophages into NOD mice was shown to prevent development of type I 
diabetes (Parsa et al. 2012). These M2 macrophages could therefore provide a balanced or 
neutralizing milieu and contribute to the observed protection of the PbA-infected mice from 
ECM.  
M1 macrophages and Th-1 cells can crosstalk via chemokines, cytokines and other signals, 
which then drive the disease to an inflammatory outcome. The Th-1 driven inflammatory cells 
and cytotoxic CD8
+
 T cells in the infected WT are continuously receiving M1 signals to exit 
the spleen and proceed to the brain. However, in the Ifnar1
-/- 
there are apparently mixed signals 
sent, with M2 macrophages providing anti-inflammatory signals associated with Th-2 to Th-1 
cells, which could be resulting in the retention/arrest of the effector cells in the spleen.  
The lack of M2a macrophages and low inflammatory monocytes in the spleens of the 
LysM
Cre
Ifnar1
fl/fl
 could have been due to a possibly different milieu resulting in polarized 
macrophages of another M2 (?) macrophage subtype. One possibility could be the M2d 
macrophage subtype, as we observed high levels of IL-6 as early as d+2 after infection, since 
IL-6 was shown to polarize macrophages to a M2d phenotype (Rőszer 2015). However, this is 
speculation and more experiments are needed to determine whether these cells had a different 
M2 phenotype, or whether they developed into regulatory macrophages (Mregs) or myeloid 
derived suppressor cells (MDSC). Mregs produce high levels of IL-10 and are immuno-
suppressive, they do not upregulate the M2a markers, YM1, Relmα nor do they produce 
arginase-1 (Fleming & Mosser 2011). MDSC are also immunosuppressive, they produce high 
amounts of IL-10, monocyte derived MDSC express iNOS while granulocyte derived MDSC 
produce arginase-1 (Talmadge & Gabrilovich 2013). Nonetheless, whether it is the presence of 
M2, Mreg or MDSC, these cells are probably all playing a role in retention/arrest of effector 
cells from entering the brain and causing severe form of disease. The immunosuppressive 
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macrophages might have contributed to the expansion of T-regs populations observed in the 
spleen of these mice which was higher than in the other infected mice but lower than the naive. 
M2 macrophages were shown to contribute to expansion of T-regs in mice treated with 
recombinant IL-33 (Besnard et al. 2015). As a proof of concept, we were able to restore ECM 
susceptibility by the adoptive transfer of CD11b
+
 cells from PbA-infected WT mice into PbA-
infected LysM
Cre
Ifnar1
fl/fl
 mice. By transferring these cells, we restored the required 
inflammatory signalling and inflammatory milieu required to drive the disease to an ECM 
outcome, confirming their central position in the pathology.  
4.5 Hypothesis of role of type I IFN signalling in ECM pathogenesis 
In viral infections, type I IFN signalling on myeloid cells was shown to have a protective role 
against murine coronavirus and West Nile virus (Cervantes-Barragan et al. 2009; Pinto et al. 
2014). Not only is the type I IFN receptor on myeloid cells required for protection during virus 
infection, a protective role during experimental autoimmune encephalomyelitis (EAE) was 
demonstrated in the mouse model for multiple sclerosis (Prinz et al. 2008). Furthermore, in 
West Nile viral infection, type I IFN signalling was shown to have a role in maintaining the 
integrity of the BBB (Pinto et al. 2014; Daniels et al. 2014). However, here we have 
demonstrated a detrimental role of type I IFN signalling on myeloid cells during PbA infection.  
It has been shown that type I IFN regulates CCL3/MIP1α production, which recruits NK cells 
to site of inflammation, these NK then produce CXCL9 at the site of infection (Salazar-Mather 
et al. 2002). NK cells are involved in recruitment of T cells into the brain in a CXCR3 
dependant manner resulting in ECM (Hansen et al. 2007) while Ly6C
hi
 inflammatory 
monocytes infiltrate into the brains earlier than other leukocytes (Pais & Chatterjee 2005; Pai et 
al. 2014), and had a role of recruitment of CD8
+
T cells, CD4
+
 T cells and NK cells (Schumak 
et al. 2015; Pai et al. 2014). In view of this, we hypothesize that one possibility by which the 
type I IFN signalling contributes to ECM pathology is by signalling via the Ifnar on the 
inflammatory monocytes and macrophages, resulting in the release of inflammatory cytokines, 
chemokines and other signals that probably enable the Ly6C
hi
 inflammatory monocytes to 
emigrate from the spleen into the brain. In the brain they release TNF, CCL3/MIP1α and other 
inflammatory mediators, which facilitates the recruitment of other leukocytes such as effector 
CD8
+
 T cells into the brain, resulting in ECM pathology. In absence of the receptor, the 
required inflammatory signal from monocytes and macrophages is missing, polarizing these 
cells an immunosuppressive phenotype and resulting in retention of cells in the spleen. 
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4.6 Malaria tolerance is driven by IL-10 via suppression of inflammatory 
responses 
In malaria endemic areas, older children and adults develop a form of natural acquired 
immunity to the disease, in which they are infected but do not develop severe forms of malaria 
(Langhorne et al. 2008). Using the ECM susceptible C57BL/6 WT mice, a malaria tolerance 
model was developed in our lab where mice were protected from ECM after infection with 
very high loads of parasites. The high parasite load resulted in dampening the immune 
response and in protection of mice from the deadly ECM outcome. Interestingly we found in 
the brain tissue of these experimentally infected mice the presence of CD8
+
T cells, Ly6C
hi
 
inflammatory monocytes and other leukocytes. Strikingly, these mice were protected from 
ECM and did not develop neurological symptoms. Importantly, these mice were able to 
recognise parasite specific antigen and lyse the cell in their spleens but showed strongly 
impaired IFNγ production.  
The presence of  CD8
+
T cells in the brain was shown to not necessarily result to pathology, as 
non-ECM Pb NK65 infected mice also contain T cells but do not develop ECM (Shaw et al. 
2015). However, the behaviour of the T cells and whether they get arrested determines whether 
ECM will develop (Shaw et al. 2015). In future experiments it would be an idea to observe 
how the few cells that we observed in the brains of the ECM protected mice interact with the 
endothelial cells by use of intravital microscopy (IVM). Through the use of IVM several 
insights have been described in the literature including; Ly6C
hi
 inflammatory monocytes are 
among the first cells to infiltrate the brain (Pai et al. 2014), perivascular arrest of CD8
+
 T cells 
occurred only in ECM positive mice (Shaw et al. 2015) and how the destruction of BBB 
occurred (Zhao et al. 2014; Hoffmann et al. 2016). 
In this tolerance model we also show how the parasite manipulated the host immune system, by 
completely blocking the production of IFNγ. The role of IFNγ has been shown to be required 
for ECM to develop, this was been demonstrated by its neutralization (Grau et al. 1989) and by 
receptor ko mice (Amani et al. 2000; Belnoue et al. 2008). Here we show that the high parasite 
dose was able to completely block IFNγ production and also partially suppress the Th-1 cell 
response, resulting in infected mice containing low amounts of T-bet expressing cells in their 
spleens, moreover, the expression of granzyme B by CD4
+
T cells was completely abrogated. 
Granzyme-B production by CD8
+
 T cells and NK cells were also significantly reduced in 
comparison to the low dose mice. 
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The high parasite load also resulted in suppressed expression of MHC class II of Ly6C
hi
 
inflammatory monocytes in the spleen, thereby indicating altered presentation capabilities. In 
Toxoplasmosis, inflammatory monocytes were shown to enhance Th-1 responses (Dunay et al. 
2008). Therefore, this low expression of MHC class II on Ly6C
hi
 inflammatory monocytes 
might have reduced their ability to prime CD4
+
T cells and hence the reduction in the Th-1 
population. Furthermore, we showed that the observed protection required IL-10 produced by 
myeloid cells and probably not by T-regs. We conclude that during high dose of infection, the 
parasite is successfully able to manipulate the host response by completely blocking IFNγ 
production and partially suppressing Th-1 response in the spleen. One possibility is that during 
high dose infection, the myeloid cells in the spleen are somehow stunned due to overwhelming 
PRR signalling and are unable to drive the disease to the inflammatory state required for ECM, 
instead produce IL-10 which creates a suppressive milieu. We were able to rule out the 
involvement of M2 macrophages in the suppressive phenotype acquired here, however more 
experiments need to be performed to determine whether other suppressive macrophage 
subpopulations were involved. 
4.7 Conclusion and relevance 
Taken together, the genetic ablation of a strong pro-inflammatory signalling pathway was 
sufficient to prevent brain inflammation, whereas parasite-specific immune responses in the 
periphery were un-impaired. Also in the malaria tolerance model, brain inflammation was 
attenuated, while peripheral immune responses were still generated. Hence, we were 
demonstrating two examples of successful immune regulation, one by the host and the second 
by the parasite. We would recommend more experiments to be done to establish whether the 
effector cells are actively retained in the spleen or the signal to emigrate is missing, and to try 
and establish what is that crucial signal required by these cells to exit the spleen. Analysis of 
the brain by histology and intravital microscopy would also be helpful in future experiments. 
The results from African children living in endemic areas have already provided evidence on 
the benefits of lacking type I IFN signalling, as the mutation of IFNaR resulted in their 
protection from severe forms of malaria (Aucan et al. 2003; Ball et al. 2013). To extrapolate 
from this mutations and our results, we would propose further investigation on cell specific 
blocking of the IFNaR and only temporarily, limiting it to the period of the disease as a way of 
preventing severe form of malaria. From our results we would also propose using of drugs that 
drive macrophages to suppressive phenotype also only during the disease phase.    
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